Acid	O
pH	O
activation	O
of	O
the	O
PmrA	B-Protein
/	O
PmrB	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
of	O
Salmonella	B-Organism
enterica	I-Organism

Acid	O
pH	O
often	O
triggers	O
changes	O
in	O
gene	O
expression	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
gene	O
products	O
that	O
sense	O
fluctuations	O
in	O
extracytoplasmic	O
pH	O
.	O

The	O
Gram	O
-	O
negative	O
pathogen	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
experiences	O
a	O
number	O
of	O
acidic	O
environments	O
both	O
inside	O
and	O
outside	O
animal	O
hosts	O
.	O

Growth	O
in	O
mild	O
acid	O
(	O
pH	O
5	O
.	O
8	O
)	O
promotes	O
transcription	O
of	O
genes	O
activated	O
by	O
the	O
response	O
regulator	O
PmrA	B-Protein
,	O
but	O
the	O
signalling	O
pathway	O
(	O
s	O
)	O
that	O
mediates	O
this	O
response	O
has	O
thus	O
far	O
remained	O
unexplored	O
.	O

Here	O
we	O
report	O
that	O
this	O
activation	O
requires	O
both	O
PmrA	B-Protein
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	B-Protein
,	O
which	O
had	O
been	O
previously	O
shown	O
to	O
respond	O
to	O
Fe3	B-Chemical
+	I-Chemical
and	O
Al3	B-Chemical
+	I-Chemical
,	O
and	O
PmrA	B-Protein
'	O
s	O
post	O
-	O
translational	O
activator	O
PmrD	B-Protein
.	O

Substitution	O
of	O
a	O
conserved	O
histidine	O
or	O
of	O
either	O
one	O
of	O
four	O
conserved	O
glutamic	O
acid	O
residues	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
severely	O
decreased	O
or	O
abolished	O
the	O
mild	O
acid	O
-	O
promoted	O
transcription	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
.	O

The	O
PmrA	B-Protein
/	O
PmrB	B-Protein
system	O
controls	O
lipopolysaccharide	B-Chemical
modifications	O
mediating	O
resistance	O
to	O
the	O
antibiotic	O
polymyxin	B-Chemical
B	I-Chemical
.	O

Wild	O
-	O
type	O
Salmonella	B-Organism
grown	O
at	O
pH	O
5	O
.	O
8	O
were	O
>	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	B-Chemical
B	I-Chemical
than	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
.	O

Our	O
results	O
suggest	O
that	O
protonation	O
of	O
the	O
PmrB	B-Protein
periplasmic	O
histidine	O
and	O
/	O
or	O
of	O
the	O
glutamic	O
acid	O
residues	O
activate	O
the	O
PmrA	B-Protein
protein	O
,	O
and	O
that	O
mild	O
acid	O
promotes	O
cellular	O
changes	O
resulting	O
in	O
polymyxin	B-Chemical
B	I-Chemical
resistance	O
.	O

Introduction	O

Free	O
-	O
living	O
organisms	O
often	O
encounter	O
wide	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Thus	O
,	O
pH	O
may	O
act	O
as	O
a	O
signal	O
that	O
triggers	O
cellular	O
responses	O
designed	O
to	O
cope	O
with	O
a	O
new	O
environment	O
.	O

The	O
Gram	O
-	O
negative	O
bacterium	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
,	O
for	O
example	O
,	O
experiences	O
a	O
number	O
of	O
acidic	O
environments	O
both	O
inside	O
and	O
outside	O
animal	O
hosts	O
.	O

During	O
infection	O
of	O
a	O
mammalian	O
host	O
,	O
Salmonella	B-Organism
is	O
exposed	O
to	O
severe	O
acidity	O
in	O
the	O
stomach	O
(	O
Rychlik	O
and	O
Barrow	O
,	O
2005	O
)	O
and	O
mild	O
acidification	O
in	O
the	O
endocytic	O
vacuoles	O
of	O
intestinal	O
epithelia	O
and	O
macrophages	O
(	O
Brumell	O
and	O
Grinstein	O
,	O
2004	O
)	O
.	O

Moreover	O
,	O
Salmonella	B-Organism
has	O
been	O
recovered	O
from	O
soil	O
and	O
water	O
(	O
Winfield	O
and	O
Groisman	O
,	O
2003	O
)	O
where	O
the	O
pH	O
can	O
be	O
significantly	O
low	O
.	O

While	O
growth	O
in	O
acidic	O
conditions	O
has	O
been	O
shown	O
to	O
promote	O
changes	O
in	O
the	O
gene	O
expression	O
profiles	O
of	O
several	O
bacterial	O
species	O
(	O
Tucker	O
et	O
al	O
.	O
,	O
2002	O
;	O
McGowan	O
et	O
al	O
.	O
,	O
2003	O
;	O
Weinrick	O
et	O
al	O
.	O
,	O
2004	O
;	O
Leaphart	O
et	O
al	O
.	O
,	O
2006	O
)	O
,	O
less	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecule	O
(	O
s	O
)	O
that	O
sense	O
extracytoplasmic	O
fluctuations	O
in	O
pH	O
and	O
the	O
mechanisms	O
by	O
which	O
such	O
sensors	O
promote	O
changes	O
in	O
gene	O
expression	O
.	O

Previous	O
studies	O
have	O
revealed	O
that	O
Salmonella	B-Organism
responds	O
to	O
acidic	O
challenges	O
through	O
an	O
adaptive	O
system	O
called	O
the	O
acid	O
tolerance	O
response	O
in	O
which	O
adaptation	O
to	O
mild	O
acid	O
conditions	O
enables	O
the	O
organism	O
to	O
survive	O
periods	O
of	O
severe	O
acid	O
stress	O
(	O
Foster	O
and	O
Hall	O
,	O
1990	O
;	O
Foster	O
,	O
1995	O
)	O
.	O

The	O
acid	O
tolerance	O
response	O
of	O
Salmonella	B-Organism
results	O
in	O
the	O
synthesis	O
of	O
over	O
50	O
acid	O
shock	O
proteins	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
that	O
are	O
likely	O
to	O
function	O
primarily	O
when	O
variations	O
in	O
internal	O
pH	O
occur	O
,	O
i	O
.	O
e	O
.	O
when	O
Salmonella	B-Organism
experiences	O
severe	O
acidic	O
conditions	O
(	O
pH	O
approximately3	O
)	O
(	O
Foster	O
,	O
2004	O
)	O
.	O

Growth	O
of	O
Salmonella	B-Organism
in	O
mild	O
acid	O
(	O
pH	O
5	O
.	O
8	O
)	O
also	O
promotes	O
transcription	O
of	O
genes	O
regulated	O
by	O
the	O
response	O
regulator	O
PmrA	B-Protein
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
.	O

The	O
expression	O
of	O
these	O
genes	O
has	O
been	O
shown	O
to	O
be	O
dispensable	O
for	O
the	O
acid	O
tolerance	O
response	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
which	O
suggests	O
that	O
there	O
are	O
still	O
uncharacterized	O
cellular	O
function	O
(	O
s	O
)	O
that	O
Salmonella	B-Organism
needs	O
to	O
regulate	O
in	O
acidic	O
environments	O
.	O

The	O
PmrA	B-Protein
protein	O
and	O
its	O
cognate	O
sensor	O
kinase	O
PmrB	B-Protein
form	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
is	O
required	O
for	O
virulence	O
in	O
mice	B-Organism
(	O
Gunn	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
infection	O
of	O
chicken	B-Organism
macrophages	O
(	O
Zhao	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
growth	O
in	O
soil	O
(	O
Chamnongpol	O
et	O
al	O
.	O
,	O
2002	O
)	O
,	O
resistance	O
to	O
the	O
cationic	O
peptide	O
antibiotic	O
polymyxin	B-Chemical
B	I-Chemical
(	O
Roland	O
et	O
al	O
.	O
,	O
1993	O
)	O
and	O
resistance	O
to	O
Fe3	B-Chemical
+	I-Chemical
-	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
and	O
Al3	B-Chemical
+	I-Chemical
-	O
mediated	O
killing	O
(	O
Nishino	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
PmrA	B-Protein
-	O
regulated	O
products	O
characterized	O
thus	O
far	O
mediate	O
modifications	O
to	O
the	O
various	O
components	O
of	O
the	O
lipopolysacharide	B-Chemical
(	O
LPS	B-Chemical
)	O
structure	O
including	O
the	O
lipid	B-Chemical
A	I-Chemical
(	O
Gunn	O
et	O
al	O
.	O
,	O
1998	O
;	O
Trent	O
et	O
al	O
.	O
,	O
2001	O
;	O
Zhou	O
et	O
al	O
.	O
,	O
2001	O
;	O
Breazeale	O
et	O
al	O
.	O
,	O
2003	O
;	O
Lee	O
et	O
al	O
.	O
,	O
2004	O
)	O
,	O
the	O
core	O
region	O
(	O
Nishino	O
et	O
al	O
.	O
,	O
2006	O
)	O
and	O
the	O
O	O
-	O
antigen	O
(	O
Delgado	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

While	O
other	O
PmrA	B-Protein
-	O
regulated	O
genes	O
have	O
been	O
identified	O
(	O
Marchal	O
et	O
al	O
.	O
,	O
2004	O
;	O
Tamayo	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
their	O
biochemical	O
activities	O
and	O
the	O
role	O
(	O
s	O
)	O
that	O
they	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
life	O
remain	O
unknown	O
.	O

Besides	O
mild	O
acid	O
pH	O
,	O
two	O
other	O
stimuli	O
are	O
known	O
to	O
promote	O
expression	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
:	O
(	O
i	O
)	O
submillimolar	O
levels	O
of	O
extracellular	O
Fe3	B-Chemical
+	I-Chemical
or	O
Al3	B-Chemical
+	I-Chemical
,	O
which	O
are	O
directly	O
sensed	O
by	O
the	O
PmrB	B-Protein
protein	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
and	O
(	O
ii	O
)	O
low	O
concentrations	O
of	O
extracellular	O
Mg2	B-Chemical
+	I-Chemical
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

The	O
low	O
Mg2	B-Chemical
+	I-Chemical
activation	O
of	O
the	O
PmrA	B-Protein
protein	O
requires	O
PhoQ	B-Protein
,	O
a	O
protein	O
that	O
senses	O
extracellular	O
Mg2	B-Chemical
+	I-Chemical
levels	O
(	O
Vescovi	O
et	O
al	O
.	O
,	O
1996	O
)	O
,	O
PhoQ	B-Protein
'	O
s	O
cognate	O
regulator	O
PhoP	B-Protein
,	O
and	O
the	O
PhoP	B-Protein
-	O
activated	O
protein	O
PmrD	B-Protein
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

PmrD	B-Protein
binds	O
to	O
the	O
phosphorylated	O
form	O
of	O
PmrA	B-Protein
protecting	O
it	O
from	O
dephosphorylation	O
by	O
PmrB	B-Protein
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Here	O
we	O
show	O
that	O
PmrA	B-Protein
'	O
s	O
cognate	O
sensor	O
kinase	O
PmrB	B-Protein
is	O
required	O
for	O
responding	O
to	O
external	O
changes	O
in	O
pH	O
through	O
a	O
mechanism	O
that	O
requires	O
a	O
histidine	O
and	O
several	O
glutamic	O
acid	O
residues	O
located	O
in	O
its	O
periplasmic	O
domain	O
,	O
as	O
well	O
as	O
the	O
post	O
-	O
translational	O
activator	O
PmrD	B-Protein
protein	O
.	O

Results	O

Mild	O
acid	O
pH	O
induces	O
transcription	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
To	O
examine	O
the	O
mild	O
acid	O
pH	O
induction	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
,	O
we	O
grew	O
Salmonella	B-Organism
cells	O
harbouring	O
chromosomal	O
lacZYA	B-Protein
transcriptional	O
fusions	O
to	O
the	O
PmrA	B-Protein
-	O
regulated	O
genes	O
pbgP	B-Protein
,	O
pmrC	B-Protein
and	O
ugd	B-Protein
(	O
Wosten	O
and	O
Groisman	O
,	O
1999	O
)	O
in	O
N	O
-	O
minimal	O
media	O
buffered	O
at	O
pH	O
5	O
.	O
8	O
or	O
7	O
.	O
7	O
.	O

This	O
medium	O
lacked	O
Fe3	B-Chemical
+	I-Chemical
or	O
Al3	B-Chemical
+	I-Chemical
,	O
the	O
only	O
known	O
PmrB	B-Protein
ligands	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
and	O
contained	O
10	O
mM	O
MgCl2	B-Chemical
,	O
which	O
represses	O
expression	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
;	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

All	O
three	O
genes	O
were	O
expressed	O
when	O
cells	O
were	O
grown	O
in	O
media	O
buffered	O
at	O
pH	O
5	O
.	O
8	O
but	O
not	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
,	O
in	O
agreement	O
with	O
previous	O
results	O
(	O
Soncini	O
and	O
Groisman	O
,	O
1996	O
)	O
.	O

A	O
similar	O
induction	O
of	O
pbgP	B-Protein
transcription	O
was	O
found	O
when	O
MES	B-Chemical
was	O
used	O
as	O
the	O
buffering	O
agent	O
in	O
the	O
media	O
at	O
pH	O
5	O
.	O
8	O
instead	O
of	O
Bis	B-Chemical
-	I-Chemical
Tris	I-Chemical
(	O
data	O
not	O
shown	O
)	O
,	O
indicating	O
that	O
the	O
mild	O
acid	O
effect	O
on	O
gene	O
expression	O
was	O
not	O
due	O
to	O
a	O
particular	O
buffering	O
system	O
.	O

The	O
transcriptional	O
activation	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
taking	O
place	O
at	O
pH	O
5	O
.	O
8	O
could	O
be	O
due	O
to	O
trace	O
amounts	O
of	O
metals	O
such	O
as	O
Fe3	B-Chemical
+	I-Chemical
,	O
which	O
is	O
more	O
soluble	O
at	O
acidic	O
pH	O
.	O

To	O
rule	O
out	O
this	O
possibility	O
,	O
we	O
treated	O
the	O
culture	O
medium	O
with	O
Chelex	B-Chemical
100	I-Chemical
resin	O
,	O
an	O
agent	O
known	O
to	O
chelate	O
polyvalent	O
metal	O
ions	O
that	O
does	O
not	O
affect	O
Salmonella	B-Organism
growth	O
.	O

We	O
determined	O
that	O
Chelex	B-Chemical
100	I-Chemical
was	O
effective	O
at	O
chelating	O
iron	B-Chemical
because	O
expression	O
of	O
the	O
pmrA	B-Protein
-	O
independent	O
iron	B-Chemical
-	O
repressed	O
iroA	B-Protein
gene	O
(	O
Hall	O
and	O
Foster	O
,	O
1996	O
)	O
was	O
induced	O
to	O
higher	O
levels	O
in	O
cultures	O
treated	O
with	O
Chelex	B-Chemical
100	I-Chemical
(	O
Fig	O
.	O
2D	O
)	O
.	O

Expression	O
of	O
pbgP	B-Protein
was	O
still	O
induced	O
when	O
Salmonella	B-Organism
was	O
grown	O
in	O
the	O
Chelex	B-Chemical
-	O
treated	O
medium	O
(	O
Fig	O
.	O
2D	O
)	O
or	O
in	O
media	O
containing	O
the	O
specific	O
Fe3	B-Chemical
+	I-Chemical
chelator	O
deferoxamine	B-Chemical
mesylate	I-Chemical
(	O
data	O
not	O
shown	O
)	O
supporting	O
the	O
notion	O
that	O
mild	O
acid	O
pH	O
is	O
responsible	O
for	O
the	O
observed	O
induction	O
.	O

We	O
determined	O
that	O
the	O
regulatory	O
protein	O
PmrA	B-Protein
is	O
required	O
for	O
the	O
transcriptional	O
activation	O
in	O
response	O
to	O
mild	O
acid	O
pH	O
because	O
there	O
was	O
no	O
induction	O
of	O
the	O
three	O
investigated	O
genes	O
in	O
a	O
pmrA	B-Protein
mutant	O
(	O
Fig	O
.	O
2A	O
-	O
C	O
)	O
.	O

Moreover	O
,	O
a	O
mutant	O
expressing	O
a	O
derivative	O
of	O
the	O
PmrA	B-Protein
protein	O
that	O
cannot	O
be	O
phosphorylated	O
due	O
to	O
substitution	O
of	O
the	O
putative	O
phosphorylation	O
residue	O
aspartate	O
51	O
by	O
alanine	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
completely	O
failed	O
to	O
promote	O
transcription	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
in	O
response	O
to	O
pH	O
5	O
.	O
8	O
,	O
in	O
a	O
similar	O
fashion	O
to	O
the	O
pmrA	B-Protein
strain	O
(	O
A	O
.	O
Kato	O
and	O
E	O
.	O
A	O
.	O
Groisman	O
,	O
unpubl	O
.	O
results	O
)	O
.	O

From	O
these	O
results	O
we	O
conclude	O
that	O
Salmonella	B-Organism
harbours	O
a	O
signalling	O
pathway	O
that	O
responds	O
to	O
mild	O
acid	O
pH	O
by	O
activating	O
the	O
PmrA	B-Protein
protein	O
through	O
phosphorylation	O
.	O

The	O
PmrB	B-Protein
protein	O
is	O
necessary	O
for	O
the	O
mild	O
acid	O
activation	O
of	O
PmrA	B-Protein

The	O
PmrB	B-Protein
protein	O
is	O
necessary	O
for	O
activation	O
of	O
the	O
PmrA	B-Protein
protein	O
in	O
low	O
Mg2	B-Chemical
+	I-Chemical
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
;	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
and	O
in	O
the	O
presence	O
of	O
Fe3	B-Chemical
+	I-Chemical
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
consistent	O
with	O
the	O
notion	O
that	O
PmrB	B-Protein
is	O
the	O
major	O
phosphodonor	O
for	O
PmrA	B-Protein
.	O

We	O
investigated	O
whether	O
PmrB	B-Protein
was	O
also	O
required	O
for	O
the	O
pH	O
-	O
dependent	O
induction	O
of	O
pbgP	B-Protein
,	O
which	O
was	O
chosen	O
as	O
a	O
prototypical	O
PmrA	B-Protein
-	O
activated	O
gene	O
because	O
the	O
PmrA	B-Protein
protein	O
binds	O
to	O
the	O
pbgP	B-Protein
promoter	O
in	O
vitro	O
(	O
Wosten	O
and	O
Groisman	O
,	O
1999	O
)	O
and	O
in	O
vivo	O
(	O
Shin	O
and	O
Groisman	O
,	O
2005	O
)	O
.	O

Thus	O
,	O
we	O
determined	O
the	O
beta	O
-	O
galactosidase	O
activity	O
of	O
isogenic	O
pmrB	B-Protein
strains	O
harbouring	O
a	O
chromosomal	O
pbgP	B-Protein
-	O
lac	O
transcriptional	O
fusion	O
:	O
expression	O
was	O
approximately	O
sixfold	O
lower	O
in	O
a	O
pmrB	B-Protein
mutant	O
than	O
in	O
the	O
pmrB	B-Protein
+	O
strain	O
following	O
growth	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
3	O
)	O
,	O
indicating	O
that	O
a	O
functional	O
pmrB	B-Protein
gene	O
is	O
necessary	O
for	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

There	O
was	O
residual	O
pbgP	B-Protein
expression	O
in	O
the	O
pmrB	B-Protein
mutant	O
induced	O
with	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
3	O
)	O
,	O
which	O
was	O
in	O
contrast	O
to	O
the	O
absence	O
of	O
pbgP	B-Protein
transcription	O
in	O
the	O
pmrA	B-Protein
mutant	O
(	O
Fig	O
.	O
2	O
)	O
.	O

This	O
suggested	O
that	O
PmrA	B-Protein
could	O
become	O
phosphorylated	O
from	O
another	O
phosphodonor	O
(	O
s	O
)	O
when	O
PmrB	B-Protein
is	O
not	O
present	O
.	O

We	O
considered	O
the	O
possibility	O
of	O
PmrA	B-Protein
being	O
phosphorylated	O
from	O
acetyl	B-Chemical
phosphate	I-Chemical
because	O
acetyl	B-Chemical
phosphate	I-Chemical
has	O
been	O
shown	O
to	O
serve	O
as	O
phosphoryl	O
donor	O
to	O
several	O
response	O
regulators	O
when	O
their	O
cognate	O
sensors	O
are	O
absent	O
(	O
see	O
Wolfe	O
,	O
2005	O
for	O
a	O
review	O
)	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
pbgP	B-Protein
transcription	O
was	O
abrogated	O
in	O
the	O
pmrB	B-Protein
mutant	O
upon	O
deletion	O
of	O
the	O
pta	B-Protein
and	O
ackA	B-Protein
genes	O
(	O
Fig	O
.	O
3	O
)	O
,	O
which	O
encode	O
the	O
two	O
enzymes	O
that	O
are	O
required	O
for	O
the	O
production	O
of	O
acetyl	B-Chemical
phosphate	I-Chemical
(	O
Wolfe	O
,	O
2005	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

In	O
contrast	O
,	O
a	O
strain	O
lacking	O
the	O
ability	O
to	O
synthesize	O
acetyl	B-Chemical
phosphate	I-Chemical
but	O
with	O
a	O
functional	O
pmrB	B-Protein
gene	O
exhibited	O
wild	O
-	O
type	O
pbgP	B-Protein
expression	O
levels	O
(	O
Fig	O
.	O
3	O
)	O
,	O
implying	O
that	O
under	O
normal	O
conditions	O
(	O
i	O
.	O
e	O
.	O
when	O
a	O
functional	O
pmrB	B-Protein
gene	O
is	O
present	O
)	O
acetyl	O
phosphate	O
does	O
not	O
contribute	O
to	O
PmrA	B-Protein
phosphorylation	O
.	O

The	O
PmrD	B-Protein
protein	O
is	O
necessary	O
for	O
normal	O
PmrA	B-Protein
activation	O
at	O
pH	O
5	O
.	O
8	O

The	O
PhoP	B-Protein
-	O
activated	O
PmrD	B-Protein
protein	O
favours	O
the	O
phosphorylated	O
state	O
of	O
the	O
PmrA	B-Protein
protein	O
(	O
Fig	O
.	O
1	O
)	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
.	O

Thus	O
,	O
we	O
tested	O
the	O
possibility	O
of	O
PmrD	B-Protein
participating	O
in	O
the	O
PmrA	B-Protein
-	O
dependent	O
response	O
to	O
acidic	O
conditions	O
,	O
and	O
thus	O
contributing	O
to	O
the	O
pbgP	B-Protein
transcription	O
remaining	O
in	O
a	O
pmrB	B-Protein
mutant	O
.	O

Expression	O
of	O
the	O
pbgP	B-Protein
gene	O
was	O
abolished	O
in	O
a	O
pmrB	B-Protein
pmrD	B-Protein
double	O
mutant	O
(	O
Fig	O
.	O
3	O
)	O
indicating	O
that	O
both	O
genes	O
are	O
necessary	O
to	O
activate	O
PmrA	B-Protein
under	O
acidic	O
conditions	O
.	O

In	O
contrast	O
to	O
the	O
phenotype	O
of	O
the	O
pta	B-Protein
ackA	B-Protein
double	O
mutant	O
,	O
pbgP	B-Protein
transcription	O
was	O
reduced	O
in	O
the	O
pmrD	B-Protein
mutant	O
(	O
Fig	O
.	O
3	O
)	O
.	O

These	O
results	O
imply	O
that	O
the	O
pmrD	B-Protein
gene	O
was	O
being	O
expressed	O
even	O
though	O
the	O
media	O
contained	O
10	O
mM	O
MgCl2	B-Chemical
,	O
a	O
concentration	O
known	O
to	O
repress	O
transcription	O
of	O
PhoP	B-Protein
-	O
activated	O
genes	O
(	O
Soncini	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

We	O
examined	O
transcription	O
of	O
the	O
pmrD	B-Protein
gene	O
using	O
RNA	O
isolated	O
from	O
organisms	O
grown	O
at	O
pH	O
5	O
.	O
8	O
or	O
7	O
.	O
7	O
.	O

Growth	O
at	O
pH	O
5	O
.	O
8	O
resulted	O
in	O
pmrD	B-Protein
transcript	O
levels	O
that	O
were	O
approximately3	O
.	O
5	O
-	O
fold	O
higher	O
than	O
in	O
organisms	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

This	O
acid	O
pH	O
-	O
promoted	O
increase	O
appears	O
to	O
be	O
specific	O
to	O
a	O
subset	O
of	O
PhoP	B-Protein
-	O
activated	O
genes	O
(	O
our	O
unpublished	O
results	O
)	O
that	O
includes	O
pmrD	B-Protein
because	O
expression	O
of	O
the	O
PhoP	B-Protein
-	O
regulated	O
slyA	B-Protein
gene	O
and	O
the	O
PhoP	B-Protein
-	O
independent	O
corA	B-Protein
gene	O
was	O
not	O
affected	O
by	O
the	O
pH	O
of	O
the	O
medium	O
(	O
Fig	O
.	O
4A	O
)	O
.	O

In	O
agreement	O
with	O
the	O
gene	O
transcription	O
data	O
,	O
Western	O
blot	O
analysis	O
of	O
crude	O
extracts	O
using	O
anti	O
-	O
PmrD	B-Protein
antibodies	O
showed	O
that	O
the	O
PmrD	B-Protein
protein	O
was	O
produced	O
in	O
cells	O
grown	O
in	O
N	O
-	O
minimal	O
medium	O
pH	O
5	O
.	O
8	O
and	O
10	O
mM	O
MgCl2	B-Chemical
but	O
not	O
in	O
cells	O
grown	O
in	O
the	O
same	O
medium	O
buffered	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

The	O
acid	O
-	O
promoted	O
expression	O
of	O
the	O
PmrD	B-Protein
protein	O
was	O
phoPQ	B-Protein
-	O
dependent	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
PhoP	B-Protein
is	O
the	O
only	O
known	O
direct	O
transcriptional	O
activator	O
of	O
pmrD	B-Protein
(	O
Kox	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

Conserved	O
histidine	O
and	O
glutamic	O
acid	O
residues	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
are	O
required	O
for	O
signalling	O
in	O
response	O
to	O
mild	O
acid	O
pH	O

The	O
results	O
described	O
above	O
established	O
that	O
PmrB	B-Protein
is	O
required	O
for	O
activation	O
of	O
PmrA	B-Protein
in	O
response	O
to	O
mild	O
acid	O
pH	O
.	O

This	O
could	O
be	O
because	O
PmrB	B-Protein
is	O
directly	O
involved	O
in	O
sensing	O
extracytoplasmic	O
pH	O
in	O
a	O
way	O
analogous	O
to	O
its	O
sensing	O
of	O
Fe3	B-Chemical
+	I-Chemical
and	O
Al3	B-Chemical
+	I-Chemical
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
or	O
because	O
PmrB	B-Protein
plays	O
an	O
indirect	O
role	O
in	O
its	O
capacity	O
of	O
main	O
(	O
if	O
not	O
sole	O
)	O
phosphodonor	O
for	O
PmrA	B-Protein
.	O

In	O
fact	O
,	O
PmrB	B-Protein
is	O
required	O
for	O
the	O
activation	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
in	O
response	O
to	O
the	O
low	O
Mg2	B-Chemical
+	I-Chemical
signal	O
,	O
which	O
is	O
sensed	O
by	O
the	O
PhoQ	B-Protein
protein	O
(	O
Kato	O
and	O
Groisman	O
,	O
2004	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
we	O
reasoned	O
that	O
if	O
PmrB	B-Protein
senses	O
extracytoplasmic	O
pH	O
directly	O
,	O
its	O
periplasmic	O
domain	O
(	O
Fig	O
.	O
5A	O
)	O
was	O
likely	O
to	O
be	O
required	O
for	O
the	O
response	O
to	O
this	O
signal	O
.	O

To	O
examine	O
this	O
hypothesis	O
,	O
we	O
tested	O
a	O
Salmonella	B-Organism
strain	O
with	O
a	O
chromosomal	O
pbgP	B-Protein
-	O
lac	O
fusion	O
,	O
deleted	O
for	O
the	O
chromosomal	O
copy	O
of	O
the	O
pmrB	B-Protein
gene	O
and	O
harbouring	O
a	O
plasmid	O
expressing	O
a	O
PmrB	B-Protein
protein	O
lacking	O
its	O
periplasmic	O
domain	O
for	O
its	O
ability	O
to	O
promote	O
pbgP	B-Protein
expression	O
in	O
response	O
to	O
different	O
signals	O
.	O

There	O
was	O
no	O
pbgP	B-Protein
expression	O
in	O
cells	O
grown	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
5B	O
)	O
or	O
in	O
the	O
presence	O
of	O
Fe3	B-Chemical
+	I-Chemical
(	O
Fig	O
.	O
5D	O
)	O
,	O
which	O
is	O
in	O
contrast	O
to	O
the	O
normal	O
activation	O
in	O
response	O
to	O
low	O
Mg2	B-Chemical
+	I-Chemical
(	O
Fig	O
.	O
5C	O
)	O
.	O

Together	O
,	O
these	O
results	O
argue	O
in	O
favour	O
of	O
the	O
notion	O
that	O
PmrB	B-Protein
senses	O
extracellular	O
pH	O
besides	O
its	O
previously	O
described	O
ligands	O
Fe3	B-Chemical
+	I-Chemical
and	O
Al3	B-Chemical
+	I-Chemical
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O

An	O
alignment	O
of	O
the	O
amino	O
acid	O
sequences	O
corresponding	O
to	O
the	O
putative	O
periplasmic	O
domain	O
of	O
the	O
PmrB	B-Protein
proteins	O
from	O
six	O
enteric	O
species	O
revealed	O
that	O
nine	O
residues	O
are	O
highly	O
conserved	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Interestingly	O
,	O
one	O
of	O
these	O
conserved	O
residues	O
was	O
a	O
histidine	O
at	O
position	O
35	O
.	O

Because	O
the	O
pKa	O
of	O
free	O
histidine	O
is	O
approximately6	O
,	O
the	O
pH	O
at	O
which	O
PmrA	B-Protein
-	O
activated	O
genes	O
are	O
induced	O
,	O
we	O
hypothesized	O
that	O
this	O
residue	O
might	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
constructed	O
a	O
plasmid	O
that	O
produced	O
a	O
PmrB	B-Protein
protein	O
containing	O
a	O
single	O
histidine	O
to	O
alanine	O
substitution	O
at	O
position	O
35	O
.	O

While	O
this	O
mutation	O
severely	O
diminished	O
the	O
ability	O
of	O
Salmonella	B-Organism
to	O
respond	O
to	O
mild	O
acid	O
pH	O
,	O
there	O
still	O
was	O
some	O
residual	O
pbgP	B-Protein
expression	O
(	O
Fig	O
.	O
6B	O
)	O
suggesting	O
that	O
other	O
residues	O
might	O
also	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

We	O
considered	O
the	O
possibility	O
that	O
a	O
second	O
histidine	O
at	O
position	O
57	O
could	O
be	O
involved	O
in	O
sensing	O
acid	O
despite	O
the	O
fact	O
that	O
this	O
residue	O
was	O
only	O
partially	O
conserved	O
across	O
species	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

However	O
,	O
the	O
substitution	O
of	O
this	O
residue	O
by	O
alanine	O
had	O
no	O
effect	O
on	O
the	O
response	O
to	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Four	O
of	O
the	O
nine	O
conserved	O
amino	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
are	O
glutamic	O
acid	O
residues	O
,	O
which	O
also	O
could	O
be	O
subjected	O
to	O
changes	O
in	O
protonation	O
upon	O
variations	O
in	O
the	O
pH	O
of	O
their	O
surroundings	O
.	O

Although	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
which	O
is	O
well	O
below	O
the	O
range	O
of	O
pH	O
at	O
which	O
PmrA	B-Protein
-	O
activated	O
genes	O
are	O
induced	O
,	O
the	O
folding	O
of	O
a	O
protein	O
can	O
dramatically	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
.	O

For	O
instance	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	B-Protein
is	O
approximately7	O
.	O
7	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
one	O
or	O
more	O
of	O
the	O
glutamates	O
might	O
be	O
required	O
for	O
pH	O
sensing	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
used	O
plasmids	O
that	O
produced	O
PmrB	B-Protein
proteins	O
containing	O
single	O
-	O
amino	O
-	O
acid	O
replacements	O
in	O
the	O
conserved	O
glutamic	O
acid	O
residues	O
.	O

When	O
either	O
one	O
of	O
the	O
four	O
conserved	O
glutamates	O
was	O
substituted	O
by	O
alanine	O
Salmonella	B-Organism
could	O
no	O
longer	O
respond	O
to	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

Strains	O
expressing	O
the	O
mutant	O
PmrB	B-Protein
proteins	O
could	O
express	O
pbgP	B-Protein
normally	O
in	O
response	O
to	O
the	O
low	O
Mg2	B-Chemical
+	I-Chemical
signal	O
(	O
Fig	O
.	O
6C	O
)	O
(	O
Wosten	O
et	O
al	O
.	O
,	O
2000	O
)	O
,	O
indicating	O
that	O
mutations	O
in	O
residues	O
of	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
do	O
not	O
impair	O
the	O
enzymatic	O
activity	O
of	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
PmrB	B-Protein
protein	O
.	O

These	O
results	O
indicate	O
that	O
the	O
periplasmic	O
glutamates	O
are	O
required	O
for	O
responding	O
to	O
mild	O
acid	O
pH	O
.	O

Mild	O
acid	O
pH	O
induces	O
resistance	O
to	O
the	O
antimicrobial	O
peptide	O
polymyxin	B-Chemical
B	I-Chemical

What	O
role	O
could	O
the	O
mild	O
acid	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
lifestyle	O
?	O

Because	O
the	O
PmrA	B-Protein
/	O
PmrB	B-Protein
system	O
is	O
required	O
for	O
resistance	O
to	O
the	O
antimicrobial	O
peptide	O
polymyxin	B-Chemical
B	I-Chemical
(	O
Roland	O
et	O
al	O
.	O
,	O
1993	O
)	O
,	O
we	O
hypothesized	O
that	O
mild	O
acid	O
pH	O
could	O
induce	O
this	O
resistance	O
.	O

In	O
fact	O
,	O
the	O
survival	O
of	O
wild	O
-	O
type	O
cells	O
to	O
a	O
challenge	O
with	O
polymyxin	B-Chemical
B	I-Chemical
was	O
100	O
000	O
-	O
fold	O
higher	O
when	O
they	O
were	O
grown	O
at	O
pH	O
5	O
.	O
8	O
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

This	O
resistance	O
was	O
PmrA	B-Protein
-	O
dependent	O
because	O
a	O
strain	O
deficient	O
in	O
the	O
pmrA	B-Protein
gene	O
was	O
approximately	O
100	O
000	O
-	O
fold	O
more	O
sensitive	O
to	O
polymyxin	B-Chemical
B	I-Chemical
than	O
the	O
wild	O
-	O
type	O
strain	O
when	O
grown	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Discussion	O

We	O
have	O
established	O
that	O
the	O
sensor	O
kinase	O
PmrB	B-Protein
is	O
the	O
primary	O
sensor	O
that	O
activates	O
the	O
PmrA	B-Protein
protein	O
when	O
Salmonella	B-Organism
experiences	O
mild	O
acid	O
pH	O
,	O
resulting	O
in	O
transcription	O
of	O
PmrA	B-Protein
-	O
activated	O
genes	O
(	O
Fig	O
.	O
1	O
)	O
.	O

That	O
PmrB	B-Protein
is	O
likely	O
to	O
sense	O
changes	O
in	O
pH	O
directly	O
is	O
supported	O
by	O
three	O
findings	O
:	O
(	O
i	O
)	O
the	O
mild	O
acid	O
pH	O
-	O
dependent	O
activation	O
of	O
the	O
PmrA	B-Protein
-	O
regulated	O
gene	O
pbgP	B-Protein
was	O
dramatically	O
reduced	O
in	O
a	O
strain	O
lacking	O
pmrB	B-Protein
(	O
Fig	O
.	O
3	O
)	O
,	O
(	O
ii	O
)	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
was	O
necessary	O
for	O
activation	O
of	O
pbgP	B-Protein
under	O
mild	O
acid	O
conditions	O
(	O
Fig	O
.	O
5	O
)	O
,	O
and	O
(	O
iii	O
)	O
single	O
amino	O
acid	O
substitutions	O
in	O
conserved	O
histidine	O
and	O
glutamic	O
acid	O
residues	O
located	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
abolished	O
its	O
ability	O
to	O
stimulate	O
pbgP	B-Protein
transcription	O
at	O
pH	O
5	O
.	O
8	O
(	O
Fig	O
.	O
6	O
)	O
.	O

The	O
periplasmic	O
histidine	O
and	O
glutamates	O
are	O
conserved	O
in	O
the	O
PmrB	B-Protein
periplasmic	O
domain	O
of	O
other	O
enteric	O
species	O
,	O
raising	O
the	O
possibility	O
that	O
the	O
signalling	O
pathway	O
described	O
in	O
this	O
article	O
may	O
be	O
operating	O
in	O
other	O
organisms	O
in	O
addition	O
to	O
S	B-Organism
.	I-Organism
enterica	I-Organism
.	O

The	O
requirement	O
of	O
periplasmic	O
PmrB	B-Protein
residues	O
in	O
the	O
mild	O
acid	O
pH	O
activation	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
suggests	O
that	O
this	O
signalling	O
pathway	O
responds	O
to	O
changes	O
in	O
extracytoplasmic	O
pH	O
.	O

Moreover	O
,	O
under	O
the	O
experimental	O
conditions	O
used	O
in	O
this	O
study	O
it	O
is	O
unlikely	O
that	O
the	O
cytoplasmic	O
pH	O
varied	O
significantly	O
because	O
:	O
first	O
,	O
bacterial	O
cells	O
can	O
maintain	O
an	O
internal	O
pH	O
of	O
up	O
to	O
2	O
units	O
higher	O
than	O
the	O
external	O
pH	O
(	O
Foster	O
,	O
2004	O
)	O
;	O
in	O
fact	O
,	O
Slonczewski	O
et	O
al	O
.	O

(	O
1981	O
)	O
determined	O
that	O
the	O
intracellular	O
pH	O
in	O
Escherichia	B-Organism
coli	I-Organism
cells	O
was	O
7	O
.	O
4	O
even	O
when	O
the	O
external	O
pH	O
was	O
5	O
.	O
5	O
.	O

Second	O
,	O
acid	O
stress	O
can	O
become	O
a	O
severe	O
challenge	O
for	O
bacterial	O
cells	O
when	O
organic	O
acids	O
such	O
as	O
acetate	B-Chemical
or	O
products	O
of	O
fermentation	O
are	O
present	O
in	O
the	O
medium	O
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
;	O
and	O
in	O
our	O
experiments	O
we	O
used	O
a	O
non	O
-	O
fermentable	O
sugar	O
(	O
glycerol	B-Chemical
)	O
and	O
inorganic	O
acids	O
which	O
are	O
not	O
expected	O
to	O
cause	O
such	O
acid	O
stress	O
.	O

Structural	O
changes	O
driven	O
by	O
a	O
relatively	O
narrow	O
variation	O
in	O
pH	O
(	O
1	O
-	O
2	O
units	O
)	O
have	O
been	O
reported	O
for	O
several	O
cytosolic	O
bacterial	O
proteins	O
(	O
Tews	O
et	O
al	O
.	O
,	O
2005	O
;	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
few	O
membrane	O
proteins	O
(	O
other	O
than	O
ion	O
channels	O
)	O
that	O
have	O
been	O
shown	O
to	O
respond	O
to	O
changes	O
in	O
extracellular	O
pH	O
of	O
a	O
similar	O
magnitude	O
.	O

For	O
example	O
,	O
the	O
eukaryotic	O
G	O
-	O
protein	O
coupled	O
receptor	O
OGR1	B-Protein
is	O
inactive	O
at	O
pH	O
7	O
.	O
8	O
and	O
fully	O
active	O
at	O
pH	O
6	O
.	O
8	O
suggesting	O
that	O
the	O
pH	O
sensing	O
mechanism	O
involves	O
protonation	O
of	O
several	O
extracytoplasmic	O
histidines	O
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
pKa	O
of	O
free	O
histidine	O
of	O
approximately6	O
.	O

In	O
the	O
case	O
of	O
PmrB	B-Protein
,	O
a	O
normal	O
response	O
to	O
mild	O
acid	O
pH	O
requires	O
not	O
only	O
a	O
periplasmic	O
histidine	O
but	O
also	O
several	O
glutamic	O
acid	O
residues	O
.	O

Therefore	O
,	O
regulation	O
of	O
PmrB	B-Protein
activity	O
may	O
involve	O
protonation	O
of	O
one	O
or	O
more	O
of	O
these	O
amino	O
acids	O
.	O

Even	O
though	O
protonation	O
of	O
the	O
glutamic	O
acid	O
residues	O
may	O
seem	O
unlikely	O
given	O
the	O
fact	O
that	O
the	O
pKa	O
of	O
free	O
glutamic	O
acid	O
is	O
approximately4	O
,	O
protein	O
folding	O
can	O
change	O
the	O
pKa	O
of	O
its	O
residues	O
(	O
Tanford	O
and	O
Roxby	O
,	O
1972	O
)	O
.	O

Indeed	O
,	O
the	O
pKa	O
of	O
one	O
of	O
the	O
glutamic	O
acid	O
residues	O
of	O
the	O
regulatory	O
protein	O
TraM	B-Protein
is	O
approximately7	O
.	O
7	O
in	O
the	O
folded	O
protein	O
(	O
Lu	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

Therefore	O
,	O
it	O
is	O
plausible	O
that	O
protonation	O
/	O
deprotonation	O
of	O
one	O
or	O
more	O
of	O
the	O
glutamic	O
acids	O
in	O
the	O
periplasmic	O
domain	O
of	O
PmrB	B-Protein
could	O
occur	O
at	O
pH	O
approximately5	O
.	O
8	O
.	O

Integral	O
membrane	O
proteins	O
that	O
recognize	O
signals	O
in	O
addition	O
to	O
extracytoplasmic	O
pH	O
,	O
such	O
as	O
PmrB	B-Protein
,	O
have	O
been	O
identified	O
both	O
in	O
prokaryotes	O
and	O
in	O
eukaryotes	O
.	O

The	O
CadC	B-Protein
protein	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
for	O
example	O
,	O
is	O
activated	O
by	O
exogenous	O
lysine	O
besides	O
acid	O
pH	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Likewise	O
,	O
the	O
human	B-Organism
receptor	O
OGR1	B-Protein
responds	O
to	O
both	O
pH	O
and	O
sphingosylphosphorylcholine	B-Chemical
(	O
Ludwig	O
et	O
al	O
.	O
,	O
2003	O
)	O
.	O

The	O
fact	O
that	O
the	O
PmrB	B-Protein
H35A	O
and	O
the	O
E64A	O
mutant	O
proteins	O
displayed	O
partial	O
activity	O
in	O
response	O
to	O
ferric	B-Chemical
iron	I-Chemical
but	O
were	O
severely	O
impaired	O
in	O
their	O
ability	O
to	O
respond	O
to	O
acid	O
pH	O
(	O
compare	O
Fig	O
.	O
6B	O
and	O
D	O
)	O
supports	O
the	O
notion	O
that	O
these	O
signals	O
are	O
sensed	O
independently	O
.	O

Similarly	O
,	O
cadC	B-Protein
mutants	O
have	O
been	O
isolated	O
that	O
are	O
impaired	O
in	O
the	O
ability	O
to	O
sense	O
only	O
one	O
of	O
its	O
two	O
inducing	O
signals	O
(	O
Dell	O
et	O
al	O
.	O
,	O
1994	O
)	O
.	O

Furthermore	O
,	O
the	O
ability	O
to	O
sense	O
two	O
different	O
compounds	O
has	O
also	O
recently	O
been	O
shown	O
to	O
be	O
genetically	O
distinguishable	O
in	O
the	O
bacterial	O
chemoreceptor	O
Tcp	B-Protein
(	O
Iwama	O
et	O
al	O
.	O
,	O
2006	O
)	O
.	O

The	O
PmrB	B-Protein
protein	O
plays	O
the	O
primary	O
role	O
in	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	B-Protein
,	O
but	O
full	O
activation	O
also	O
requires	O
PmrD	B-Protein
,	O
the	O
post	O
-	O
translational	O
activator	O
of	O
the	O
PmrA	B-Protein
protein	O
(	O
Fig	O
.	O
3	O
)	O
.	O

The	O
levels	O
of	O
phosphorylated	O
PmrA	B-Protein
are	O
determined	O
by	O
the	O
balance	O
of	O
the	O
autokinase	O
+	O
phosphotransferase	O
activity	O
of	O
PmrB	B-Protein
and	O
PmrB	B-Protein
'	O
s	O
phosphatase	O
activity	O
towards	O
phospho	O
-	O
PmrA	B-Protein
.	O

Thus	O
,	O
PmrD	B-Protein
may	O
be	O
necessary	O
to	O
ensure	O
that	O
the	O
amount	O
of	O
phosphorylated	O
PmrA	B-Protein
is	O
such	O
to	O
promote	O
transcription	O
of	O
its	O
regulated	O
genes	O
.	O

Consistent	O
with	O
its	O
role	O
in	O
acid	O
pH	O
activation	O
,	O
expression	O
of	O
the	O
pmrD	B-Protein
gene	O
was	O
promoted	O
in	O
media	O
of	O
mild	O
acid	O
pH	O
(	O
Fig	O
.	O
4	O
)	O
.	O

The	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
acid	O
pH	O
leads	O
to	O
an	O
increase	O
in	O
the	O
levels	O
of	O
the	O
pmrD	B-Protein
transcript	O
,	O
however	O
,	O
remains	O
unclear	O
.	O

Although	O
it	O
has	O
been	O
suggested	O
that	O
the	O
Salmonella	B-Organism
PhoQ	B-Protein
protein	O
senses	O
acid	O
pH	O
(	O
Aranda	O
et	O
al	O
.	O
,	O
1992	O
)	O
or	O
responds	O
to	O
both	O
pH	O
and	O
Mg2	B-Chemical
+	I-Chemical
(	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
a	O
direct	O
role	O
for	O
PhoQ	B-Protein
in	O
responding	O
to	O
acid	O
pH	O
appears	O
unlikely	O
because	O
not	O
all	O
PhoP	B-Protein
-	O
regulated	O
genes	O
are	O
activated	O
under	O
these	O
conditions	O
,	O
which	O
is	O
in	O
contrast	O
to	O
low	O
Mg2	B-Chemical
+	I-Chemical
activating	O
the	O
whole	O
PhoP	B-Protein
regulon	O
(	O
see	O
Groisman	O
and	O
Mouslim	O
,	O
2006	O
for	O
a	O
review	O
)	O
.	O

What	O
role	O
could	O
the	O
pH	O
-	O
dependent	O
activation	O
of	O
PmrA	B-Protein
-	O
regulated	O
genes	O
play	O
in	O
Salmonella	B-Organism
'	O
s	O
lifestyle	O
?	O

Because	O
several	O
PmrA	B-Protein
-	O
activated	O
gene	O
products	O
are	O
responsible	O
for	O
remodelling	O
the	O
LPS	B-Chemical
structure	O
and	O
these	O
modifications	O
are	O
required	O
for	O
resistance	O
to	O
certain	O
antimicrobial	O
peptides	O
and	O
toxic	O
metals	O
,	O
one	O
possibility	O
is	O
that	O
acidic	O
environments	O
provide	O
a	O
means	O
to	O
induce	O
the	O
cell	O
envelope	O
changes	O
resulting	O
in	O
resistance	O
.	O

Indeed	O
,	O
when	O
grown	O
at	O
pH	O
5	O
.	O
8	O
wild	O
-	O
type	O
Salmonella	B-Organism
were	O
100	O
000	O
-	O
fold	O
more	O
resistant	O
to	O
polymyxin	B-Chemical
B	I-Chemical
than	O
when	O
grown	O
at	O
pH	O
7	O
.	O
7	O
(	O
Fig	O
.	O
7	O
)	O
.	O

This	O
may	O
be	O
particularly	O
important	O
for	O
Salmonella	B-Organism
living	O
in	O
soil	O
due	O
to	O
the	O
fact	O
that	O
the	O
antimicrobial	O
peptide	O
polymyxin	B-Chemical
B	I-Chemical
is	O
produced	O
by	O
the	O
soil	O
bacterium	O
Paenibacillus	B-Organism
polymyxa	I-Organism
(	O
Paulus	O
and	O
Gray	O
,	O
1964	O
)	O
and	O
because	O
the	O
solubility	O
of	O
metals	O
such	O
as	O
Fe3	B-Chemical
+	I-Chemical
increases	O
in	O
acid	O
pH	O
.	O

On	O
the	O
other	O
hand	O
,	O
although	O
mild	O
acid	O
(	O
pH	O
6	O
.	O
0	O
)	O
per	O
se	O
,	O
i	O
.	O
e	O
.	O
even	O
in	O
the	O
presence	O
of	O
high	O
Mg2	B-Chemical
+	I-Chemical
,	O
promotes	O
LPS	B-Chemical
modifications	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
,	O
the	O
low	O
pH	O
signal	O
may	O
also	O
act	O
synergistically	O
with	O
the	O
low	O
Mg2	B-Chemical
+	I-Chemical
signal	O
in	O
vivo	O
because	O
Mg2	B-Chemical
+	I-Chemical
deprivation	O
alone	O
is	O
not	O
sufficient	O
to	O
provide	O
all	O
the	O
LPS	B-Chemical
modifications	O
seen	O
in	O
Salmonella	B-Organism
when	O
present	O
inside	O
macrophages	O
(	O
Gibbons	O
et	O
al	O
.	O
,	O
2005	O
)	O
.	O

Finally	O
,	O
while	O
a	O
role	O
for	O
the	O
PmrA	B-Protein
-	O
dependent	O
LPS	B-Chemical
modifications	O
in	O
the	O
previously	O
described	O
acid	O
tolerance	O
response	O
is	O
unlikely	O
because	O
survival	O
to	O
acid	O
stress	O
(	O
pH	O
approximately3	O
)	O
was	O
not	O
reduced	O
in	O
cells	O
deficient	O
in	O
pmrA	B-Protein
(	O
data	O
not	O
shown	O
and	O
Bearson	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
some	O
of	O
the	O
PmrA	B-Protein
-	O
regulated	O
genes	O
to	O
which	O
no	O
function	O
has	O
been	O
ascribed	O
yet	O
could	O
mediate	O
other	O
cellular	O
responses	O
to	O
acid	O
pH	O
.	O

Mlc	B-Protein
regulation	O
of	O
Salmonella	B-Organism
pathogenicity	O
island	O
I	O
gene	O
expression	O
via	O
hilE	B-Protein
repression	O

The	O
global	O
regulator	O
Mlc	B-Protein
is	O
a	O
repressor	O
of	O
several	O
genes	O
and	O
operons	O
that	O
are	O
involved	O
in	O
sugar	O
uptake	O
and	O
metabolism	O
.	O

A	O
Salmonella	O
enterica	O
serovar	O
Typhimurium	O
mlc	B-Protein
mutant	O
showed	O
reduced	O
levels	O
of	O
invasion	O
and	O
cytotoxicity	O
compared	O
to	O
the	O
wild	O
-	O
type	O
,	O
and	O
exhibited	O
reduced	O
expression	O
levels	O
of	O
hilD	B-Protein
,	O
hilA	B-Protein
and	O
invF	B-Protein
,	O
which	O
are	O
regulatory	O
genes	O
in	O
the	O
Salmonella	B-Organism
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
.	O

However	O
,	O
the	O
effects	O
of	O
Mlc	B-Protein
on	O
hilD	B-Protein
expression	O
and	O
bacterial	O
invasiveness	O
were	O
not	O
seen	O
in	O
the	O
hilE	B-Protein
mutant	O
,	O
and	O
hilE	B-Protein
expression	O
was	O
increased	O
in	O
the	O
mlc	B-Protein
mutant	O
,	O
which	O
suggests	O
that	O
Mlc	B-Protein
exerts	O
positive	O
effects	O
on	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
reducing	O
the	O
expression	O
of	O
HilE	B-Protein
,	O
which	O
is	O
known	O
to	O
down	O
-	O
regulate	O
the	O
expression	O
of	O
SPI1	O
genes	O
through	O
direct	O
interaction	O
with	O
HilD	B-Protein
.	O

We	O
found	O
that	O
the	O
two	O
known	O
promoters	O
of	O
hilE	B-Protein
were	O
not	O
modulated	O
by	O
Mlc	B-Protein
,	O
and	O
we	O
identified	O
a	O
third	O
promoter	O
,	O
designated	O
P3	O
,	O
which	O
was	O
repressed	O
by	O
Mlc	B-Protein
.	O

The	O
gel	O
mobility	O
shift	O
assay	O
and	O
footprinting	O
analysis	O
revealed	O
that	O
Mlc	B-Protein
repressed	O
hilE	B-Protein
in	O
a	O
direct	O
manner	O
by	O
binding	O
to	O
two	O
distinct	O
sites	O
in	O
the	O
hilE	B-Protein
P3	O
promoter	O
region	O
.	O

The	O
specific	O
down	O
-	O
regulation	O
of	O
hilD	B-Protein
observed	O
in	O
the	O
presence	O
of	O
Mlc	B-Protein
regulon	O
-	O
inducible	O
sugars	O
,	O
such	O
as	O
glucose	B-Chemical
and	O
mannose	B-Chemical
,	O
could	O
not	O
be	O
detected	O
in	O
the	O
mlc	B-Protein
mutant	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
propose	O
that	O
Mlc	B-Protein
functions	O
to	O
sense	O
the	O
availability	O
of	O
sugars	O
and	O
is	O
linked	O
to	O
virulence	O
gene	O
regulation	O
by	O
its	O
ability	O
to	O
control	O
hilE	B-Protein
expression	O
in	O
Salmonella	B-Organism
.	O

INTRODUCTION	O

Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
is	O
a	O
facultative	O
intracellular	O
pathogen	O
that	O
initiates	O
disease	O
,	O
which	O
is	O
normally	O
limited	O
to	O
gastroenteritis	O
in	O
humans	B-Organism
.	O

However	O
,	O
this	O
bacterium	O
causes	O
systemic	O
disease	O
in	O
mice	B-Organism
and	O
has	O
been	O
used	O
as	O
an	O
animal	O
model	O
of	O
typhoid	O
fever	O
.	O

Since	O
Salmonella	B-Organism
is	O
acquired	O
usually	O
by	O
oral	O
ingestion	O
of	O
contaminated	O
materials	O
,	O
a	O
key	O
step	O
in	O
the	O
infection	O
process	O
is	O
passage	O
across	O
the	O
intestinal	O
epithelium	O
by	O
invasion	O
of	O
M	O
cells	O
in	O
Peyer	O
'	O
s	O
patches	O
(	O
1	O
)	O
.	O

Many	O
of	O
the	O
genes	O
required	O
for	O
intestinal	O
penetration	O
and	O
invasion	O
of	O
host	O
cells	O
are	O
carried	O
on	O
the	O
40	O
-	O
kb	O
region	O
at	O
centisome	O
63	O
,	O
which	O
is	O
called	O
Salmonella	B-Organism
pathogenicity	O
island	O
1	O
(	O
SPI1	O
)	O
(	O
2	O
)	O
.	O

SPI1	O
contains	O
at	O
least	O
37	O
genes	O
,	O
which	O
encode	O
various	O
components	O
of	O
the	O
type	O
III	O
secretion	O
systems	O
(	O
T3SSs	O
)	O
,	O
its	O
regulators	O
and	O
its	O
secreted	O
effectors	O
(	O
3	O
)	O
.	O

The	O
effector	O
proteins	O
mediate	O
actin	O
cytoskeleton	O
rearrangement	O
,	O
in	O
the	O
form	O
of	O
large	O
membrane	O
ruffles	O
,	O
which	O
engulf	O
the	O
bacteria	O
into	O
the	O
host	O
cell	O
(	O
4	O
,	O
5	O
)	O
.	O

The	O
expression	O
of	O
SPI1	O
is	O
controlled	O
in	O
response	O
to	O
a	O
specific	O
combination	O
of	O
environmental	O
signals	O
,	O
including	O
pH	O
,	O
oxygen	B-Chemical
tension	O
,	O
medium	O
osmolarity	O
,	O
bile	O
,	O
Mg2	B-Chemical
+	I-Chemical
concentration	O
,	O
short	O
-	O
chain	O
fatty	O
acids	O
(	O
SCFAS	O
)	O
,	O
and	O
growth	O
stage	O
of	O
the	O
bacteria	O
(	O
3	O
,	O
6	O
)	O
.	O

Although	O
many	O
factors	O
and	O
a	O
complex	O
mechanism	O
related	O
to	O
environmental	O
stimuli	O
are	O
involved	O
in	O
the	O
modulation	O
of	O
SPI1	O
genes	O
,	O
they	O
are	O
thought	O
to	O
converge	O
on	O
the	O
activation	O
of	O
several	O
transcriptional	O
regulators	O
encoded	O
within	O
SPI1	O
,	O
such	O
as	O
HilA	B-Protein
,	O
HilC	B-Protein
,	O
HilD	B-Protein
and	O
InvF	B-Protein
(	O
7	O
-	O
9	O
)	O
.	O

HilA	B-Protein
plays	O
a	O
crucial	O
role	O
in	O
the	O
expression	O
of	O
genes	O
that	O
encode	O
the	O
SPI1	O
-	O
T3SS	O
apparatus	O
,	O
the	O
prg	B-Regulon-operon
and	O
inv	B-Regulon-operon
/	I-Regulon-operon
spa	I-Regulon-operon
operons	O
,	O
by	O
binding	O
upstream	O
of	O
prgH	B-Protein
and	O
invF	B-Protein
(	O
10	O
)	O
.	O

The	O
expression	O
of	O
invF	B-Protein
leads	O
to	O
the	O
induction	O
of	O
several	O
effector	O
genes	O
encoded	O
both	O
within	O
SPI1	O
(	O
sic	B-Regulon-operon
/	I-Regulon-operon
sip	I-Regulon-operon
operon	O
)	O
and	O
outside	O
SPI1	O
(	O
sigD	B-Protein
/	O
sopB	B-Protein
and	O
sopE	B-Protein
)	O
,	O
with	O
SicA	B-Protein
as	O
a	O
co	O
-	O
factor	O
(	O
11	O
)	O
.	O

HilC	B-Protein
and	O
HilD	B-Protein
,	O
which	O
are	O
members	O
of	O
the	O
AraC	B-Protein
/	O
XylS	B-Protein
family	O
,	O
have	O
been	O
postulated	O
to	O
act	O
as	O
a	O
derepressor	O
of	O
hilA	B-Protein
expression	O
by	O
counteracting	O
the	O
action	O
of	O
negative	O
regulatory	O
elements	O
at	O
the	O
hilA	B-Protein
promoter	O
(	O
12	O
,	O
13	O
)	O
.	O

However	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilD	B-Protein
provides	O
an	O
essential	O
activating	O
function	O
for	O
hilA	B-Protein
in	O
the	O
absence	O
of	O
negative	O
regulators	O
(	O
14	O
)	O
.	O

HilC	B-Protein
and	O
HilD	B-Protein
also	O
directly	O
activate	O
the	O
alternative	O
promoter	O
of	O
the	O
invF	B-Protein
operon	O
,	O
which	O
is	O
independent	O
of	O
HilA	B-Protein
(	O
15	O
,	O
16	O
)	O
.	O

Similar	O
to	O
HilC	B-Protein
and	O
HilD	B-Protein
,	O
RtsA	B-Protein
activates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
binding	O
upstream	O
of	O
the	O
master	O
regulatory	O
gene	O
,	O
hilA	B-Protein
,	O
to	O
induce	O
its	O
expression	O
(	O
9	O
,	O
17	O
)	O
.	O

Recently	O
,	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
shown	O
that	O
HilE	B-Protein
is	O
an	O
important	O
Salmonella	B-Organism
-	O
specific	O
regulator	O
of	O
hilA	B-Protein
expression	O
.	O

A	O
null	O
mutation	O
in	O
hilE	B-Protein
causes	O
an	O
increase	O
in	O
hilA	B-Protein
expression	O
and	O
invasion	O
.	O

Using	O
two	O
-	O
hybrid	O
analysis	O
,	O
it	O
has	O
been	O
shown	O
that	O
HilE	B-Protein
interacts	O
with	O
HilD	B-Protein
,	O
which	O
suggests	O
that	O
HilE	B-Protein
represses	O
hilA	B-Protein
expression	O
by	O
inhibiting	O
the	O
activity	O
of	O
HilD	B-Protein
through	O
a	O
protein	O
-	O
protein	O
interaction	O
(	O
19	O
,	O
20	O
)	O
.	O

Several	O
other	O
genes	O
have	O
been	O
identified	O
that	O
exert	O
positive	O
or	O
negative	O
effects	O
on	O
these	O
direct	O
regulators	O
of	O
SPI1	O
in	O
response	O
to	O
the	O
changes	O
in	O
environmental	O
conditions	O
.	O

These	O
genes	O
include	O
those	O
that	O
encode	O
several	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
PhoP	B-Protein
/	O
Q	B-Protein
,	O
PhoBR	B-Protein
,	O
OmpR	B-Protein
/	O
EnvZ	B-Protein
and	O
SirA	B-Protein
/	O
BarA	B-Protein
)	O
,	O
post	O
-	O
transcriptional	O
systems	O
(	O
CsrAB	B-Protein
,	O
RNase	B-Protein
E	I-Protein
,	O
PNPase	B-Protein
and	O
Lon	B-Protein
)	O
,	O
nucleoid	O
proteins	O
(	O
HU	B-Protein
,	O
FIS	B-Protein
,	O
H	B-Protein
-	I-Protein
NS	I-Protein
and	O
Hha	B-Protein
)	O
,	O
signaling	O
molecules	O
(	O
ppGpp	B-Chemical
and	O
NpnN	B-Chemical
)	O
,	O
and	O
other	O
regulatory	O
proteins	O
(	O
FliZ	B-Protein
,	O
FadD	B-Protein
and	O
CpxA	B-Protein
)	O
(	O
6	O
,	O
7	O
,	O
19	O
,	O
21	O
,	O
22	O
)	O
.	O

The	O
phosphoenolpyruvate	B-Chemical
:	O
sugar	O
phosphotransferase	O
system	O
(	O
PTS	O
)	O
is	O
the	O
major	O
sugar	O
transport	O
system	O
in	O
many	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacterial	O
species	O
.	O

In	O
the	O
animal	O
model	O
,	O
attenuation	O
of	O
virulence	O
has	O
been	O
noted	O
for	O
Salmonella	B-Organism
strains	O
that	O
carry	O
mutations	O
in	O
the	O
pts	B-Protein
,	O
crr	B-Protein
,	O
cya	B-Protein
or	O
crp	B-Protein
genes	O
,	O
which	O
encode	O
the	O
general	O
energy	O
-	O
coupling	O
enzymes	O
of	O
the	O
PTS	O
,	O
enzyme	O
IIAGlc	B-Protein
of	O
the	O
PTS	O
,	O
adenylate	B-Protein
cyclase	I-Protein
and	O
cyclic	B-Protein
AMP	I-Protein
receptor	I-Protein
protein	I-Protein
,	O
respectively	O
(	O
23	O
,	O
24	O
)	O
.	O

Mlc	B-Protein
is	O
a	O
global	O
regulator	O
of	O
carbohydrate	O
metabolism	O
and	O
controls	O
several	O
genes	O
involved	O
in	O
sugar	O
utilization	O
(	O
25	O
-	O
27	O
)	O
.	O

Therefore	O
,	O
it	O
seemed	O
possible	O
that	O
Mlc	B-Protein
also	O
affects	O
the	O
virulence	O
of	O
Salmonella	B-Organism
.	O

In	O
the	O
present	O
study	O
,	O
a	O
Salmonella	O
Typhimurium	O
mlc	B-Protein
mutant	O
was	O
constructed	O
to	O
investigate	O
the	O
contribution	O
of	O
Mlc	B-Protein
to	O
the	O
virulence	O
phenotype	O
.	O

We	O
have	O
found	O
that	O
Mlc	B-Protein
activates	O
SPI1	O
gene	O
expression	O
by	O
repressing	O
hilE	B-Protein
expression	O
.	O

RESULTS	O

Mutation	O
of	O
the	O
mlc	B-Protein
gene	O
reduces	O
Salmonella	B-Organism
invasiveness	O
The	O
process	O
of	O
invasion	O
into	O
non	O
-	O
phagocytic	O
epithelial	O
cells	O
,	O
which	O
is	O
known	O
to	O
be	O
mediated	O
by	O
proteins	O
secreted	O
by	O
the	O
SPI1	O
-	O
encoded	O
type	O
III	O
machinery	O
(	O
3	O
)	O
,	O
is	O
an	O
important	O
initial	O
step	O
in	O
the	O
pathogenesis	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
.	O

We	O
examined	O
the	O
ability	O
of	O
an	O
mlc	B-Protein
mutant	O
,	O
SR1304	B-Organism
,	O
to	O
invade	O
cultured	O
HEp	B-Organism
-	I-Organism
2	I-Organism
and	O
HeLa	O
epithelial	O
cells	O
.	O

SL1344	B-Organism
was	O
used	O
as	O
the	O
control	O
strain	O
,	O
and	O
the	O
invasiveness	O
of	O
this	O
strain	O
was	O
arbitrarily	O
set	O
at	O
100	O
%	O
.	O

When	O
the	O
Salmonella	B-Organism
bacteria	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
the	O
exponential	O
phase	O
(	O
SPI1	O
-	O
inducing	O
condition	O
)	O
,	O
the	O
invasiveness	O
of	O
SR1304	B-Organism
for	O
both	O
epithelial	O
cell	O
lines	O
was	O
reduced	O
by	O
about	O
3	O
-	O
fold	O
,	O
compared	O
to	O
that	O
of	O
SL1344	B-Organism
(	O
Figure	O
1A	O
and	O
B	O
)	O
.	O

S	B-Organism
.	I-Organism

Typhimurium	B-Organism
induces	O
the	O
apoptosis	O
of	O
infected	O
macrophages	O
.	O

This	O
process	O
is	O
rapid	O
,	O
specific	O
and	O
depends	O
on	O
the	O
T3SS	O
encoded	O
within	O
SPI1	O
(	O
33	O
,	O
34	O
)	O
.	O

To	O
discover	O
whether	O
the	O
mlc	B-Protein
mutant	O
grown	O
under	O
the	O
SPI1	O
-	O
inducing	O
condition	O
affects	O
the	O
capacity	O
to	O
induce	O
apoptosis	O
in	O
macrophages	O
,	O
the	O
release	O
of	O
the	O
cytoplasmic	O
enzyme	O
LDH	O
was	O
determined	O
in	O
a	O
cytotoxicity	O
assay	O
(	O
33	O
)	O
.	O

Figure	O
1C	O
shows	O
that	O
SL1344	B-Organism
killed	O
42	O
%	O
of	O
the	O
macrophages	O
,	O
whereas	O
SR1304	B-Organism
killed	O
only	O
16	O
%	O
of	O
the	O
macrophages	O
4h	O
after	O
infection	O
,	O
which	O
demonstrates	O
that	O
the	O
mlc	B-Protein
gene	O
plays	O
an	O
important	O
role	O
in	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
cytotoxicity	O
.	O

We	O
also	O
tested	O
the	O
effect	O
of	O
the	O
mlc	B-Protein
mutation	O
on	O
the	O
ability	O
to	O
replicate	O
within	O
the	O
RAW264	O
.	O
7	O
macrophage	O
cell	O
line	O
.	O

After	O
cultivation	O
to	O
the	O
stationary	O
phase	O
with	O
aeration	O
,	O
the	O
bacteria	O
were	O
opsonized	O
with	O
10	O
%	O
normal	O
mouse	B-Organism
serum	O
and	O
added	O
to	O
the	O
cell	O
monolayer	O
(	O
30	O
)	O
.	O

When	O
the	O
number	O
of	O
intracellular	O
bacteria	O
were	O
measured	O
at	O
2	O
and	O
18h	O
post	O
-	O
infection	O
,	O
the	O
degree	O
of	O
replication	O
was	O
similar	O
for	O
SL1344	B-Organism
and	O
SR1304	B-Organism
(	O
Figure	O
1D	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
main	O
target	O
of	O
Mlc	B-Protein
action	O
in	O
Salmonella	B-Organism
virulence	O
is	O
SPI1	O
,	O
which	O
is	O
known	O
to	O
encode	O
various	O
genes	O
that	O
are	O
required	O
for	O
Salmonella	B-Organism
invasion	O
of	O
host	O
cells	O
.	O

The	O
expression	O
levels	O
of	O
hilA	B-Protein
,	O
invF	B-Protein
and	O
hilD	B-Protein
,	O
but	O
not	O
of	O
hilC	B-Protein
,	O
are	O
decreased	O
in	O
the	O
mlc	B-Protein
mutant	O

To	O
identify	O
the	O
target	O
gene	O
in	O
SPI1	O
that	O
is	O
regulated	O
by	O
Mlc	B-Protein
,	O
the	O
expression	O
patterns	O
of	O
the	O
SPI1	O
-	O
regulatory	O
genes	O
,	O
which	O
include	O
hilA	B-Protein
,	O
invF	B-Protein
,	O
hilC	B-Protein
and	O
hilD	B-Protein
,	O
were	O
examined	O
by	O
primer	O
extension	O
analysis	O
of	O
total	O
RNA	O
from	O
SL1344	B-Organism
and	O
SR1304	B-Organism
grown	O
statically	O
to	O
the	O
exponential	O
phase	O
.	O

The	O
transcriptional	O
start	O
sites	O
of	O
these	O
genes	O
have	O
been	O
reported	O
previously	O
(	O
12	O
,	O
16	O
,	O
35	O
,	O
36	O
)	O
.	O

SR1304	B-Organism
exhibited	O
a	O
>	O
10	O
-	O
fold	O
reduction	O
in	O
hilA	B-Protein
and	O
HilA	B-Protein
-	O
dependent	O
invF	B-Protein
(	O
invFA	B-Protein
)	O
expression	O
,	O
and	O
about	O
a	O
3	O
-	O
fold	O
reduction	O
in	O
hilD	B-Protein
and	O
HilC	B-Protein
/	O
D	B-Protein
-	O
dependent	O
invF	B-Protein
(	O
invFD	B-Protein
)	O
expression	O
,	O
compared	O
to	O
SL1344	B-Organism
.	O

However	O
,	O
hilC	B-Protein
expression	O
was	O
unchanged	O
(	O
Figure	O
2A	O
)	O
.	O

We	O
also	O
observed	O
reduced	O
expression	O
of	O
the	O
prgH	B-Protein
and	O
sigD	B-Protein
genes	O
,	O
which	O
are	O
known	O
to	O
be	O
regulated	O
by	O
HilA	B-Protein
and	O
InvF	B-Protein
(	O
10	O
,	O
11	O
,	O
29	O
,	O
35	O
)	O
,	O
in	O
SR1304	B-Organism
(	O
Figure	O
2B	O
)	O
.	O

The	O
expression	O
levels	O
of	O
hilA	B-Protein
and	O
invF	B-Protein
were	O
previously	O
shown	O
to	O
be	O
affected	O
by	O
both	O
HilC	B-Protein
and	O
HilD	B-Protein
(	O
8	O
,	O
9	O
,	O
16	O
)	O
but	O
since	O
hilC	B-Protein
levels	O
are	O
unaffected	O
by	O
the	O
mlc	B-Protein
mutation	O
(	O
Figure	O
2A	O
)	O
we	O
speculated	O
that	O
Mlc	B-Protein
was	O
regulating	O
hilA	B-Protein
and	O
invF	B-Protein
expression	O
indirectly	O
probably	O
by	O
modulating	O
the	O
expression	O
of	O
hilD	B-Protein
or	O
the	O
higher	O
regulator	O
of	O
hilD	B-Protein
.	O

Mlc	B-Protein
modulates	O
the	O
expression	O
of	O
SPI1	O
genes	O
by	O
repressing	O
hilE	B-Protein

Subsequently	O
,	O
we	O
studied	O
whether	O
hilE	B-Protein
expression	O
was	O
affected	O
by	O
Mlc	B-Protein
.	O

Baxter	O
et	O
al	O
.	O

(	O
20	O
)	O
have	O
found	O
that	O
HilE	B-Protein
plays	O
an	O
important	O
regulatory	O
role	O
in	O
the	O
expression	O
of	O
the	O
Salmonella	B-Organism
-	O
invasive	O
phenotype	O
by	O
affecting	O
hilA	B-Protein
transcription	O
through	O
direct	O
interaction	O
with	O
HilD	B-Protein
.	O

To	O
study	O
the	O
effect	O
of	O
Mlc	B-Protein
on	O
hilE	B-Protein
expression	O
,	O
we	O
measured	O
the	O
expression	O
of	O
hilE	B-Protein
-	O
lacZY	B-Protein
on	O
the	O
low	O
-	O
copy	O
plasmid	O
pMAB69	O
,	O
which	O
contains	O
the	O
hilE	B-Protein
promoter	O
region	O
from	O
-	O
886	O
to	O
+	O
121	O
,	O
relative	O
to	O
the	O
translation	O
start	O
site	O
.	O

When	O
these	O
cells	O
were	O
grown	O
in	O
static	O
cultures	O
to	O
exponential	O
phase	O
,	O
SL1344	B-Organism
-	I-Organism
pMAB69	I-Organism
expressed	O
28	O
.	O
9	O
+	O
/	O
-	O
3	O
.	O
5	O
Miller	O
units	O
of	O
beta	B-Protein
-	I-Protein
galactosidase	I-Protein
,	O
whereas	O
SR1304	B-Organism
-	I-Organism
pMAB69	I-Organism
expressed	O
49	O
.	O
5	O
+	O
/	O
-	O
5	O
.	O
3	O
Miller	O
units	O
of	O
beta	B-Protein
-	I-Protein
galactosidase	I-Protein
;	O
the	O
level	O
of	O
hilE	B-Protein
expression	O
in	O
the	O
mlc	B-Protein
mutant	O
was	O
almost	O
1	O
.	O
8	O
-	O
fold	O
higher	O
than	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

The	O
hilE	B-Protein
mRNA	O
level	O
measured	O
by	O
real	O
-	O
time	O
PCR	O
also	O
revealed	O
that	O
hilE	B-Protein
expression	O
was	O
increased	O
in	O
SR1304	B-Organism
by	O
about	O
2	O
-	O
fold	O
(	O
Figure	O
3A	O
)	O
.	O

These	O
results	O
suggest	O
that	O
Mlc	B-Protein
can	O
act	O
as	O
a	O
negative	O
regulator	O
of	O
hilE	B-Protein
.	O

The	O
role	O
of	O
HilE	B-Protein
in	O
the	O
regulation	O
of	O
SPI1	O
gene	O
expression	O
by	O
Mlc	B-Protein
was	O
further	O
studied	O
by	O
comparing	O
the	O
invasive	O
abilities	O
of	O
the	O
hilE	B-Protein
and	O
hilE	B-Protein
/	O
mlc	B-Protein
mutant	O
strains	O
of	O
Salmonella	B-Organism
.	O

Invasiveness	O
for	O
HEp	O
-	O
2	O
cells	O
was	O
reduced	O
to	O
39	O
.	O
1	O
%	O
of	O
the	O
wild	O
-	O
type	O
level	O
by	O
mlc	B-Protein
mutation	O
,	O
whereas	O
it	O
was	O
increased	O
by	O
1	O
.	O
57	O
-	O
fold	O
by	O
hilE	B-Protein
mutation	O
(	O
Figure	O
3B	O
)	O
.	O

However	O
,	O
the	O
hilE	B-Protein
/	O
mlc	B-Protein
double	O
mutant	O
showed	O
an	O
almost	O
similar	O
invasion	O
ability	O
to	O
that	O
of	O
the	O
hilE	B-Protein
mutant	O
(	O
Figure	O
3B	O
)	O
,	O
which	O
suggests	O
that	O
the	O
effect	O
of	O
the	O
mlc	B-Protein
mutation	O
on	O
the	O
invasive	O
phenotype	O
is	O
mainly	O
dependent	O
upon	O
HilE	B-Protein
function	O
.	O

The	O
requirement	O
of	O
hilE	B-Protein
for	O
Mlc	B-Protein
function	O
was	O
reflected	O
in	O
the	O
levels	O
of	O
hilD	B-Protein
transcription	O
.	O

While	O
hilD	B-Protein
expression	O
was	O
reduced	O
in	O
the	O
mlc	B-Protein
mutant	O
,	O
it	O
was	O
slightly	O
higher	O
than	O
the	O
wild	O
-	O
type	O
level	O
in	O
both	O
the	O
hilE	B-Protein
and	O
hilE	B-Protein
/	O
mlc	B-Protein
mutant	O
strains	O
(	O
Figure	O
3C	O
)	O
.	O

Additionally	O
,	O
the	O
over	O
-	O
expression	O
of	O
HilD	B-Protein
from	O
the	O
plasmid	O
pJB3	O
containing	O
hilD	B-Protein
gene	O
under	O
the	O
control	O
of	O
a	O
lac	B-Regulon-operon
promoter	O
caused	O
the	O
induction	O
of	O
hilA	B-Protein
by	O
approximately2	O
-	O
fold	O
and	O
invF	B-Protein
by	O
approximately6	O
-	O
fold	O
irrespective	O
of	O
hilE	B-Protein
or	O
mlc	B-Protein
mutation	O
when	O
real	O
-	O
time	O
PCR	O
was	O
used	O
to	O
compare	O
the	O
expression	O
levels	O
(	O
data	O
not	O
shown	O
)	O
.	O

Since	O
HilD	B-Protein
activates	O
the	O
transcription	O
of	O
hilA	B-Protein
(	O
14	O
)	O
,	O
which	O
in	O
turn	O
can	O
activate	O
HilA	B-Protein
-	O
dependent	O
invFA	B-Protein
expression	O
(	O
10	O
)	O
,	O
and	O
directly	O
activates	O
HilC	B-Protein
/	O
D	B-Protein
-	O
dependent	O
invFD	B-Protein
expression	O
(	O
16	O
)	O
,	O
these	O
results	O
establish	O
that	O
the	O
mlc	B-Protein
mutation	O
exerts	O
a	O
negative	O
effect	O
on	O
SPI1	O
gene	O
expression	O
,	O
mainly	O
by	O
increasing	O
the	O
level	O
of	O
hilE	B-Protein
expression	O
.	O

The	O
low	O
level	O
of	O
hilD	B-Protein
expression	O
in	O
the	O
mlc	B-Protein
mutant	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
the	O
increased	O
level	O
of	O
HilE	B-Protein
in	O
the	O
mlc	B-Protein
mutant	O
can	O
repress	O
the	O
activity	O
of	O
HilD	B-Protein
,	O
which	O
is	O
known	O
to	O
act	O
as	O
an	O
activator	O
of	O
its	O
own	O
expression	O
(	O
9	O
,	O
36	O
)	O
.	O

The	O
hilE	B-Protein
P3	O
promoter	O
is	O
repressed	O
by	O
Mlc	B-Protein

Baxter	O
and	O
Jones	O
(	O
18	O
)	O
have	O
identified	O
two	O
independent	O
hilE	B-Protein
promoters	O
,	O
P1	O
and	O
P2	O
.	O

We	O
performed	O
a	O
primer	O
extension	O
assay	O
of	O
total	O
RNA	O
isolated	O
from	O
SL1344	B-Organism
grown	O
to	O
exponential	O
phase	O
in	O
static	O
culture	O
,	O
using	O
the	O
primer	O
described	O
by	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
,	O
to	O
discover	O
which	O
promoter	O
is	O
regulated	O
by	O
Mlc	B-Protein
.	O

The	O
transcriptional	O
start	O
site	O
of	O
one	O
transcript	O
,	O
designated	O
P1	O
,	O
agreed	O
with	O
the	O
previous	O
report	O
,	O
although	O
the	O
promoter	O
activity	O
was	O
very	O
low	O
under	O
the	O
conditions	O
used	O
in	O
our	O
experiment	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
detected	O
a	O
stronger	O
transcript	O
,	O
designated	O
P2	O
,	O
upstream	O
of	O
P1	O
,	O
although	O
the	O
transcription	O
start	O
site	O
of	O
P2	O
was	O
mapped	O
12	O
nucleotides	O
upstream	O
of	O
that	O
reported	O
by	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
(	O
Figures	O
4A	O
and	O
5C	O
)	O
.	O

This	O
difference	O
could	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
experimental	O
model	O
conditions	O
;	O
in	O
our	O
study	O
,	O
total	O
RNA	O
from	O
a	O
Salmonella	B-Organism
strain	O
was	O
used	O
in	O
the	O
primer	O
extension	O
assay	O
,	O
whereas	O
Baxter	O
and	O
Jones	O
(	O
18	O
)	O
used	O
total	O
RNA	O
prepared	O
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
harboring	O
the	O
hilE	B-Protein
reporter	O
plasmid	O
pMAB69	O
.	O

However	O
,	O
the	O
activities	O
of	O
the	O
two	O
promoters	O
were	O
not	O
changed	O
by	O
mlc	B-Protein
mutation	O
.	O

Using	O
a	O
primer	O
extension	O
assay	O
with	O
the	O
hilE5	B-Protein
primer	O
(	O
Table	O
2	O
)	O
,	O
the	O
promoter	O
of	O
hilE	B-Protein
,	O
which	O
is	O
designated	O
as	O
P3	O
,	O
was	O
newly	O
identified	O
;	O
this	O
promoter	O
initiates	O
335	O
nucleotides	O
upstream	O
of	O
the	O
translation	O
start	O
site	O
of	O
hilE	B-Protein
(	O
Figure	O
4B	O
,	O
lane	O
1	O
)	O
.	O

We	O
observed	O
putative	O
-	O
10	O
(	O
TTAAAT	O
)	O
and	O
-	O
35	O
(	O
ATAACA	O
)	O
motifs	O
for	O
hilE	B-Protein
P3	O
(	O
Figure	O
4C	O
)	O
(	O
37	O
)	O
.	O

Transcription	O
from	O
the	O
P3	O
promoter	O
was	O
increased	O
substantially	O
by	O
mlc	B-Protein
mutation	O
(	O
Figure	O
4B	O
,	O
lane	O
2	O
)	O
.	O

The	O
specificity	O
of	O
the	O
Mlc	B-Protein
effect	O
was	O
verified	O
by	O
complementation	O
,	O
as	O
the	O
plasmid	O
pKB	O
,	O
which	O
expresses	O
mlc	B-Protein
,	O
restored	O
the	O
transcriptional	O
level	O
of	O
hilE	B-Protein
in	O
SR1304	B-Organism
almost	O
to	O
that	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
4B	O
,	O
lane	O
4	O
)	O
.	O

Mlc	B-Protein
directly	O
represses	O
hilE	B-Protein
by	O
binding	O
to	O
the	O
P3	O
promoter	O

A	O
gel	O
mobility	O
shift	O
assay	O
was	O
performed	O
with	O
purified	O
Mlc	B-Protein
,	O
to	O
test	O
whether	O
Mlc	B-Protein
directly	O
represses	O
the	O
hilE	B-Protein
P3	O
promoter	O
.	O

The	O
Mlc	B-Protein
-	O
His6	O
protein	O
was	O
produced	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
purified	O
to	O
>	O
90	O
%	O
homogeneity	O
by	O
Ni2	B-Chemical
+	I-Chemical
affinity	O
chromatography	O
.	O

The	O
activity	O
of	O
the	O
purified	O
Mlc	B-Protein
-	O
His6	O
protein	O
was	O
verified	O
with	O
the	O
control	O
gel	O
mobility	O
shift	O
experiment	O
employing	O
the	O
Salmonella	B-Organism
ptsG	O
DNA	O
fragment	O
that	O
contains	O
the	O
known	O
Mlc	B-Protein
-	O
binding	O
site	O
(	O
data	O
not	O
shown	O
)	O
.	O

When	O
the	O
labeled	O
hilE	B-Protein
promoter	O
DNA	O
was	O
incubated	O
with	O
2	O
-	O
fold	O
dilutions	O
of	O
the	O
purified	O
Mlc	B-Protein
-	O
His6	O
protein	O
(	O
100	O
-	O
800nM	O
)	O
in	O
the	O
presence	O
of	O
the	O
non	O
-	O
specific	O
DNA	O
competitor	O
poly	O
dI	O
-	O
dC	O
,	O
the	O
concentration	O
-	O
dependent	O
formation	O
of	O
protein	O
-	O
DNA	O
complexes	O
was	O
observed	O
(	O
Figure	O
5A	O
)	O
.	O

The	O
addition	O
of	O
cold	O
probe	O
released	O
the	O
labeled	O
probe	O
from	O
the	O
retarded	O
complex	O
(	O
Figure	O
5A	O
,	O
right	O
panel	O
)	O
,	O
which	O
indicates	O
specific	O
binding	O
of	O
Mlc	B-Protein
to	O
the	O
hilE	B-Protein
P3	O
promoter	O
DNA	O
.	O

The	O
precise	O
locations	O
of	O
the	O
Mlc	B-Protein
-	O
binding	O
sites	O
were	O
determined	O
by	O
DNase	O
I	O
footprinting	O
with	O
His	O
-	O
tagged	O
Mlc	B-Protein
.	O

Two	O
Mlc	B-Protein
-	O
binding	O
sites	O
,	O
one	O
at	O
position	O
-	O
10	O
to	O
+	O
12	O
(	O
Mlc	B-Protein
1	O
)	O
and	O
the	O
other	O
at	O
position	O
-	O
86	O
to	O
-	O
108	O
(	O
Mlc	B-Protein
2	O
)	O
with	O
respect	O
to	O
the	O
transcriptional	O
start	O
site	O
of	O
hilE	B-Protein
P3	O
,	O
were	O
identified	O
(	O
Figure	O
5B	O
)	O
.	O

Inspection	O
of	O
the	O
DNA	O
sequences	O
at	O
these	O
sites	O
showed	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	B-Protein
-	O
binding	O
sequence	O
,	O
which	O
has	O
the	O
conserved	O
TT	O
-	O
9bp	O
-	O
AA	O
motif	O
and	O
an	O
AT	O
-	O
rich	O
region	O
at	O
positions	O
+	O
/	O
-	O
7	O
to	O
+	O
/	O
-	O
11	O
,	O
showing	O
imperfect	O
dyad	O
symmetry	O
(	O
38	O
)	O
(	O
Figure	O
5C	O
)	O
.	O

These	O
results	O
clearly	O
demonstrate	O
that	O
Mlc	B-Protein
can	O
regulate	O
directly	O
the	O
hilE	B-Protein
P3	O
promoter	O
by	O
binding	O
to	O
the	O
promoter	O
.	O

Sugars	O
that	O
induce	O
the	O
Mlc	B-Protein
regulon	O
repress	O
hilD	B-Protein
expression	O
by	O
activating	O
hilE	B-Protein

Sequestration	O
of	O
Mlc	B-Protein
by	O
the	O
unphosphorylated	O
form	O
of	O
glucose	O
permease	O
,	O
enzyme	O
IICBGlc	B-Protein
,	O
is	O
known	O
to	O
displace	O
Mlc	B-Protein
from	O
its	O
DNA	O
-	O
binding	O
sites	O
,	O
thereby	O
allowing	O
transcription	O
of	O
its	O
target	O
genes	O
(	O
25	O
-	O
27	O
)	O
.	O

The	O
Mlc	B-Protein
regulon	O
can	O
be	O
induced	O
by	O
glucose	B-Chemical
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
by	O
mannose	B-Chemical
(	O
39	O
)	O
.	O

The	O
effects	O
of	O
various	O
carbon	O
sources	O
on	O
the	O
expression	O
of	O
hilE	B-Protein
and	O
hilD	B-Protein
were	O
studied	O
with	O
two	O
Mlc	B-Protein
regulon	O
-	O
inducing	O
sugars	O
,	O
glucose	B-Chemical
and	O
mannose	B-Chemical
,	O
and	O
two	O
Mlc	B-Protein
regulon	O
-	O
non	O
-	O
inducing	O
carbohydrates	O
,	O
arabinose	B-Chemical
and	O
glycerol	B-Chemical
.	O

SL1344	B-Organism
and	O
SR1304	B-Organism
carrying	O
either	O
pMAB69	O
(	O
hilE	B-Protein
-	O
lacZY	B-Protein
)	O
or	O
pJB5	O
(	O
hilD	B-Protein
-	O
lacZY	B-Protein
)	O
were	O
cultivated	O
in	O
TB	O
that	O
was	O
buffered	O
to	O
pH	O
7	O
.	O
0	O
with	O
0	O
.	O
1M	O
MOPS	B-Chemical
,	O
to	O
minimize	O
pH	O
effects	O
arising	O
from	O
growth	O
in	O
the	O
presence	O
of	O
the	O
various	O
carbon	O
sources	O
.	O

In	O
the	O
wild	O
-	O
type	O
strain	O
,	O
glucose	B-Chemical
and	O
mannose	B-Chemical
increased	O
hilE	B-Protein
expression	O
2	O
-	O
fold	O
and	O
hilE	B-Protein
activation	O
reduced	O
hilD	B-Protein
expression	O
(	O
Figure	O
6	O
)	O
.	O

The	O
expression	O
levels	O
of	O
hilE	B-Protein
and	O
hilD	B-Protein
remained	O
almost	O
unaffected	O
in	O
the	O
presence	O
of	O
glycerol	B-Chemical
.	O

Interestingly	O
,	O
arabinose	B-Chemical
also	O
activated	O
hilE	B-Protein
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
than	O
either	O
glucose	B-Chemical
or	O
mannose	B-Chemical
.	O

Nevertheless	O
,	O
this	O
caused	O
a	O
minute	O
increase	O
in	O
hilD	B-Protein
expression	O
.	O

In	O
the	O
absence	O
of	O
sugars	O
,	O
the	O
mlc	B-Protein
mutation	O
increased	O
hilE	B-Protein
expression	O
1	O
.	O
5	O
-	O
fold	O
,	O
with	O
a	O
concomitant	O
reduction	O
in	O
hilD	B-Protein
expression	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
expression	O
in	O
SR1304	B-Organism
of	O
both	O
hilE	B-Protein
and	O
hilD	B-Protein
was	O
increased	O
in	O
the	O
presence	O
of	O
glucose	B-Chemical
,	O
mannose	B-Chemical
or	O
arabinose	B-Chemical
.	O

These	O
results	O
imply	O
that	O
multiple	O
regulatory	O
pathways	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
hilE	B-Protein
and	O
hilD	B-Protein
by	O
carbohydrates	O
.	O

DISCUSSION	O

Analysis	O
of	O
the	O
Salmonella	O
mlc	B-Protein
mutant	O
revealed	O
that	O
invasiveness	O
for	O
epithelial	O
cells	O
was	O
impaired	O
by	O
the	O
mlc	B-Protein
mutation	O
(	O
Figure	O
1	O
)	O
.	O

It	O
is	O
well	O
known	O
that	O
SPI1	O
is	O
required	O
for	O
the	O
invasion	O
of	O
host	O
cells	O
and	O
induction	O
of	O
macrophage	O
apoptosis	O
(	O
2	O
,	O
3	O
,	O
40	O
)	O
.	O

The	O
genetic	O
evidence	O
to	O
date	O
is	O
consistent	O
with	O
a	O
regulatory	O
cascade	O
of	O
transcriptional	O
activation	O
,	O
in	O
which	O
HilD	B-Protein
,	O
HilA	B-Protein
and	O
InvF	B-Protein
act	O
sequentially	O
to	O
activate	O
SPI1	O
expression	O
.	O

In	O
brief	O
,	O
HilD	B-Protein
binds	O
directly	O
to	O
sites	O
upstream	O
of	O
hilA	B-Protein
and	O
invFD	B-Protein
and	O
acts	O
as	O
an	O
activator	O
(	O
14	O
,	O
16	O
,	O
36	O
)	O
.	O

HilA	B-Protein
activates	O
the	O
transcription	O
of	O
invFA	B-Protein
and	O
SPI1	O
-	O
T3SS	O
apparatus	O
genes	O
required	O
for	O
the	O
secretion	O
of	O
effector	O
proteins	O
,	O
whereas	O
the	O
expression	O
of	O
effector	O
proteins	O
is	O
regulated	O
by	O
InvF	B-Protein
(	O
10	O
,	O
11	O
)	O
.	O

This	O
regulatory	O
cascade	O
implies	O
that	O
the	O
reduced	O
invasive	O
phenotype	O
of	O
mlc	B-Protein
mutant	O
is	O
the	O
result	O
of	O
hilD	B-Protein
repression	O
,	O
which	O
affects	O
both	O
hilA	B-Protein
and	O
invF	B-Protein
expression	O
(	O
Figures	O
1	O
and	O
2	O
)	O
.	O

The	O
2	O
-	O
3	O
-	O
fold	O
decrease	O
in	O
hilD	B-Protein
expression	O
caused	O
by	O
the	O
mlc	B-Protein
mutation	O
is	O
sufficient	O
to	O
account	O
for	O
the	O
nearly	O
10	O
-	O
fold	O
decrease	O
in	O
hilA	B-Protein
and	O
invFA	B-Protein
transcription	O
,	O
owing	O
to	O
the	O
nature	O
of	O
the	O
feed	O
-	O
forward	O
regulatory	O
loop	O
,	O
in	O
that	O
moderate	O
effects	O
on	O
HilD	B-Protein
production	O
are	O
amplified	O
(	O
9	O
)	O
.	O

Although	O
the	O
Salmonella	O
mlc	B-Protein
mutant	O
was	O
less	O
invasive	O
for	O
epithelial	O
cells	O
than	O
the	O
wild	O
-	O
type	O
strain	O
,	O
the	O
extent	O
of	O
the	O
reduction	O
in	O
invasiveness	O
and	O
cytotoxicity	O
of	O
the	O
mlc	B-Protein
mutant	O
was	O
not	O
as	O
great	O
as	O
we	O
had	O
expected	O
,	O
considering	O
the	O
observed	O
reduction	O
in	O
SPI1	O
gene	O
expression	O
(	O
Figure	O
2	O
)	O
.	O

This	O
may	O
be	O
partly	O
due	O
to	O
the	O
expression	O
of	O
hilC	B-Protein
,	O
a	O
de	O
-	O
repressor	O
of	O
hilA	B-Protein
,	O
which	O
was	O
not	O
reduced	O
in	O
the	O
mlc	B-Protein
mutant	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
hilC	B-Protein
mutation	O
had	O
little	O
effect	O
on	O
SPI1	O
gene	O
expression	O
or	O
the	O
invasive	O
phenotype	O
,	O
whereas	O
the	O
over	O
-	O
expression	O
of	O
hilC	B-Protein
suppressed	O
the	O
hilD	B-Protein
mutation	O
,	O
thereby	O
promoting	O
high	O
levels	O
of	O
hilA	B-Protein
and	O
invF	B-Protein
expression	O
,	O
which	O
suggests	O
that	O
HilC	B-Protein
can	O
partially	O
compensate	O
for	O
the	O
loss	O
of	O
function	O
of	O
HilD	B-Protein
and	O
the	O
invasive	O
phenotype	O
(	O
8	O
,	O
9	O
,	O
15	O
)	O
.	O

We	O
have	O
reported	O
previously	O
that	O
there	O
may	O
be	O
an	O
independent	O
hilC	B-Protein
regulatory	O
pathway	O
that	O
is	O
not	O
applicable	O
to	O
hilA	B-Protein
or	O
invFA	B-Protein
regulation	O
when	O
bacteria	O
respond	O
to	O
changes	O
in	O
osmolarity	O
(	O
29	O
)	O
.	O

Our	O
data	O
clearly	O
demonstrate	O
that	O
Mlc	B-Protein
directly	O
regulates	O
hilE	B-Protein
expression	O
by	O
binding	O
to	O
the	O
hilE	B-Protein
P3	O
promoter	O
(	O
Figure	O
5	O
)	O
.	O

The	O
two	O
Mlc	B-Protein
-	O
binding	O
sites	O
in	O
hilE	B-Protein
P3	O
identified	O
by	O
the	O
gel	O
mobility	O
shift	O
assay	O
and	O
DNase	O
I	O
footprinting	O
analysis	O
show	O
high	O
-	O
level	O
homology	O
with	O
the	O
known	O
consensus	O
Mlc	B-Protein
-	O
binding	O
sequences	O
;	O
additionally	O
,	O
the	O
two	O
Mlc	B-Protein
-	O
binding	O
sites	O
are	O
separated	O
by	O
98nt	O
,	O
as	O
is	O
the	O
case	O
for	O
other	O
promoters	O
that	O
have	O
two	O
Mlc	B-Protein
-	O
binding	O
sites	O
(	O
41	O
)	O
.	O

The	O
transcriptional	O
start	O
site	O
of	O
the	O
hilE	B-Protein
P3	O
promoter	O
lies	O
335nt	O
upstream	O
of	O
the	O
ATG	O
start	O
codon	O
of	O
hilE	B-Protein
(	O
Figures	O
4B	O
and	O
5C	O
)	O
.	O

It	O
is	O
unusual	O
that	O
the	O
5	O
'	O
-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
mRNA	O
is	O
more	O
than	O
300nt	O
in	O
bacteria	O
(	O
42	O
)	O
.	O

However	O
,	O
this	O
length	O
of	O
5	O
'	O
-	O
UTR	O
has	O
been	O
observed	O
in	O
other	O
SPI1	O
regulators	O
.	O

The	O
HilC	B-Protein
/	O
D	B-Protein
-	O
dependent	O
transcriptional	O
start	O
site	O
of	O
the	O
invFD	B-Protein
promoter	O
is	O
631bp	O
upstream	O
of	O
the	O
invF	B-Protein
open	O
reading	O
frame	O
(	O
16	O
)	O
.	O

The	O
UTR	O
of	O
the	O
hilA	B-Protein
gene	O
is	O
also	O
up	O
to	O
350nt	O
in	O
length	O
,	O
and	O
is	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
complex	O
regulation	O
of	O
hilA	B-Protein
in	O
response	O
to	O
environmental	O
signals	O
(	O
8	O
,	O
12	O
)	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
region	O
190	O
-	O
270	O
-	O
bp	O
upstream	O
of	O
the	O
hilE	B-Protein
promoter	O
is	O
required	O
for	O
the	O
activation	O
of	O
hilE	B-Protein
P2	O
expression	O
by	O
FimYZ	B-Protein
,	O
which	O
is	O
a	O
response	O
regulator	O
that	O
is	O
involved	O
in	O
the	O
expression	O
of	O
type	O
1	O
fimbriae	O
and	O
motility	O
genes	O
(	O
18	O
,	O
Figure	O
5C	O
)	O
.	O

Therefore	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
possibility	O
that	O
additional	O
cis	O
-	O
or	O
trans	O
-	O
acting	O
regulatory	O
elements	O
,	O
which	O
have	O
not	O
yet	O
been	O
characterized	O
,	O
are	O
involved	O
in	O
hilE	B-Protein
expression	O
.	O

Glucose	B-Chemical
and	O
mannose	B-Chemical
induce	O
the	O
Mlc	B-Protein
regulon	O
(	O
39	O
)	O
by	O
dephosphorylating	O
EIICBGlc	B-Protein
,	O
which	O
then	O
sequesters	O
Mlc	B-Protein
from	O
its	O
binding	O
sites	O
(	O
27	O
,	O
43	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
glucose	B-Chemical
plays	O
a	O
negative	O
role	O
in	O
the	O
expression	O
of	O
invasion	O
-	O
associated	O
genes	O
in	O
Salmonella	B-Organism
.	O

The	O
addition	O
of	O
excess	O
glucose	B-Chemical
to	O
the	O
culture	O
medium	O
results	O
in	O
the	O
reduction	O
of	O
cell	O
association	O
by	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
(	O
44	O
)	O
.	O

The	O
glucose	B-Chemical
present	O
in	O
DLB	O
(	O
LB	O
broth	O
diluted	O
1	O
:	O
5	O
)	O
decreased	O
hilA	B-Protein
expression	O
2	O
.	O
5	O
-	O
fold	O
,	O
as	O
compared	O
to	O
DLB	O
without	O
glucose	B-Chemical
,	O
while	O
lactose	B-Chemical
and	O
arabinose	B-Chemical
had	O
little	O
effect	O
on	O
hilA	B-Protein
expression	O
(	O
45	O
)	O
.	O

The	O
results	O
presented	O
in	O
this	O
study	O
support	O
the	O
notion	O
that	O
hilE	B-Protein
expression	O
is	O
activated	O
as	O
a	O
result	O
of	O
Mlc	B-Protein
sequestration	O
by	O
unphosphorylated	O
EIICBGlc	B-Protein
in	O
the	O
presence	O
of	O
glucose	B-Chemical
.	O

We	O
observed	O
a	O
2	O
-	O
fold	O
activation	O
of	O
hilE	B-Protein
and	O
concomitant	O
repression	O
of	O
hilD	B-Protein
in	O
the	O
presence	O
of	O
glucose	B-Chemical
or	O
mannose	B-Chemical
,	O
which	O
are	O
known	O
inducers	O
of	O
the	O
Mlc	B-Protein
regulon	O
,	O
when	O
TB	O
was	O
used	O
(	O
Figure	O
6	O
)	O
.	O

However	O
,	O
the	O
effect	O
of	O
the	O
sugar	O
was	O
not	O
seen	O
when	O
LB	O
was	O
used	O
(	O
data	O
not	O
shown	O
)	O
.	O

We	O
speculate	O
that	O
the	O
nutrient	O
-	O
rich	O
LB	O
broth	O
may	O
mask	O
the	O
effect	O
of	O
the	O
sugar	O
on	O
hilE	B-Protein
expression	O
because	O
the	O
effect	O
of	O
sugar	O
addition	O
on	O
hilA	B-Protein
expression	O
was	O
more	O
distinct	O
in	O
DLB	O
than	O
LB	O
(	O
45	O
)	O
.	O

In	O
addition	O
,	O
hilE	B-Protein
expression	O
was	O
also	O
increased	O
in	O
the	O
presence	O
of	O
arabinose	B-Chemical
,	O
which	O
suggests	O
an	O
additional	O
regulatory	O
mechanism	O
mediated	O
by	O
arabinose	B-Chemical
.	O

Interestingly	O
,	O
carbohydrate	O
regulation	O
of	O
hilE	B-Protein
and	O
hilD	B-Protein
expression	O
in	O
the	O
mlc	B-Protein
mutant	O
created	O
a	O
different	O
story	O
.	O

All	O
of	O
the	O
carbohydrates	O
tested	O
in	O
this	O
study	O
,	O
with	O
the	O
exception	O
of	O
glycerol	B-Chemical
,	O
increased	O
hilD	B-Protein
expression	O
by	O
approximately1	O
.	O
1	O
-	O
1	O
.	O
2	O
-	O
fold	O
,	O
even	O
though	O
hilE	B-Protein
expression	O
in	O
the	O
mlc	B-Protein
mutant	O
was	O
increased	O
by	O
approximately30	O
%	O
in	O
the	O
presence	O
of	O
the	O
sugars	O
tested	O
(	O
Figure	O
6	O
)	O
.	O

These	O
results	O
suggest	O
that	O
the	O
presence	O
of	O
complex	O
regulatory	O
mechanisms	O
for	O
hilE	B-Protein
is	O
required	O
for	O
optimal	O
regulation	O
of	O
the	O
SPI1	O
genes	O
,	O
as	O
can	O
be	O
expected	O
from	O
the	O
complex	O
regulatory	O
networks	O
identified	O
in	O
Salmonella	B-Organism
(	O
46	O
)	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
PhoR	B-Protein
-	O
PhoB	B-Protein
leads	O
to	O
increased	O
hilE	B-Protein
P2	O
expression	O
and	O
subsequent	O
repression	O
of	O
hilA	B-Protein
and	O
invasion	O
genes	O
(	O
7	O
,	O
18	O
)	O
.	O

The	O
PhoR	B-Protein
sensor	O
kinase	O
phosphorylates	O
PhoB	B-Protein
when	O
extracellular	O
Pi	B-Chemical
levels	O
are	O
low	O
,	O
and	O
the	O
phosphorylated	O
PhoB	B-Protein
then	O
binds	O
and	O
activates	O
the	O
promoters	O
in	O
the	O
Pho	B-Regulon-operon
regulon	O
.	O

However	O
,	O
even	O
in	O
the	O
absence	O
of	O
PhoR	B-Protein
,	O
many	O
carbon	O
sources	O
are	O
known	O
to	O
activate	O
the	O
Pho	B-Regulon-operon
regulon	O
via	O
CreC	B-Protein
,	O
which	O
is	O
a	O
PhoR	B-Protein
homolog	O
(	O
47	O
)	O
.	O

Thus	O
,	O
carbon	O
metabolism	O
sensed	O
by	O
PhoB	B-Protein
/	O
R	B-Protein
may	O
also	O
affect	O
hilE	B-Protein
expression	O
(	O
22	O
)	O
,	O
and	O
this	O
may	O
be	O
one	O
of	O
the	O
reasons	O
for	O
the	O
elevated	O
hilE	B-Protein
expression	O
in	O
the	O
presence	O
of	O
carbohydrates	O
in	O
the	O
mlc	B-Protein
mutant	O
(	O
Figure	O
6A	O
)	O
.	O

Recently	O
,	O
Teplitski	O
et	O
al	O
.	O

(	O
48	O
)	O
have	O
reported	O
that	O
the	O
expression	O
of	O
sirA	B-Protein
,	O
which	O
is	O
a	O
response	O
regulator	O
for	O
BarA	B-Protein
(	O
49	O
)	O
,	O
is	O
decreased	O
in	O
the	O
presence	O
of	O
50mM	O
glucose	B-Chemical
.	O

The	O
repressive	O
effect	O
of	O
glucose	B-Chemical
was	O
also	O
observed	O
for	O
the	O
downstream	O
members	O
of	O
the	O
SirA	B-Regulon-operon
regulon	O
,	O
such	O
as	O
csrB	B-Protein
,	O
csrC	B-Protein
and	O
hilA	B-Protein
(	O
48	O
,	O
49	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
SPI1	O
is	O
not	O
activated	O
when	O
Salmonella	B-Organism
is	O
grown	O
in	O
the	O
presence	O
of	O
glucose	B-Chemical
(	O
Figure	O
6	O
;	O
44	O
,	O
45	O
,	O
48	O
)	O
.	O

Since	O
the	O
environmental	O
conditions	O
faced	O
by	O
Salmonella	B-Organism
change	O
constantly	O
during	O
passage	O
through	O
the	O
intestine	O
of	O
the	O
animal	O
host	O
,	O
this	O
bacterium	O
should	O
use	O
multiple	O
signals	O
to	O
modulate	O
the	O
virulence	O
genes	O
needed	O
for	O
survival	O
.	O

It	O
is	O
known	O
that	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
uses	O
bile	O
or	O
SCFAs	O
including	O
acetate	B-Chemical
,	O
propionate	B-Chemical
and	O
butyrate	B-Chemical
,	O
as	O
environmental	O
signals	O
to	O
modulate	O
its	O
invasion	O
of	O
the	O
gastrointestinal	O
tract	O
(	O
50	O
-	O
52	O
)	O
.	O

We	O
propose	O
that	O
Salmonella	B-Organism
can	O
use	O
the	O
glucose	B-Chemical
concentration	O
of	O
the	O
mammalian	O
intestinal	O
tract	O
as	O
one	O
of	O
many	O
signals	O
for	O
the	O
regulation	O
of	O
invasion	O
genes	O
.	O

Salmonella	B-Organism
may	O
use	O
Mlc	B-Protein
to	O
sense	O
the	O
availability	O
of	O
sugars	O
,	O
thereby	O
allowing	O
decisions	O
as	O
to	O
when	O
and	O
where	O
to	O
initiate	O
the	O
expression	O
of	O
genes	O
involved	O
in	O
invasion	O
.	O

S	B-Organism
.	I-Organism

Typhimurium	B-Organism
typically	O
invades	O
the	O
distal	O
small	O
intestine	O
(	O
ileum	O
)	O
of	O
the	O
mammalian	O
upper	O
gastrointestinal	O
tract	O
(	O
53	O
)	O
.	O

Simple	O
sugars	O
,	O
such	O
as	O
glucose	B-Chemical
,	O
are	O
rarely	O
encountered	O
in	O
the	O
distal	O
ileum	O
,	O
as	O
most	O
are	O
absorbed	O
in	O
the	O
proximal	O
portion	O
of	O
the	O
small	O
intestine	O
(	O
54	O
)	O
.	O

The	O
relatively	O
high	O
glucose	B-Chemical
concentration	O
in	O
the	O
proximal	O
small	O
intestine	O
may	O
repress	O
SPI1	O
gene	O
expression	O
through	O
Mlc	B-Protein
,	O
perhaps	O
together	O
with	O
PhoR	B-Protein
-	O
PhoB	B-Protein
and	O
/	O
or	O
SirA	B-Protein
,	O
whereas	O
upon	O
transit	O
to	O
the	O
distal	O
ileum	O
,	O
the	O
glucose	B-Chemical
concentration	O
becomes	O
low	O
enough	O
to	O
activate	O
the	O
invasion	O
genes	O
of	O
SPI1	O
.	O

The	O
effects	O
of	O
various	O
sugars	O
on	O
the	O
differential	O
regulation	O
of	O
SPI1	O
genes	O
require	O
further	O
investigation	O
to	O
understand	O
their	O
roles	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

SalK	B-Protein
/	O
SalR	B-Protein
,	O
a	O
Two	O
-	O
Component	O
Signal	O
Transduction	O
System	O
,	O
Is	O
Essential	O
for	O
Full	O
Virulence	O
of	O
Highly	O
Invasive	O
Streptococcus	B-Organism
suis	I-Organism
Serotype	I-Organism
2	I-Organism

Background	O
Streptococcus	B-Organism
suis	I-Organism
serotype	I-Organism
2	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
2	I-Organism
,	O
SS2	B-Organism
)	O
has	O
evolved	O
into	O
a	O
highly	O
infectious	O
entity	O
,	O
which	O
caused	O
the	O
two	O
recent	O
large	O
-	O
scale	O
outbreaks	O
of	O
human	B-Organism
SS2	B-Organism
epidemic	O
in	O
China	O
,	O
and	O
is	O
characterized	O
by	O
a	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O

However	O
,	O
the	O
molecular	O
pathogenesis	O
of	O
this	O
new	O
emerging	O
pathogen	O
is	O
still	O
poorly	O
understood	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
89K	O
is	O
a	O
newly	O
predicted	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
which	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
strains	O
isolated	O
from	O
these	O
two	O
SS2	B-Organism
outbreaks	O
.	O

Further	O
bioinformatics	O
analysis	O
revealed	O
a	O
unique	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
located	O
in	O
the	O
candidate	O
89K	O
PAI	O
,	O
which	O
is	O
orthologous	O
to	O
the	O
SalK	B-Protein
/	O
SalR	B-Protein
regulatory	O
system	O
of	O
Streptococcus	B-Organism
salivarius	I-Organism
.	O

Knockout	O
of	O
salKR	B-Protein
eliminated	O
the	O
lethality	O
of	O
SS2	B-Organism
in	O
experimental	O
infection	O
of	O
piglets	B-Organism
.	O

Functional	O
complementation	O
of	O
salKR	B-Protein
into	O
the	O
isogenic	O
mutant	O
DeltasalKR	B-Protein
restored	O
its	O
soaring	O
pathogenicity	O
.	O

Colonization	O
experiments	O
showed	O
that	O
the	O
DeltasalKR	B-Protein
mutant	O
could	O
not	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	B-Organism
when	O
administered	O
alone	O
.	O

Bactericidal	O
assays	O
demonstrated	O
that	O
resistance	O
of	O
the	O
mutant	O
to	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	O
)	O
-	O
mediated	O
killing	O
was	O
greatly	O
decreased	O
.	O

Expression	O
microarray	O
analysis	O
exhibited	O
a	O
transcription	O
profile	O
alteration	O
of	O
26	O
various	O
genes	O
down	O
-	O
regulated	O
in	O
the	O
DeltasalKR	B-Protein
mutant	O
.	O

Conclusions	O
/	O
Significance	O
These	O
findings	O
suggest	O
that	O
SalK	B-Protein
/	O
SalR	B-Protein
is	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
ethnic	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
,	O
thus	O
providing	O
experimental	O
evidence	O
for	O
the	O
validity	O
of	O
this	O
bioinformatically	O
predicted	O
PAI	O
.	O

Introduction	O

Streptococcus	B-Organism
suis	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
)	O
is	O
considered	O
an	O
important	O
zoonotic	O
pathogen	O
causing	O
a	O
variety	O
of	O
life	O
-	O
threatening	O
infections	O
that	O
include	O
meningitis	O
,	O
arthritis	O
,	O
septicaemia	O
and	O
even	O
sudden	O
death	O
in	O
pigs	B-Organism
and	O
humans	B-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Among	O
the	O
known	O
35	O
serotypes	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
S	B-Organism
.	I-Organism
suis	I-Organism
serotype	I-Organism
2	I-Organism
(	O
S	B-Organism
.	I-Organism
suis	I-Organism
2	I-Organism
or	O
SS2	B-Organism
)	O
is	O
the	O
most	O
virulent	O
and	O
the	O
most	O
frequently	O
isolated	O
serotype	O
.	O

It	O
was	O
previously	O
thought	O
that	O
SS2	B-Organism
caused	O
only	O
sporadic	O
cases	O
of	O
meningitis	O
and	O
sepsis	O
in	O
humans	B-Organism
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

However	O
,	O
two	O
major	O
emerging	O
infectious	O
disease	O
outbreaks	O
of	O
SS2	B-Organism
in	O
China	O
(	O
one	O
in	O
Jiangsu	O
Province	O
,	O
1998	O
,	O
and	O
the	O
other	O
in	O
Sichuan	O
Province	O
,	O
2005	O
)	O
,	O
raised	O
considerable	O
international	O
concerns	O
among	O
the	O
public	O
health	O
professionals	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

A	O
key	O
feature	O
of	O
these	O
two	O
Chinese	O
outbreaks	O
is	O
the	O
prevalence	O
of	O
a	O
toxic	O
shock	O
-	O
like	O
syndrome	O
manifesting	O
itself	O
as	O
acute	O
high	O
fever	O
,	O
multiple	O
organ	O
failures	O
,	O
short	O
course	O
of	O
disease	O
and	O
high	O
lethality	O
[	O
5	O
]	O
.	O

Despite	O
the	O
growing	O
significance	O
of	O
such	O
infections	O
,	O
little	O
is	O
known	O
about	O
the	O
factors	O
that	O
govern	O
the	O
physiological	O
responses	O
of	O
this	O
emerging	O
organism	O
,	O
especially	O
the	O
genetic	O
repertoire	O
that	O
the	O
streptococcus	O
employs	O
to	O
cause	O
the	O
toxic	O
shock	O
-	O
like	O
syndrome	O
.	O

To	O
shed	O
light	O
on	O
the	O
mystery	O
of	O
high	O
virulence	O
of	O
the	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
,	O
our	O
joint	O
research	O
group	O
completed	O
a	O
comprehensive	O
study	O
of	O
comparative	O
genomics	O
,	O
decoding	O
the	O
whole	O
genome	O
sequences	O
of	O
two	O
virulent	O
SS2	B-Organism
strains	O
(	O
98HAH12	B-Organism
and	O
05ZYH33	B-Organism
)	O
isolated	O
from	O
Chinese	O
infected	O
patients	B-Organism
[	O
6	O
]	O
.	O

A	O
candidate	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
called	O
89K	O
was	O
predicted	O
,	O
which	O
is	O
only	O
present	O
in	O
the	O
epidemic	O
strains	O
in	O
these	O
two	O
SS2	B-Organism
outbtreaks	O
but	O
not	O
in	O
other	O
domestic	O
clinical	O
isolates	O
or	O
international	O
virulent	O
strains	O
[	O
6	O
]	O
.	O

However	O
,	O
this	O
bioinformatically	O
predicted	O
candidate	O
PAI	O
needs	O
experimental	O
validation	O
and	O
its	O
linkage	O
to	O
SS2	B-Organism
-	O
related	O
high	O
pathogenicity	O
remains	O
unknown	O
.	O

As	O
a	O
subgroup	O
of	O
genomic	O
islands	O
(	O
GIs	O
)	O
,	O
PAI	O
usually	O
contains	O
some	O
distinct	O
genetic	O
elements	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

A	O
wide	O
range	O
of	O
molecular	O
machineries	O
such	O
as	O
quorum	O
sensing	O
,	O
TCSTS	O
,	O
and	O
ABC	O
transporters	O
,	O
are	O
often	O
involved	O
in	O
a	O
putative	O
PAI	O
,	O
whereby	O
the	O
PAI	O
responds	O
to	O
environmental	O
signals	O
and	O
fulfills	O
its	O
critical	O
functions	O
contributing	O
to	O
the	O
virulence	O
in	O
pathogens	O
[	O
8	O
]	O
-	O
[	O
10	O
]	O
.	O

Further	O
bioinformatics	O
analysis	O
of	O
the	O
89K	O
island	O
revealed	O
a	O
distinct	O
two	O
-	O
component	O
signal	O
transduction	O
system	O
(	O
TCSTS	O
)	O
encoded	O
therein	O
appears	O
to	O
be	O
orthologous	O
to	O
the	O
SalK	B-Protein
/	O
SalR	B-Protein
system	O
of	O
S	B-Organism
.	I-Organism
salivarius	I-Organism
,	O
a	O
salivaricin	O
regulated	O
TCSTS	O
[	O
11	O
]	O
.	O

TCSTS	O
,	O
composed	O
of	O
a	O
membrane	O
sensor	O
(	O
histidine	O
kinase	O
,	O
HK	O
)	O
and	O
a	O
cytoplasmic	O
response	O
regulator	O
(	O
RR	O
)	O
,	O
is	O
an	O
important	O
mechanism	O
used	O
by	O
bacteria	O
to	O
adapt	O
to	O
and	O
survive	O
in	O
the	O
changing	O
environments	O
.	O

In	O
pathogens	O
,	O
various	O
members	O
of	O
TCSTSs	O
have	O
been	O
shown	O
to	O
play	O
critical	O
roles	O
in	O
both	O
metabolism	O
and	O
pathogenesis	O
[	O
12	O
]	O
-	O
[	O
23	O
]	O
.	O

Up	O
until	O
now	O
,	O
only	O
one	O
orphan	O
response	O
regulator	O
,	O
RevS	B-Protein
,	O
has	O
been	O
found	O
to	O
be	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
SS2	B-Organism
[	O
24	O
]	O
.	O

To	O
date	O
,	O
SalK	B-Protein
/	O
SalR	B-Protein
is	O
still	O
a	O
little	O
-	O
reported	O
TCSTS	O
in	O
the	O
fast	O
-	O
growing	O
field	O
of	O
bacterial	O
pathogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
attempted	O
to	O
generate	O
the	O
deletion	O
mutant	O
of	O
salKR	B-Protein
and	O
assess	O
the	O
contribution	O
of	O
this	O
TCSTS	O
to	O
the	O
high	O
pathogenicity	O
of	O
Chinese	O
SS2	B-Organism
strains	O
.	O

Virulence	O
assays	O
together	O
with	O
a	O
series	O
of	O
experiments	O
enabled	O
us	O
to	O
identify	O
a	O
novel	O
genetic	O
determinant	O
which	O
is	O
required	O
for	O
the	O
overall	O
virulence	O
of	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
.	O

Results	O

Discovery	O
and	O
Characterization	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
The	O
newly	O
decoded	O
genomic	O
sequence	O
of	O
S	B-Organism
.	I-Organism
suis	I-Organism
05ZYH33	I-Organism
makes	O
it	O
possible	O
to	O
systematically	O
investigate	O
the	O
genetic	O
basis	O
of	O
streptococcal	O
pathogenicity	O
.	O

We	O
focused	O
on	O
the	O
putative	O
89K	O
PAI	O
to	O
perform	O
further	O
molecular	O
analysis	O
.	O

On	O
the	O
negative	O
strand	O
of	O
89K	O
,	O
peptides	O
encoded	O
by	O
05SSU0944	B-Protein
and	O
05SSU0943	B-Protein
exhibit	O
27	O
%	O
and	O
41	O
%	O
amino	O
acid	O
sequence	O
identity	O
with	O
the	O
SalK	B-Protein
and	O
the	O
SalR	B-Protein
proteins	O
of	O
Streptococcus	B-Organism
salivarius	I-Organism
,	O
respectively	O
,	O
forming	O
a	O
TCSTS	O
belonging	O
to	O
the	O
Nar	B-Protein
/	O
LuxR	B-Protein
family	O
.	O

05SSU0944	B-Protein
and	O
05SSU0943	B-Protein
were	O
accordingly	O
renamed	O
salK	B-Protein
and	O
salR	B-Protein
(	O
Fig	O
.	O
1	O
)	O
.	O

Notably	O
,	O
the	O
average	O
GC	O
content	O
of	O
salKR	B-Protein
,	O
29	O
.	O
9	O
%	O
,	O
is	O
much	O
less	O
than	O
that	O
of	O
both	O
89K	O
and	O
the	O
whole	O
genome	O
of	O
05ZYH33	B-Organism
(	O
36	O
.	O
8	O
%	O
and	O
41	O
.	O
1	O
%	O
,	O
respectively	O
)	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

The	O
results	O
of	O
bioinformatics	O
analysis	O
indicated	O
that	O
the	O
response	O
regulator	O
,	O
SalR	B-Protein
,	O
contains	O
199	O
amino	O
acids	O
(	O
aa	O
)	O
with	O
the	O
three	O
N	O
-	O
terminal	O
invariant	O
aa	O
residues	O
(	O
D30	O
,	O
D54	O
and	O
K107	O
)	O
of	O
the	O
receiver	O
domain	O
of	O
response	O
regulators	O
from	O
Gram	O
-	O
positive	O
bacteria	O
[	O
25	O
]	O
.	O

In	O
the	O
C	O
-	O
terminal	O
domain	O
,	O
it	O
contains	O
two	O
residues	O
(	O
E142	O
,	O
G152	O
)	O
that	O
are	O
absolutely	O
conserved	O
in	O
the	O
winged	O
helix	O
-	O
turn	O
-	O
helix	O
DNA	O
-	O
binding	O
domains	O
of	O
response	O
regulators	O
belonging	O
to	O
the	O
LuxR	B-Protein
family	O
[	O
26	O
]	O
.	O

salK	B-Protein
encodes	O
a	O
396	O
aa	O
long	O
protein	O
,	O
with	O
five	O
N	O
-	O
terminal	O
transmembrane	O
domains	O
and	O
a	O
transmitter	O
domain	O
signature	O
motif	O
in	O
the	O
C	O
-	O
terminal	O
-	O
typical	O
of	O
sensor	O
histidine	O
protein	O
kinases	O
of	O
TCSTSs	O
[	O
25	O
]	O
.	O

As	O
some	O
TCSTS	O
gene	O
pairs	O
are	O
adjacent	O
to	O
the	O
genes	O
that	O
they	O
control	O
,	O
the	O
genetic	O
structure	O
of	O
the	O
salKR	B-Protein
locus	O
and	O
its	O
flanking	O
genes	O
was	O
defined	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

The	O
salK	B-Protein
coding	O
region	O
overlaps	O
that	O
of	O
salR	B-Protein
by	O
20	O
base	O
pairs	O
(	O
bp	O
)	O
,	O
and	O
no	O
putative	O
promoter	O
or	O
transcriptional	O
terminator	O
could	O
be	O
identified	O
within	O
either	O
gene	O
.	O

A	O
putative	O
promoter	O
located	O
approximately	O
50	O
bp	O
upstream	O
from	O
the	O
TTG	O
initiation	O
codon	O
of	O
salK	B-Protein
,	O
was	O
predicted	O
using	O
the	O
online	O
server	O
of	O
Neutral	O
Network	O
Promoter	O
Prediction	O
.	O

Further	O
sequence	O
analysis	O
revealed	O
a	O
palindrome	O
of	O
55	O
bp	O
with	O
the	O
potential	O
to	O
form	O
a	O
stem	O
-	O
loop	O
structure	O
situated	O
in	O
the	O
intergenic	O
region	O
between	O
salR	B-Protein
and	O
05SSU0942	B-Protein
,	O
which	O
may	O
function	O
as	O
a	O
transcriptional	O
terminator	O
.	O

05SSU0945	B-Protein
,	O
situated	O
upstream	O
(	O
729	O
bp	O
long	O
intergenic	O
region	O
)	O
of	O
the	O
salKR	B-Protein
locus	O
,	O
encodes	O
a	O
94	O
aa	O
polypeptide	O
for	O
which	O
there	O
were	O
no	O
significant	O
database	O
matches	O
.	O

Downstream	O
of	O
salKR	B-Protein
,	O
the	O
05SSU0942	B-Protein
,	O
05SSU0941	B-Protein
,	O
05SSU0940	B-Protein
,	O
05SSU0939	B-Protein
,	O
05SSU0938	B-Protein
genes	O
were	O
predicted	O
to	O
encode	O
peptides	O
with	O
significant	O
identities	O
to	O
the	O
orthologues	O
of	O
Streptococcus	B-Organism
agalactiae	I-Organism
.	O

The	O
function	O
of	O
these	O
downstream	O
gene	O
products	O
are	O
unknown	O
except	O
for	O
05SSU0941	B-Protein
,	O
which	O
encodes	O
a	O
predicted	O
DNA	O
primase	O
that	O
might	O
be	O
involed	O
in	O
DNA	O
replication	O
.	O

The	O
genetic	O
organization	O
of	O
this	O
locus	O
indicates	O
that	O
salK	B-Protein
might	O
be	O
cotranscribed	O
with	O
salR	B-Protein
initiating	O
from	O
the	O
PsalK	B-Protein
promoter	O
.	O

Transcriptional	O
Analysis	O
of	O
the	O
salKR	B-Protein
Locus	O
and	O
its	O
Flanking	O
Sequences	O

To	O
confirm	O
the	O
predicted	O
transcripts	O
of	O
salKR	B-Protein
and	O
the	O
flanking	O
genes	O
,	O
RNA	O
extracted	O
from	O
S	B-Organism
.	I-Organism
suis	I-Organism
05ZYH33	I-Organism
cells	O
was	O
subjected	O
to	O
RT	O
-	O
PCR	O
analysis	O
by	O
using	O
primers	O
amplifying	O
each	O
intergenic	O
region	O
of	O
salKR	B-Protein
and	O
the	O
flanking	O
genes	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

2B	O
,	O
RT	O
-	O
PCR	O
products	O
were	O
obtained	O
with	O
five	O
pairs	O
of	O
the	O
primers	O
(	O
P3	O
/	O
P4	O
,	O
P5	O
/	O
P6	O
,	O
P7	O
/	O
P8	O
,	O
P9	O
/	O
P10	O
and	O
P13	O
/	O
P14	O
)	O
,	O
but	O
not	O
with	O
the	O
other	O
three	O
primer	O
pairs	O
(	O
P1	O
/	O
P2	O
,	O
P11	O
/	O
P12	O
and	O
P15	O
/	O
P16	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
when	O
genomic	O
DNA	O
was	O
used	O
as	O
a	O
template	O
,	O
all	O
these	O
primer	O
pairs	O
yielded	O
the	O
expected	O
PCR	O
products	O
(	O
Fig	O
.	O
2B	O
,	O
PCR	O
)	O
.	O

These	O
results	O
suggested	O
that	O
salK	B-Protein
and	O
salR	B-Protein
are	O
transcriptionally	O
coupled	O
,	O
and	O
the	O
five	O
downstream	O
(	O
05SSU0942	B-Protein
-	O
05SSU0938	B-Protein
)	O
genes	O
are	O
co	O
-	O
transcribed	O
from	O
a	O
promoter	O
positioned	O
immediately	O
upstream	O
of	O
05SSU0942	B-Protein
and	O
that	O
their	O
transcription	O
ends	O
between	O
the	O
05SSU0938	B-Protein
-	O
05SSU0937	B-Protein
intergenic	O
region	O
which	O
contains	O
a	O
terminator	O
-	O
like	O
inverted	O
repeat	O
sequence	O
.	O

Construction	O
of	O
DeltasalKR	B-Protein

To	O
test	O
the	O
role	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
in	O
the	O
pathogenesis	O
of	O
SS2	B-Organism
,	O
we	O
constructed	O
a	O
homologous	O
suicide	O
plasmid	O
,	O
pUC	O
:	O
:	O
salKR	B-Protein
with	O
a	O
SpcR	B-Protein
cassette	O
(	O
Fig	O
.	O
3A	O
)	O
,	O
and	O
electrotransformed	O
the	O
competent	O
cells	O
of	O
05ZYH33	B-Organism
.	O

Positive	O
transformants	O
were	O
first	O
screened	O
on	O
THB	O
agar	O
plates	O
under	O
the	O
selective	O
pressure	O
of	O
spectinomycin	B-Chemical
.	O

Colony	O
PCR	O
-	O
based	O
assays	O
were	O
performed	O
to	O
detect	O
whether	O
salKR	B-Protein
was	O
still	O
present	O
in	O
the	O
genome	O
or	O
not	O
.	O

One	O
candidate	O
mutant	O
in	O
which	O
salKR	B-Protein
failed	O
to	O
be	O
amplified	O
was	O
obtained	O
.	O

To	O
check	O
this	O
suspected	O
mutant	O
,	O
Southern	O
hybridization	O
analyses	O
were	O
employed	O
using	O
probes	O
of	O
SpcR	B-Protein
gene	O
,	O
an	O
internal	O
fragment	O
of	O
salKR	B-Protein
,	O
and	O
pUC18	O
,	O
respectively	O
.	O

In	O
wild	O
type	O
strain	O
05ZYH33	B-Organism
,	O
the	O
internal	O
fragment	O
of	O
salKR	B-Protein
probe	O
hybridized	O
with	O
a	O
single	O
4	O
.	O
0	O
kb	O
Cla	O
I	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
1	O
)	O
,	O
whereas	O
the	O
SpcR	B-Protein
and	O
pUC18	O
probes	O
did	O
not	O
hybridized	O
with	O
the	O
genomic	O
DNA	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
1	O
)	O
.	O

In	O
the	O
suspected	O
mutant	O
,	O
a	O
3	O
.	O
6	O
kb	O
restriction	O
fragment	O
hybridized	O
with	O
the	O
SpcR	B-Protein
probe	O
(	O
Fig	O
.	O
3B	O
,	O
lane	O
2	O
)	O
,	O
while	O
no	O
hybridization	O
signal	O
was	O
detected	O
when	O
the	O
internal	O
fragment	O
of	O
salKR	B-Protein
and	O
pUC18	O
served	O
as	O
the	O
probes	O
(	O
Fig	O
.	O
3C	O
and	O
3D	O
,	O
lane	O
2	O
)	O
.	O

In	O
a	O
single	O
cross	O
-	O
over	O
mutant	O
which	O
was	O
set	O
as	O
the	O
reference	O
,	O
both	O
the	O
SpcR	B-Protein
and	O
pUC18	O
probe	O
hybridized	O
with	O
a	O
6	O
.	O
1	O
kb	O
Cla	O
I	O
restriction	O
fragment	O
(	O
Fig	O
.	O
3B	O
and	O
3D	O
,	O
lane	O
3	O
)	O
,	O
and	O
the	O
salKR	B-Protein
probe	O
hybridized	O
with	O
a	O
4	O
.	O
0	O
kb	O
fragment	O
(	O
Fig	O
.	O
3C	O
,	O
lane	O
3	O
)	O
,	O
indicating	O
that	O
this	O
strain	O
had	O
pUC	O
:	O
:	O
salKR	B-Protein
integrated	O
into	O
its	O
chromosome	O
by	O
a	O
single	O
cross	O
-	O
over	O
event	O
at	O
the	O
3	O
'	O
-	O
flanking	O
region	O
of	O
the	O
salKR	B-Protein
genes	O
(	O
Fig	O
.	O
3A	O
,	O
III	O
)	O
.	O

Additionally	O
,	O
the	O
allelic	O
replacement	O
of	O
the	O
wild	O
-	O
type	O
salKR	B-Protein
genes	O
by	O
the	O
SpcR	B-Protein
cassette	O
in	O
the	O
suspected	O
mutant	O
was	O
also	O
confirmed	O
by	O
multiple	O
-	O
PCR	O
analysis	O
and	O
sequencing	O
with	O
primers	O
specific	O
to	O
genomic	O
regions	O
lying	O
out	O
the	O
homologous	O
left	O
and	O
right	O
arms	O
(	O
Fig	O
.	O
3A	O
and	O
3E	O
)	O
.	O

All	O
these	O
results	O
demonstrate	O
that	O
an	O
isogenic	O
knockout	O
mutant	O
of	O
salKR	B-Protein
(	O
namely	O
DeltasalKR	B-Protein
)	O
was	O
successfully	O
constructed	O
.	O

RT	O
-	O
PCR	O
experiments	O
later	O
also	O
showed	O
that	O
neither	O
salK	B-Protein
nor	O
salR	B-Protein
could	O
be	O
transcribed	O
in	O
DeltasalKR	B-Protein
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
further	O
confirmed	O
that	O
salKR	B-Protein
had	O
been	O
deleted	O
from	O
the	O
bacterial	O
chromosome	O
.	O

Role	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
in	O
Virulence	O

Given	O
the	O
multiple	O
roles	O
of	O
TCSTS	O
in	O
bacteria	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
salKR	B-Protein
deletion	O
on	O
the	O
general	O
biological	O
characteristics	O
of	O
SS2	B-Organism
prior	O
to	O
in	O
vivo	O
work	O
.	O

First	O
,	O
the	O
ability	O
of	O
the	O
mutant	O
strain	O
to	O
retain	O
spectinomycin	B-Chemical
resistance	O
was	O
assessed	O
.	O

The	O
spectinomycin	B-Chemical
resistance	O
phenotype	O
was	O
stable	O
in	O
DeltasalKR	B-Protein
during	O
in	O
vitro	O
culture	O
(	O
data	O
not	O
shown	O
)	O
.	O

Next	O
,	O
the	O
growth	O
kinetics	O
curves	O
of	O
DeltasalKR	B-Protein
were	O
compared	O
with	O
that	O
of	O
WT	O
,	O
and	O
no	O
obvious	O
distinctions	O
were	O
observed	O
.	O

When	O
streaked	O
on	O
THB	O
plates	O
with	O
5	O
%	O
sheep	O
blood	O
,	O
DeltasalKR	B-Protein
and	O
WT	O
colonies	O
displayed	O
a	O
similar	O
haemolytic	O
phenotype	O
.	O

Finally	O
,	O
cell	O
morphology	O
and	O
ultrastructure	O
of	O
these	O
two	O
strains	O
were	O
examined	O
under	O
light	O
microscope	O
and	O
transmission	O
electron	O
microscope	O
respectively	O
,	O
however	O
,	O
no	O
significant	O
differences	O
were	O
found	O
(	O
Fig	O
.	O
4	O
)	O
.	O

An	O
experimental	O
infection	O
model	O
in	O
piglets	B-Organism
was	O
designed	O
to	O
assess	O
the	O
role	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
in	O
virulence	O
.	O

As	O
shown	O
in	O
Figure	O
5	O
,	O
all	O
six	O
SPF	O
-	O
piglets	B-Organism
inoculated	O
intravenously	O
with	O
WT	O
developed	O
most	O
of	O
the	O
typical	O
disease	O
symptoms	O
,	O
including	O
high	O
fever	O
,	O
limping	O
,	O
swollen	O
joints	O
,	O
shivering	O
,	O
CNS	O
failure	O
and	O
respiratory	O
failure	O
within	O
24	O
hrs	O
.	O

Five	O
of	O
them	O
died	O
on	O
day	O
2	O
post	O
-	O
infection	O
,	O
and	O
the	O
last	O
one	O
on	O
day	O
3	O
.	O

In	O
contrast	O
,	O
six	O
infected	O
piglets	B-Organism
with	O
an	O
avirulent	O
strain	O
,	O
05HAS68	B-Organism
(	O
as	O
negative	O
control	O
)	O
,	O
survived	O
nearly	O
without	O
any	O
obvious	O
symptoms	O
until	O
the	O
end	O
of	O
the	O
experiment	O
(	O
14	O
days	O
after	O
infection	O
)	O
.	O

Wherein	O
the	O
six	O
piglets	B-Organism
challenged	O
with	O
the	O
DeltasalKR	B-Protein
mutant	O
were	O
all	O
alive	O
and	O
symptom	O
-	O
free	O
during	O
the	O
entire	O
course	O
monitored	O
.	O

This	O
was	O
similar	O
to	O
those	O
observed	O
in	O
the	O
negative	O
control	O
group	O
,	O
indicating	O
that	O
DeltasalKR	B-Protein
totally	O
loses	O
its	O
lethality	O
.	O

The	O
experiments	O
of	O
functional	O
complementation	O
with	O
the	O
complemented	O
strain	O
CDeltasalKR	B-Protein
showed	O
clearly	O
that	O
the	O
reintroduction	O
of	O
salKR	B-Protein
into	O
DeltasalKR	B-Protein
restored	O
its	O
high	O
pathogenicity	O
.	O

Five	O
out	O
of	O
six	O
piglets	B-Organism
succumbed	O
to	O
the	O
lethal	O
infections	O
of	O
CDeltasalKR	B-Protein
and	O
died	O
,	O
with	O
median	O
survival	O
times	O
of	O
2	O
to	O
3	O
days	O
.	O

The	O
last	O
one	O
recovered	O
from	O
serious	O
clinical	O
symptoms	O
and	O
survived	O
at	O
the	O
experiments	O
end	O
.	O

All	O
these	O
results	O
strongly	O
suggest	O
that	O
SalK	B-Protein
/	O
SalR	B-Protein
plays	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
Chinese	O
isolates	O
of	O
highly	O
invasive	O
SS2	B-Organism
.	O

To	O
better	O
evaluate	O
the	O
virulence	O
attenuation	O
of	O
DeltasalKR	B-Protein
,	O
colonization	O
experiments	O
were	O
carried	O
out	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
wild	O
-	O
type	O
bacteria	O
were	O
found	O
in	O
all	O
of	O
the	O
SS2	B-Organism
specific	O
tissues	O
of	O
WT	O
-	O
infected	O
piglets	B-Organism
,	O
including	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
,	O
tonsil	O
,	O
brain	O
,	O
blood	O
,	O
joints	O
and	O
so	O
on	O
.	O

In	O
contrast	O
,	O
in	O
the	O
mutant	O
-	O
inoculated	O
group	O
,	O
no	O
mutant	O
bacteria	O
could	O
be	O
recovered	O
from	O
any	O
of	O
the	O
examined	O
tissue	O
specimens	O
.	O

Obviously	O
,	O
lack	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
badly	O
impaired	O
the	O
capability	O
of	O
05ZYH33	B-Organism
to	O
colonize	O
the	O
various	O
tissues	O
of	O
piglets	B-Organism
.	O

In	O
the	O
WT	O
/	O
DeltasalKR	B-Protein
coinfection	O
group	O
,	O
besides	O
the	O
detection	O
of	O
wild	O
-	O
type	O
bacteria	O
in	O
all	O
the	O
specimens	O
,	O
DeltasalKR	B-Protein
mutant	O
bacteria	O
could	O
also	O
be	O
isolated	O
from	O
some	O
susceptible	O
tissues	O
(	O
such	O
as	O
heart	O
,	O
kidney	O
,	O
tonsil	O
and	O
brain	O
)	O
at	O
a	O
lower	O
degree	O
than	O
the	O
wild	O
-	O
type	O
strain	O
.	O

We	O
anticipated	O
that	O
the	O
DeltasalKR	B-Protein
mutant	O
is	O
still	O
able	O
to	O
colonize	O
these	O
organs	O
,	O
is	O
just	O
due	O
to	O
the	O
WT	O
-	O
mediated	O
impairment	O
of	O
host	O
defense	O
against	O
SS2	B-Organism
infection	O
in	O
these	O
tissues	O
.	O

Decreased	O
Resistance	O
of	O
DeltasalKR	B-Protein
to	O
PMN	O
-	O
Mediated	O
Killing	O

Together	O
with	O
the	O
wild	O
type	O
strain	O
,	O
DeltasalKR	B-Protein
was	O
subjected	O
to	O
PMN	O
-	O
mediated	O
killing	O
assays	O
.	O

We	O
found	O
that	O
the	O
mortality	O
rate	O
of	O
both	O
strains	O
(	O
WT	O
and	O
DeltasalKR	B-Protein
)	O
increased	O
coordinately	O
with	O
the	O
extension	O
of	O
the	O
co	O
-	O
culture	O
time	O
with	O
PMN	O
cells	O
(	O
Fig	O
.	O
6	O
)	O
.	O

However	O
,	O
DeltasalKR	B-Protein
had	O
a	O
higher	O
mortality	O
rate	O
than	O
that	O
of	O
WT	O
,	O
which	O
means	O
that	O
DeltasalKR	B-Protein
was	O
less	O
able	O
to	O
resist	O
killing	O
by	O
PMNs	O
,	O
key	O
mediators	O
of	O
innate	O
immunity	O
.	O

This	O
result	O
may	O
account	O
partially	O
,	O
if	O
not	O
most	O
of	O
all	O
,	O
for	O
the	O
virulence	O
loss	O
in	O
DeltasalKR	B-Protein
.	O

Expression	O
Microarray	O
Analysis	O
of	O
the	O
Mutant	O
Strain	O
DeltasalKR	B-Protein

To	O
gain	O
further	O
insights	O
into	O
the	O
network	O
/	O
circuit	O
mediated	O
by	O
SalK	B-Protein
/	O
SalR	B-Protein
,	O
whole	O
-	O
genome	O
DNA	O
microarray	O
was	O
applied	O
to	O
reveal	O
the	O
differential	O
transcription	O
profiles	O
between	O
DeltasalKR	B-Protein
and	O
WT	O
[	O
13	O
]	O
,	O
[	O
19	O
]	O
.	O

For	O
identifying	O
genes	O
whose	O
expression	O
was	O
significantly	O
different	O
,	O
the	O
threshold	O
for	O
the	O
expression	O
ratio	O
between	O
the	O
mutant	O
and	O
wild	O
type	O
strain	O
was	O
set	O
at	O
2	O
.	O

In	O
total	O
,	O
the	O
absence	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
led	O
to	O
decreased	O
expression	O
of	O
26	O
genes	O
spread	O
throughout	O
the	O
genome	O
(	O
i	O
.	O
e	O
.	O
1	O
.	O
2	O
%	O
of	O
the	O
2194	O
tested	O
)	O
.	O

These	O
down	O
-	O
regulated	O
genes	O
can	O
be	O
roughly	O
categorized	O
into	O
the	O
3	O
groups	O
,	O
which	O
can	O
be	O
found	O
in	O
Table	O
2	O
.	O

Genes	O
involved	O
in	O
substance	O
transport	O
and	O
metabolism	O
In	O
the	O
DeltasalKR	B-Protein
mutant	O
,	O
transcripts	O
of	O
several	O
ABC	O
-	O
transporters	O
are	O
less	O
abundant	O
.	O

As	O
learned	O
,	O
ABC	O
-	O
transporters	O
and	O
permeases	O
are	O
usually	O
involved	O
in	O
controlling	O
influx	O
and	O
efflux	O
of	O
small	O
molecules	O
through	O
metabolic	O
pathways	O
in	O
response	O
to	O
environmental	O
changes	O
in	O
bacteria	O
[	O
27	O
]	O
.	O

Multidrug	O
resistance	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
and	O
pathogenicity	O
[	O
10	O
]	O
can	O
also	O
be	O
attributed	O
to	O
ABC	O
-	O
transporters	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
over	O
-	O
expression	O
of	O
ABC	O
-	O
type	O
multidrug	O
transporters	O
can	O
efficiently	O
evade	O
the	O
pressure	O
of	O
drugs	O
and	O
enhance	O
the	O
invasion	O
ability	O
of	O
pathogens	O
[	O
28	O
]	O
-	O
[	O
30	O
]	O
.	O

Furthermore	O
,	O
orotidine	B-Chemical
-	I-Chemical
5	I-Chemical
-	I-Chemical
phosphate	I-Chemical
decarboxylase	O
(	O
05SSU1009	B-Protein
)	O
,	O
a	O
newly	O
identified	O
pathogenesis	O
-	O
related	O
protein	O
in	O
Vibrio	B-Organism
vulnificus	I-Organism
[	O
31	O
]	O
,	O
was	O
also	O
found	O
to	O
be	O
repressed	O
greatly	O
in	O
DeltasalKR	B-Protein
.	O

Daigle	O
et	O
al	O
.	O

[	O
32	O
]	O
has	O
shown	O
that	O
mutation	O
of	O
phosphotransferase	O
system	O
(	O
PST	O
)	O
in	O
extraintestinal	B-Organism
pathogenic	I-Organism
E	I-Organism
.	I-Organism
coli	I-Organism
(	O
ExPEC	B-Organism
)	O
can	O
cause	O
the	O
loss	O
of	O
its	O
colonization	O
ability	O
in	O
extraintestinal	O
organs	O
,	O
and	O
bacteria	O
are	O
cleared	O
rapidly	O
from	O
the	O
bloodstream	O
.	O

Similarly	O
,	O
we	O
observed	O
that	O
pst	B-Protein
(	O
05SSU0451	B-Protein
)	O
is	O
down	O
-	O
regulated	O
in	O
DeltasalKR	B-Protein
whose	O
survival	O
in	O
the	O
bloodstream	O
is	O
drastically	O
affected	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Genes	O
revolved	O
in	O
recombination	O
/	O
repair	O
and	O
transcription	O

Together	O
with	O
some	O
elements	O
of	O
DNA	O
recombination	O
/	O
repair	O
(	O
05SSU0063	B-Protein
,	O
05SSU0588	B-Protein
and	O
05SSU0953	B-Protein
)	O
,	O
two	O
transcription	O
regulators	O
(	O
05SSU0503	B-Protein
and	O
05SSU1233	B-Protein
)	O
were	O
also	O
under	O
the	O
regulation	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
.	O

Although	O
these	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
,	O
it	O
is	O
not	O
understood	O
how	O
they	O
are	O
associated	O
with	O
the	O
attenuation	O
of	O
DeltasalKR	B-Protein
.	O

Genes	O
encoding	O
proteins	O
of	O
unknown	O
function	O

Several	O
membrane	O
proteins	O
such	O
as	O
05SSU0677	B-Protein
and	O
05SSU1912	B-Protein
were	O
also	O
repressed	O
in	O
DeltasalKR	B-Protein
.	O

It	O
is	O
well	O
documented	O
that	O
surface	O
proteins	O
or	O
cell	O
wall	O
-	O
anchored	O
proteins	O
are	O
usually	O
thought	O
to	O
contribute	O
to	O
the	O
immunogenicity	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
,	O
invasiveness	O
[	O
35	O
]	O
-	O
[	O
37	O
]	O
,	O
and	O
even	O
pathogenesis	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
of	O
pathogens	O
.	O

Moreover	O
,	O
it	O
should	O
be	O
noted	O
that	O
numerous	O
proteins	O
of	O
unknown	O
function	O
are	O
also	O
depressed	O
in	O
DeltasalKR	B-Protein
,	O
which	O
may	O
in	O
part	O
lead	O
to	O
the	O
virulence	O
loss	O
of	O
the	O
mutant	O
via	O
some	O
thus	O
-	O
far	O
-	O
unknown	O
mechanisms	O
.	O

Remarkably	O
,	O
no	O
gene	O
was	O
found	O
to	O
be	O
up	O
-	O
regulated	O
(	O
more	O
than	O
twice	O
)	O
in	O
DeltasalKR	B-Protein
.	O

To	O
examine	O
the	O
validity	O
of	O
the	O
microarray	O
data	O
,	O
we	O
performed	O
further	O
quantitative	O
real	O
-	O
time	O
PCR	O
analysis	O
on	O
42	O
genes	O
using	O
RNA	O
from	O
three	O
independent	O
cultures	O
of	O
each	O
strain	O
(	O
WT	O
,	O
the	O
DeltasalKR	B-Protein
mutant	O
and	O
the	O
complemented	O
strain	O
CDeltasalKR	B-Protein
)	O
.	O

These	O
genes	O
include	O
the	O
total	O
26	O
ones	O
that	O
are	O
down	O
-	O
regulated	O
in	O
the	O
DeltasalKR	B-Protein
mutant	O
,	O
four	O
virulence	O
factors	O
(	O
CPS	O
,	O
MRP	O
,	O
EF	O
,	O
SLY	O
)	O
coding	O
genes	O
[	O
40	O
]	O
-	O
[	O
44	O
]	O
,	O
genes	O
immediately	O
flanking	O
the	O
salKR	B-Protein
locus	O
(	O
05SSU0945	B-Protein
and	O
05SSU0942	B-Protein
)	O
,	O
and	O
10	O
genes	O
that	O
selected	O
from	O
the	O
chromosome	O
of	O
05ZYH33	B-Organism
every	O
200	O
ORFs	O
.	O

As	O
shown	O
in	O
Table	O
S1	O
,	O
the	O
quantitative	O
results	O
of	O
RT	O
-	O
PCR	O
were	O
highly	O
compatible	O
to	O
the	O
microarray	O
data	O
,	O
in	O
the	O
DeltasalKR	B-Protein
mutant	O
,	O
41	O
out	O
of	O
42	O
selected	O
genes	O
(	O
97	O
.	O
6	O
%	O
)	O
were	O
confirmed	O
to	O
have	O
similar	O
transcript	O
levels	O
using	O
these	O
two	O
different	O
techniques	O
,	O
thus	O
independently	O
confirming	O
the	O
microarray	O
results	O
.	O

The	O
discrepancies	O
of	O
target	O
genes	O
expression	O
between	O
microarray	O
data	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
results	O
probably	O
best	O
reflects	O
differences	O
in	O
the	O
relative	O
sensitivity	O
and	O
specificity	O
of	O
the	O
two	O
methods	O
.	O

Among	O
the	O
26	O
down	O
-	O
regulated	O
genes	O
in	O
the	O
DeltasalKR	B-Protein
mutant	O
,	O
five	O
did	O
not	O
recover	O
to	O
expression	O
level	O
of	O
the	O
wild	O
-	O
type	O
strain	O
,	O
indicating	O
that	O
the	O
complemented	O
strain	O
does	O
not	O
imitate	O
completely	O
the	O
exact	O
tuning	O
of	O
gene	O
expression	O
as	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Discussion	O

Since	O
the	O
first	O
description	O
of	O
human	B-Organism
infection	O
in	O
Denmark	O
in	O
1968	O
,	O
SS2	B-Organism
seems	O
to	O
have	O
developed	O
some	O
unknown	O
machinery	O
to	O
behave	O
much	O
more	O
invasively	O
,	O
which	O
is	O
supported	O
by	O
two	O
recent	O
large	O
-	O
scale	O
outbreaks	O
of	O
human	B-Organism
epidemics	O
in	O
China	O
(	O
one	O
had	O
25	O
cases	O
with	O
14	O
deaths	O
in	O
Jiangsu	O
in	O
1998	O
,	O
the	O
second	O
had	O
204	O
cases	O
with	O
38	O
deaths	O
in	O
Sichuan	O
in	O
2005	O
)	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
.	O

During	O
the	O
past	O
decades	O
,	O
a	O
series	O
of	O
virulence	O
determinants	O
of	O
SS2	B-Organism
involved	O
in	O
the	O
survival	O
,	O
spread	O
and	O
pathopoiesis	O
of	O
the	O
bacterium	O
within	O
the	O
host	O
have	O
been	O
identified	O
,	O
such	O
as	O
capsule	B-Chemical
polysaccharide	I-Chemical
(	O
CPS	B-Chemical
)	O
,	O
muramidase	O
-	O
related	O
protein	O
(	O
MRP	O
)	O
,	O
suilysin	B-Chemical
,	O
etc	O
.	O

Very	O
recently	O
,	O
Chen	O
et	O
al	O
.	O

[	O
6	O
]	O
reported	O
a	O
candidate	O
PAI	O
of	O
approximately89	O
kb	O
in	O
the	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
infections	O
in	O
China	O
,	O
gave	O
some	O
genomic	O
clues	O
for	O
elucidating	O
molecular	O
pathways	O
by	O
which	O
SS2	B-Organism
behaved	O
so	O
aggressively	O
.	O

However	O
,	O
they	O
did	O
not	O
provide	O
sufficient	O
experimental	O
evidence	O
supporting	O
the	O
prediction	O
of	O
89K	O
PAI	O
which	O
was	O
largely	O
based	O
on	O
the	O
results	O
of	O
bioinformatical	O
analysis	O
,	O
and	O
the	O
functions	O
of	O
the	O
vast	O
majority	O
of	O
genes	O
encoding	O
within	O
the	O
89K	O
island	O
remain	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
carried	O
out	O
a	O
detailed	O
structural	O
and	O
functional	O
analysis	O
of	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
designated	O
SalK	B-Protein
/	O
SalR	B-Protein
which	O
is	O
located	O
in	O
the	O
putative	O
89K	O
PAI	O
.	O

Bioinformatics	O
analysis	O
revealed	O
that	O
the	O
GC	O
content	O
of	O
salKR	B-Protein
is	O
far	O
less	O
than	O
that	O
of	O
89K	O
island	O
and	O
the	O
whole	O
genome	O
,	O
implying	O
that	O
this	O
TCSTS	O
is	O
of	O
foreign	O
origin	O
which	O
may	O
have	O
been	O
acquired	O
through	O
horizontal	O
gene	O
transfer	O
.	O

It	O
has	O
been	O
well	O
documented	O
that	O
horizontal	O
gene	O
transfer	O
events	O
occur	O
frequently	O
in	O
pathogens	O
[	O
45	O
]	O
-	O
[	O
47	O
]	O
,	O
and	O
some	O
of	O
them	O
have	O
been	O
implicated	O
in	O
high	O
pathogenicity	O
[	O
48	O
]	O
and	O
even	O
in	O
the	O
causation	O
of	O
severe	O
diseases	O
[	O
49	O
]	O
.	O

Suilysin	B-Chemical
,	O
a	O
known	O
virulence	O
factor	O
,	O
was	O
believed	O
to	O
be	O
introduced	O
into	O
SS2	B-Organism
via	O
lateral	O
gene	O
transfer	O
[	O
43	O
]	O
.	O

Moreover	O
,	O
PCR	O
analysis	O
using	O
primers	O
amplifying	O
the	O
salKR	B-Protein
locus	O
also	O
demonstrated	O
that	O
this	O
TCSTS	O
is	O
specific	O
to	O
Chinese	O
epidemic	O
outbreak	O
strains	O
of	O
SS2	B-Organism
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
its	O
tight	O
linkage	O
to	O
the	O
virulence	O
of	O
this	O
new	O
emerging	O
pathogenic	O
species	O
.	O

In	O
order	O
to	O
define	O
the	O
role	O
of	O
SalK	B-Protein
/	O
SalR	B-Protein
in	O
SS2	B-Organism
infection	O
,	O
an	O
isogenic	O
SalK	B-Protein
/	O
SalR	B-Protein
-	O
deficient	O
mutant	O
was	O
generated	O
and	O
the	O
impact	O
of	O
salKR	B-Protein
deletion	O
on	O
virulence	O
of	O
SS2	B-Organism
was	O
assessed	O
.	O

Results	O
of	O
piglets	B-Organism
experimental	O
infections	O
clearly	O
showed	O
that	O
the	O
deletion	O
of	O
salKR	B-Protein
leads	O
to	O
elimination	O
of	O
the	O
lethality	O
of	O
this	O
important	O
pathogen	O
.	O

Colonization	O
analysis	O
also	O
revealed	O
the	O
incapability	O
of	O
the	O
DeltasalKR	B-Protein
mutant	O
to	O
colonize	O
any	O
susceptible	O
tissue	O
of	O
piglets	B-Organism
when	O
administered	O
alone	O
.	O

These	O
results	O
indicate	O
definitely	O
that	O
SalK	B-Protein
/	O
SalR	B-Protein
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenicity	O
of	O
SS2	B-Organism
.	O

The	O
reduction	O
in	O
virulence	O
was	O
mostly	O
restored	O
in	O
a	O
complemented	O
strain	O
upon	O
reintroduction	O
of	O
functional	O
copies	O
of	O
salK	B-Protein
and	O
salR	B-Protein
into	O
the	O
mutant	O
,	O
suggesting	O
that	O
it	O
did	O
not	O
result	O
from	O
polar	O
effects	O
on	O
expression	O
of	O
flanking	O
genes	O
.	O

We	O
consider	O
that	O
the	O
partial	O
complementation	O
observed	O
in	O
the	O
piglets	B-Organism
infection	O
model	O
is	O
inherent	O
to	O
the	O
pleiotropic	O
role	O
of	O
this	O
regulatory	O
system	O
which	O
makes	O
it	O
difficult	O
to	O
restore	O
the	O
fine	O
tuning	O
of	O
gene	O
expression	O
as	O
in	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Results	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
also	O
confirmed	O
that	O
,	O
in	O
the	O
complemented	O
strain	O
CDeltasalKR	B-Protein
,	O
only	O
partial	O
genes	O
identified	O
as	O
down	O
-	O
regulated	O
in	O
the	O
mutant	O
rebounded	O
to	O
comparative	O
transcript	O
levels	O
of	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Those	O
unrecovered	O
genes	O
were	O
probably	O
irrelavent	O
to	O
the	O
bacterial	O
virulence	O
of	O
SS2	B-Organism
.	O

It	O
is	O
known	O
that	O
TCSTSs	O
are	O
often	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
direct	O
downstream	O
genes	O
.	O

However	O
,	O
genes	O
immediately	O
flanking	O
the	O
salKR	B-Protein
locus	O
were	O
identified	O
as	O
transcriptionally	O
unaffected	O
by	O
the	O
disruption	O
of	O
the	O
salKR	B-Protein
genes	O
.	O

This	O
result	O
is	O
in	O
agreement	O
with	O
the	O
predicted	O
operon	O
organization	O
in	O
the	O
genome	O
,	O
which	O
suggests	O
that	O
salK	B-Protein
and	O
salR	B-Protein
are	O
a	O
single	O
co	O
-	O
transcriptional	O
unit	O
.	O

Among	O
the	O
26	O
target	O
genes	O
affected	O
by	O
SalK	B-Protein
/	O
SalR	B-Protein
,	O
17	O
of	O
them	O
(	O
65	O
.	O
4	O
%	O
)	O
were	O
predicted	O
to	O
be	O
monocistronically	O
transcribed	O
,	O
the	O
others	O
to	O
be	O
part	O
of	O
larger	O
transcriptional	O
units	O
(	O
Table	O
2	O
)	O
.	O

For	O
those	O
members	O
belonging	O
to	O
putative	O
transcriptional	O
operons	O
,	O
microarray	O
results	O
showed	O
that	O
most	O
of	O
those	O
genes	O
cotranscribed	O
with	O
them	O
were	O
also	O
down	O
-	O
regulated	O
to	O
a	O
various	O
degree	O
,	O
although	O
under	O
the	O
threshold	O
of	O
2	O
.	O

In	O
the	O
89K	O
island	O
,	O
transcripts	O
of	O
only	O
two	O
genes	O
designated	O
05SSU0935	B-Protein
and	O
05SSU0953	B-Protein
that	O
encode	O
a	O
hypothetical	O
protein	O
and	O
a	O
DNA	O
recombinase	O
respectively	O
,	O
were	O
decreased	O
in	O
DeltasalKR	B-Protein
,	O
their	O
contributions	O
to	O
the	O
attenuation	O
are	O
unknown	O
.	O

It	O
seems	O
that	O
SalK	B-Protein
/	O
SalR	B-Protein
may	O
control	O
the	O
full	O
virulence	O
of	O
SS2	B-Organism
by	O
regulating	O
distant	O
gene	O
expression	O
at	O
the	O
genome	O
-	O
wide	O
level	O
.	O

Further	O
investigation	O
of	O
other	O
transcriptional	O
alterations	O
observed	O
in	O
the	O
microarray	O
data	O
will	O
be	O
required	O
for	O
a	O
better	O
understanding	O
of	O
pathogenesis	O
of	O
this	O
highly	O
pathogenic	O
pathogen	O
.	O

Efforts	O
are	O
currently	O
being	O
made	O
in	O
order	O
to	O
address	O
functions	O
of	O
those	O
down	O
-	O
regulated	O
hypothetical	O
proteins	O
individually	O
.	O

It	O
has	O
been	O
described	O
that	O
genes	O
essential	O
for	O
viability	O
and	O
important	O
virulence	O
factors	O
are	O
often	O
under	O
the	O
regulation	O
of	O
TCSTS	O
.	O

However	O
,	O
in	O
our	O
study	O
,	O
neither	O
microarray	O
findings	O
nor	O
further	O
analysis	O
of	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
any	O
differences	O
in	O
level	O
of	O
transcription	O
of	O
the	O
known	O
virulence	O
factors	O
(	O
CPS	B-Chemical
,	O
suilysin	B-Chemical
,	O
MRP	O
and	O
EF	O
)	O
between	O
the	O
wild	O
type	O
and	O
mutant	O
strain	O
.	O

Several	O
possible	O
explanations	O
may	O
be	O
envisaged	O
.	O

First	O
,	O
some	O
pathogenic	O
determinants	O
are	O
environmentally	O
regulated	O
and	O
induced	O
at	O
specific	O
stages	O
of	O
the	O
infection	O
process	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

Secondly	O
,	O
some	O
of	O
the	O
TCSTSs	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
were	O
suggested	O
to	O
be	O
involved	O
in	O
key	O
processes	O
of	O
pathogenesis	O
,	O
such	O
as	O
autolysis	O
and	O
cell	O
-	O
cell	O
signaling	O
[	O
52	O
]	O
,	O
SalK	B-Protein
/	O
SalR	B-Protein
might	O
regulate	O
similar	O
processes	O
in	O
Chinese	O
SS2	B-Organism
virulent	O
isolates	O
.	O

More	O
importantly	O
,	O
accumulated	O
evidence	O
suggests	O
that	O
some	O
of	O
the	O
known	O
virulent	O
factors	O
are	O
not	O
requisite	O
for	O
the	O
full	O
virulence	O
of	O
SS2	B-Organism
,	O
as	O
the	O
absence	O
of	O
one	O
or	O
more	O
of	O
these	O
proteins	O
in	O
isolates	O
from	O
infected	O
animals	O
cannot	O
necessarily	O
be	O
associated	O
with	O
a	O
lack	O
of	O
virulence	O
[	O
53	O
]	O
-	O
[	O
56	O
]	O
.	O

In	O
conclusion	O
,	O
a	O
unique	O
two	O
-	O
component	O
regulatory	O
system	O
SalK	B-Protein
/	O
SalR	B-Protein
has	O
been	O
identified	O
from	O
a	O
putative	O
89K	O
PAI	O
in	O
Chinese	O
isolates	O
of	O
highly	O
pathogenic	O
SS2	B-Organism
.	O

Prior	O
to	O
this	O
study	O
,	O
SalK	B-Protein
/	O
SalR	B-Protein
is	O
only	O
known	O
to	O
be	O
associated	O
with	O
the	O
production	O
of	O
a	O
kind	O
of	O
lantibiotic	O
peptide	O
named	O
salivaricin	B-Chemical
A	I-Chemical
(	O
SalA	B-Chemical
)	O
in	O
S	B-Organism
.	I-Organism
salivarius	I-Organism
[	O
11	O
]	O
,	O
as	O
yet	O
,	O
this	O
TCSTS	O
has	O
not	O
been	O
linked	O
to	O
the	O
regulation	O
of	O
bacterial	O
virulence	O
.	O

Our	O
data	O
confirm	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
SalK	B-Protein
/	O
SalR	B-Protein
is	O
absolutely	O
indispensable	O
for	O
the	O
full	O
virulence	O
of	O
Chinese	O
highly	O
invasive	O
SS2	B-Organism
strains	O
,	O
although	O
we	O
fails	O
to	O
define	O
its	O
precise	O
regulatory	O
mechanism	O
.	O

Not	O
only	O
does	O
this	O
investigation	O
provide	O
experimental	O
evidence	O
for	O
the	O
validity	O
of	O
the	O
candidate	O
89K	O
PAI	O
,	O
but	O
it	O
adds	O
novel	O
insights	O
into	O
the	O
infectious	O
disease	O
pathogenesis	O
of	O
SS2	B-Organism
.	O

RpoE	B-Protein
fine	O
tunes	O
expression	O
of	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
factors	O
in	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism

Background	O
The	O
survival	O
of	O
Salmonella	B-Organism
enterica	I-Organism
within	O
the	O
intracellular	O
host	O
niche	O
requires	O
highly	O
co	O
-	O
ordinated	O
expression	O
of	O
virulence	O
effectors	O
predominantly	O
regulated	O
by	O
the	O
SsrAB	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
.	O

S	B-Organism
.	I-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
mutants	I-Organism
lacking	O
the	O
ssrAB	B-Protein
genes	O
are	O
avirulent	O
in	O
mice	B-Organism
,	O
highlighting	O
the	O
importance	O
of	O
this	O
regulatory	O
system	O
in	O
vivo	O
.	O

Mutants	O
lacking	O
the	O
gene	O
encoding	O
the	O
alternative	O
sigma	O
factor	O
sigmaE	B-Protein
(	O
rpoE	B-Protein
)	O
are	O
also	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
,	O
pointing	O
to	O
a	O
potential	O
connection	O
with	O
the	O
SsrAB	B-Protein
regulatory	O
system	O
.	O

Results	O
In	O
this	O
study	O
we	O
demonstrate	O
that	O
RpoE	B-Protein
is	O
involved	O
in	O
fine	O
-	O
tuning	O
the	O
expression	O
of	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
found	O
in	O
the	O
Salmonella	B-Organism
pathogenicity	O
island	O
-	O
2	O
(	O
SPI	O
-	O
2	O
)	O
genetic	O
locus	O
that	O
encodes	O
a	O
horizontally	O
acquired	O
type	O
III	O
secretion	O
system	O
,	O
and	O
unlinked	O
genes	O
integrated	O
into	O
this	O
regulon	O
that	O
are	O
required	O
for	O
virulence	O
in	O
host	O
animals	O
.	O

Conclusion	O
These	O
data	O
point	O
to	O
a	O
potential	O
connection	O
between	O
the	O
virulence	O
phenotype	O
of	O
strains	O
lacking	O
ssrB	B-Protein
and	O
rpoE	B-Protein
,	O
and	O
highlight	O
new	O
transcriptional	O
regulation	O
that	O
might	O
be	O
essential	O
for	O
appropriate	O
temporal	O
and	O
spatial	O
control	O
of	O
the	O
virulence	O
-	O
associated	O
type	O
III	O
secretion	O
system	O
during	O
host	O
infection	O
.	O

Background	O

Salmonella	B-Organism
enterica	I-Organism
are	O
enteric	O
pathogens	O
that	O
acquired	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
through	O
horizontal	O
gene	O
transfer	O
of	O
a	O
genomic	O
island	O
termed	O
Salmonella	O
Pathogenicity	O
Island	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
and	O
its	O
translocated	O
effectors	O
modify	O
the	O
intracellular	O
host	O
niche	O
for	O
Salmonella	B-Organism
replication	O
[	O
3	O
-	O
5	O
]	O
.	O

SPI	O
-	O
2	O
also	O
has	O
genes	O
,	O
ssrA	B-Protein
and	O
ssrB	B-Protein
,	O
which	O
code	O
for	O
SsrAB	B-Protein
,	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
needed	O
for	O
expression	O
of	O
the	O
T3SS	O
[	O
6	O
,	O
7	O
]	O
.	O

SsrB	B-Protein
regulates	O
the	O
expression	O
of	O
SPI	O
-	O
2	O
encoded	O
substrate	O
effectors	O
including	O
ssaB	B-Protein
,	O
as	O
well	O
as	O
several	O
integrated	O
virulence	O
effectors	O
such	O
as	O
sseL	B-Protein
[	O
8	O
]	O
and	O
srfN	B-Protein
[	O
9	O
]	O
that	O
are	O
encoded	O
elsewhere	O
on	O
the	O
chromosome	O
but	O
that	O
have	O
integrated	O
into	O
the	O
SsrB	B-Protein
regulon	O
.	O

Mutants	O
lacking	O
ssrAB	B-Protein
are	O
unable	O
to	O
survive	O
within	O
macrophages	O
and	O
are	O
avirulent	O
in	O
mice	B-Organism
[	O
1	O
]	O
.	O

Alternative	O
sigma	O
factors	O
coordinate	O
gene	O
expression	O
in	O
response	O
to	O
environmental	O
cues	O
sensed	O
by	O
the	O
bacterium	O
.	O

Sigma	O
factors	O
have	O
a	O
specific	O
recognition	O
motif	O
at	O
the	O
-	O
35	O
and	O
-	O
10	O
positions	O
and	O
function	O
to	O
concentrate	O
RNA	O
polymerase	O
at	O
a	O
subset	O
of	O
promoters	O
[	O
10	O
]	O
.	O

One	O
alternative	O
sigma	O
factor	O
,	O
RpoE	B-Protein
(	O
sigmaE	B-Protein
)	O
responds	O
to	O
envelope	O
stress	O
at	O
the	O
cell	O
surface	O
.	O

Release	O
of	O
sigmaE	B-Protein
from	O
its	O
inner	O
membrane	O
anchored	O
anti	O
-	O
sigma	O
factor	O
,	O
RseA	B-Protein
,	O
leads	O
to	O
induction	O
of	O
genes	O
required	O
to	O
maintain	O
cell	O
envelope	O
integrity	O
[	O
11	O
]	O
.	O

SsrB	B-Protein
-	O
regulated	O
translocated	O
effectors	O
protect	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
against	O
host	O
cell	O
defences	O
such	O
as	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
that	O
perturb	O
bacterial	O
membrane	O
integrity	O
and	O
provide	O
a	O
stimulus	O
for	O
sigmaE	B-Protein
release	O
[	O
4	O
,	O
12	O
-	O
15	O
]	O
.	O

Although	O
proficient	O
at	O
cellular	O
invasion	O
,	O
rpoE	B-Organism
or	O
ssrB	B-Protein
mutants	O
are	O
highly	O
attenuated	O
for	O
intracellular	O
survival	O
in	O
both	O
cultured	O
cells	O
and	O
animal	O
hosts	O
[	O
16	O
]	O
.	O

In	O
addition	O
,	O
the	O
expression	O
of	O
rpoE	B-Protein
and	O
ssrB	B-Protein
is	O
up	O
-	O
regulated	O
within	O
macrophages	O
[	O
17	O
]	O
.	O

Links	O
between	O
RpoE	B-Protein
and	O
virulence	O
gene	O
expression	O
is	O
evident	O
in	O
other	O
bacterial	O
systems	O
as	O
well	O
.	O

Deletion	O
of	O
rseA	B-Protein
in	O
Yersinia	B-Organism
pseudotuberculosis	I-Organism
causes	O
elevated	O
virulence	O
effector	O
synthesis	O
and	O
secretion	O
[	O
18	O
]	O
,	O
establishing	O
links	O
between	O
alternative	O
sigma	O
factors	O
and	O
virulence	O
-	O
specific	O
regulators	O
.	O

Taken	O
together	O
,	O
a	O
connection	O
between	O
sigmaE	B-Regulon-operon
and	O
SsrB	B-Protein
is	O
suggested	O
from	O
the	O
available	O
literature	O
,	O
however	O
the	O
role	O
of	O
sigmaE	B-Regulon-operon
in	O
activating	O
SsrB	B-Protein
-	O
regulated	O
genes	O
has	O
not	O
been	O
studied	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
RpoE	B-Protein
is	O
involved	O
in	O
expression	O
of	O
genes	O
that	O
use	O
the	O
SsrB	B-Protein
response	O
regulator	O
for	O
activation	O
.	O

By	O
testing	O
six	O
promoters	O
representing	O
four	O
classes	O
of	O
SsrB	B-Protein
-	O
regulated	O
promoters	O
(	O
(	O
i	O
)	O
two	O
type	O
III	O
secretion	O
structural	O
operons	O
in	O
SPI	O
-	O
2	O
,	O
(	O
ii	O
)	O
the	O
effector	O
operon	O
in	O
SPI	O
-	O
2	O
,	O
(	O
iii	O
)	O
two	O
effector	O
genes	O
unlinked	O
with	O
SPI	O
-	O
2	O
,	O
and	O
(	O
iv	O
)	O
an	O
integrated	O
virulence	O
gene	O
unlinked	O
with	O
SPI	O
-	O
2	O
)	O
we	O
demonstrate	O
that	O
RpoE	B-Protein
elicits	O
an	O
effect	O
on	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
.	O

This	O
effect	O
was	O
bidirectional	O
depending	O
on	O
the	O
promoter	O
and	O
was	O
downstream	O
of	O
ssrB	B-Protein
expression	O
itself	O
,	O
since	O
deletion	O
of	O
rpoE	B-Protein
had	O
no	O
effect	O
on	O
SsrB	B-Protein
levels	O
in	O
the	O
mutant	O
cells	O
.	O

These	O
data	O
help	O
unite	O
the	O
virulence	O
phenotypes	O
of	O
strains	O
lacking	O
SsrB	B-Protein
and	O
RpoE	B-Protein
,	O
and	O
highlight	O
new	O
transcriptional	O
regulation	O
that	O
might	O
be	O
essential	O
for	O
appropriate	O
temporal	O
and	O
spatial	O
control	O
of	O
the	O
virulence	O
-	O
associated	O
type	O
III	O
secretion	O
system	O
during	O
host	O
infection	O
.	O

Results	O

Deletion	O
of	O
rpoE	B-Protein
affects	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
Salmonella	B-Organism
virulence	O
gene	O
expression	O
is	O
coordinated	O
in	O
vivo	O
and	O
may	O
be	O
regulated	O
,	O
in	O
part	O
,	O
by	O
alternative	O
sigma	O
factor	O
(	O
s	O
)	O
in	O
order	O
to	O
quickly	O
respond	O
to	O
the	O
host	O
environment	O
.	O

To	O
date	O
,	O
no	O
sigma	O
factor	O
has	O
been	O
identified	O
as	O
regulating	O
SsrB	B-Protein
-	O
dependent	O
virulence	O
genes	O
.	O

To	O
start	O
,	O
we	O
first	O
screened	O
four	O
alternative	O
sigma	O
factor	O
mutants	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
(	O
rpoS	B-Protein
,	O
rpoN	B-Protein
,	O
rpoE	B-Protein
,	O
rpoH	B-Protein
)	O
for	O
their	O
ability	O
to	O
express	O
a	O
key	O
virulence	O
gene	O
,	O
sseB	B-Protein
,	O
that	O
requires	O
SsrB	B-Protein
for	O
expression	O
and	O
whose	O
gene	O
product	O
is	O
essential	O
for	O
intracellular	O
pathogenesis	O
.	O

For	O
an	O
rpoH	B-Protein
deletion	O
,	O
this	O
strain	O
was	O
only	O
viable	O
at	O
temperatures	O
below	O
30degreesC	O
.	O

Since	O
SPI	O
-	O
2	O
gene	O
activation	O
is	O
integrated	O
into	O
a	O
thermosensing	O
circuit	O
[	O
19	O
]	O
we	O
were	O
unable	O
to	O
test	O
the	O
role	O
of	O
sigmaH	B-Protein
in	O
this	O
study	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
this	O
screen	O
,	O
rpoS	B-Protein
deletion	O
resulted	O
in	O
a	O
slight	O
increase	O
in	O
SseB	B-Protein
levels	O
(	O
Figure	O
1A	O
)	O
indicating	O
a	O
role	O
for	O
RpoS	B-Protein
in	O
the	O
repression	O
of	O
SPI	O
-	O
2	O
.	O

Both	O
rpoE	B-Protein
and	O
rpoN	B-Protein
deletions	O
resulted	O
in	O
decreased	O
SseB	B-Protein
levels	O
with	O
a	O
more	O
pronounced	O
effect	O
in	O
the	O
rpoE	B-Protein
deletion	O
.	O

Since	O
we	O
were	O
predominantly	O
interested	O
in	O
sigma	O
factors	O
that	O
activate	O
SPI	O
-	O
2	O
and	O
which	O
could	O
be	O
linked	O
to	O
the	O
previous	O
observation	O
that	O
rpoE	B-Protein
mutants	O
are	O
highly	O
attenuated	O
in	O
vivo	O
we	O
choose	O
to	O
focus	O
on	O
RpoE	B-Protein
in	O
the	O
current	O
study	O
,	O
which	O
had	O
the	O
most	O
influence	O
on	O
SseB	B-Protein
levels	O
in	O
the	O
cell	O
.	O

An	O
unmarked	O
in	O
-	O
frame	O
deletion	O
of	O
rpoE	B-Protein
was	O
then	O
generated	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
strain	I-Organism
SL1344	I-Organism
and	O
we	O
verified	O
that	O
this	O
in	O
-	O
frame	O
deletion	O
had	O
the	O
same	O
effect	O
on	O
SseB	B-Protein
as	O
the	O
rpoE	B-Protein
:	O
:	O
cat	B-Protein
mutant	O
used	O
previously	O
(	O
Figure	O
1B	O
)	O
.	O

A	O
low	O
-	O
copy	O
plasmid	O
containing	O
full	O
-	O
length	O
rpoE	B-Protein
and	O
the	O
three	O
endogenous	O
promoters	O
that	O
can	O
drive	O
its	O
expression	O
[	O
20	O
]	O
was	O
able	O
to	O
restore	O
wild	O
type	O
levels	O
of	O
SseB	B-Protein
to	O
DeltarpoE	B-Protein
cells	O
(	O
Figure	O
1B	O
)	O
demonstrating	O
that	O
the	O
results	O
were	O
specific	O
to	O
the	O
rpoE	B-Protein
deletion	O
.	O

In	O
these	O
complementation	O
experiments	O
,	O
attempts	O
were	O
made	O
to	O
examine	O
the	O
levels	O
of	O
SseB	B-Protein
secreted	O
into	O
the	O
culture	O
supernatant	O
[	O
21	O
]	O
,	O
however	O
consistent	O
with	O
previous	O
observations	O
[	O
22	O
,	O
23	O
]	O
perturbations	O
to	O
the	O
rpoE	B-Protein
pathway	O
increased	O
cell	O
lysis	O
resulting	O
in	O
contamination	O
of	O
secreted	O
fractions	O
with	O
cytosolic	O
proteins	O
which	O
precluded	O
accurate	O
interpretation	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
examine	O
the	O
effect	O
of	O
sigmaE	B-Protein
(	O
rpoE	B-Protein
)	O
on	O
the	O
expression	O
of	O
a	O
broad	O
range	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
,	O
we	O
tested	O
whether	O
or	O
not	O
the	O
effect	O
of	O
rpoE	B-Protein
deletion	O
was	O
specific	O
to	O
sseB	B-Protein
or	O
if	O
it	O
extended	O
to	O
other	O
SsrB	B-Protein
-	O
regulated	O
genes	O
.	O

To	O
do	O
this	O
we	O
examined	O
the	O
levels	O
of	O
SseL	B-Protein
-	I-Protein
2HA	I-Protein
,	O
SifA	B-Protein
-	I-Protein
2HA	I-Protein
and	O
SrfN	B-Protein
-	I-Protein
2HA	I-Protein
expressed	O
from	O
their	O
endogenous	O
promoters	O
under	O
SPI	O
-	O
2	O
inducing	O
conditions	O
(	O
Figure	O
1C	O
)	O
.	O

Consistent	O
with	O
the	O
results	O
for	O
SseB	B-Protein
,	O
there	O
was	O
a	O
decrease	O
in	O
SifA	B-Protein
-	I-Protein
2HA	I-Protein
levels	O
in	O
DeltarpoE	B-Protein
compared	O
to	O
wild	O
type	O
,	O
although	O
deletion	O
of	O
rpoE	B-Protein
did	O
not	O
have	O
an	O
effect	O
on	O
SseL	B-Protein
-	I-Protein
2HA	I-Protein
.	O

Relative	O
to	O
its	O
expression	O
in	O
wild	O
type	O
cells	O
,	O
the	O
level	O
of	O
SrfN	B-Protein
-	I-Protein
2HA	I-Protein
was	O
reproducibly	O
increased	O
in	O
the	O
DeltarpoE	B-Protein
cells	O
,	O
suggesting	O
a	O
role	O
for	O
sigmaE	B-Regulon-operon
in	O
the	O
repression	O
of	O
SrfN	B-Protein
,	O
although	O
it	O
is	O
unlikely	O
that	O
this	O
is	O
through	O
a	O
direct	O
mechanism	O
.	O

RpoE	B-Protein
is	O
involved	O
in	O
transcriptional	O
activity	O
of	O
a	O
subset	O
of	O
virulence	O
genes	O

In	O
order	O
to	O
confirm	O
the	O
effect	O
of	O
sigmaE	B-Protein
on	O
the	O
expression	O
of	O
a	O
broad	O
range	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
,	O
we	O
used	O
wild	O
type	O
and	O
DeltarpoE	B-Protein
cells	O
and	O
integrated	O
into	O
the	O
chromosome	O
individually	O
six	O
single	O
-	O
copy	O
transcriptional	O
fusions	O
representing	O
promoters	O
for	O
four	O
classes	O
of	O
SsrB	B-Protein
-	O
dependent	O
genes	O
or	O
operons	O
(	O
(	O
i	O
)	O
type	B-Regulon-operon
III	I-Regulon-operon
secretion	I-Regulon-operon
effector	I-Regulon-operon
operon	I-Regulon-operon
(	O
sseA	B-Protein
)	O
;	O
(	O
ii	O
)	O
structural	B-Regulon-operon
operon	I-Regulon-operon
I	I-Regulon-operon
(	O
ssaB	B-Protein
)	O
;	O
(	O
iii	O
)	O
structural	B-Regulon-operon
operon	I-Regulon-operon
II	I-Regulon-operon
(	O
ssaG	B-Protein
)	O
;	O
(	O
iv	O
and	O
v	O
)	O
effectors	O
encoded	O
outside	O
of	O
SPI	O
-	O
2	O
(	O
sseL	B-Protein
and	O
sifA	B-Protein
)	O
;	O
and	O
(	O
vi	O
)	O
integrated	O
virulence	O
genes	O
unlinked	O
to	O
SPI	O
-	O
2	O
(	O
srfN	B-Protein
)	O
[	O
9	O
]	O
.	O

Transcriptional	O
fusions	O
to	O
lacZ	B-Protein
of	O
the	O
sseA	B-Protein
,	O
ssaB	B-Protein
,	O
ssaG	B-Protein
,	O
sseL	B-Protein
,	O
sifA	B-Protein
and	O
srfN	B-Protein
promoters	O
(	O
mapped	O
previously	O
;	O
[	O
9	O
,	O
24	O
]	O
were	O
integrated	O
into	O
the	O
chromosome	O
of	O
wild	O
type	O
and	O
DeltarpoE	B-Protein
cells	O
and	O
then	O
grown	O
in	O
the	O
SsrB	B-Protein
-	O
activating	O
medium	O
LPM	O
.	O

The	O
activity	O
of	O
each	O
promoter	O
was	O
measured	O
using	O
a	O
beta	B-Protein
-	I-Protein
galactosidase	I-Protein
assay	O
during	O
exponential	O
growth	O
.	O

Although	O
DeltarpoE	B-Protein
was	O
observed	O
to	O
have	O
a	O
slightly	O
prolonged	O
lag	O
phase	O
relative	O
to	O
wild	O
type	O
cells	O
under	O
these	O
experimental	O
conditions	O
,	O
at	O
later	O
time	O
points	O
the	O
mutant	O
grew	O
similarly	O
to	O
wild	O
type	O
.	O

To	O
account	O
for	O
any	O
differences	O
in	O
growth	O
kinetics	O
of	O
the	O
cultures	O
,	O
all	O
data	O
was	O
normalized	O
to	O
the	O
optical	O
density	O
at	O
600	O
nm	O
of	O
the	O
culture	O
,	O
which	O
permitted	O
direct	O
comparisons	O
.	O

In	O
wild	O
type	O
cells	O
,	O
promoter	O
activity	O
from	O
all	O
the	O
transcriptional	O
fusions	O
was	O
high	O
,	O
as	O
expected	O
,	O
because	O
LPM	O
medium	O
is	O
highly	O
inducing	O
for	O
SsrB	B-Protein
activity	O
[	O
21	O
]	O
.	O

In	O
contrast	O
,	O
promoter	O
activity	O
for	O
sseA	B-Protein
,	O
ssaB	B-Protein
,	O
and	O
sifA	B-Protein
decreased	O
in	O
the	O
rpoE	B-Protein
mutant	O
compared	O
to	O
wild	O
type	O
cells	O
(	O
Figure	O
2A	O
,	O
B	O
and	O
2D	O
)	O
,	O
whereas	O
promoter	O
activity	O
from	O
the	O
ssaG	B-Protein
and	O
srfN	B-Protein
reporters	O
was	O
upregulated	O
in	O
the	O
rpoE	B-Protein
mutant	O
(	O
Figure	O
2C	O
and	O
2F	O
)	O
.	O
beta	B-Protein
-	I-Protein
galactosidase	I-Protein
activity	O
observed	O
from	O
the	O
sseL	B-Protein
reporter	O
was	O
unaltered	O
in	O
the	O
rpoE	B-Protein
deletion	O
compared	O
to	O
that	O
in	O
wild	O
type	O
cells	O
(	O
Figure	O
2E	O
)	O
.	O

These	O
data	O
are	O
consistent	O
with	O
the	O
protein	O
levels	O
detected	O
for	O
these	O
gene	O
products	O
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
sigmaE	B-Protein
can	O
have	O
a	O
variable	O
and	O
bidirectional	O
effect	O
on	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
.	O

The	O
effect	O
of	O
RpoE	B-Protein
on	O
virulence	O
genes	O
is	O
downstream	O
of	O
ssrB	B-Protein
expression	O

The	O
variable	O
effects	O
of	O
rpoE	B-Protein
deletion	O
on	O
SsrB	B-Protein
-	O
regulated	O
effectors	O
suggested	O
that	O
RpoE	B-Protein
might	O
direct	O
transcription	O
downstream	O
of	O
ssrB	B-Protein
expression	O
.	O

To	O
test	O
this	O
,	O
we	O
replaced	O
the	O
ssrB	B-Protein
gene	O
in	O
DeltarpoE	B-Protein
and	O
wild	O
type	O
cells	O
with	O
an	O
ssrB	B-Protein
:	O
:	O
FLAG	O
allele	O
[	O
19	O
]	O
and	O
examined	O
the	O
levels	O
of	O
SsrB	B-Protein
protein	O
in	O
the	O
strains	O
by	O
western	O
blot	O
.	O

There	O
was	O
no	O
change	O
in	O
the	O
levels	O
of	O
SsrB	B-Protein
-	O
FLAG	O
between	O
wild	O
type	O
and	O
DeltarpoE	B-Protein
cells	O
(	O
Figure	O
3	O
)	O
,	O
indicating	O
that	O
the	O
effects	O
of	O
RpoE	B-Protein
on	O
the	O
four	O
classes	O
of	O
virulence	O
gene	O
promoters	O
examined	O
here	O
was	O
not	O
mediated	O
through	O
changes	O
to	O
SsrB	B-Protein
protein	O
levels	O
.	O

Together	O
these	O
data	O
establish	O
a	O
role	O
for	O
RpoE	B-Protein
in	O
the	O
fine	O
-	O
tuning	O
of	O
virulence	O
gene	O
expression	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
.	O

Discussion	O

In	O
this	O
work	O
we	O
found	O
that	O
the	O
alternative	O
sigma	O
factor	O
,	O
sigmaE	B-Protein
,	O
is	O
involved	O
in	O
fine	O
tuning	O
the	O
expressing	O
of	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
required	O
for	O
Salmonella	B-Organism
pathogenesis	O
.	O

Although	O
the	O
effect	O
of	O
rpoE	B-Protein
deletion	O
on	O
promoter	O
activity	O
in	O
some	O
cases	O
was	O
mild	O
,	O
we	O
have	O
previously	O
shown	O
that	O
gene	O
regulators	O
providing	O
only	O
modest	O
transcriptional	O
input	O
have	O
a	O
profound	O
influence	O
on	O
bacterial	O
fitness	O
in	O
a	O
host	O
animal	O
[	O
25	O
]	O
.	O

In	O
cases	O
where	O
the	O
regulator	O
is	O
deleted	O
,	O
the	O
loss	O
of	O
genetic	O
fine	O
-	O
tuning	O
causes	O
incongruous	O
changes	O
in	O
the	O
timing	O
and	O
magnitude	O
of	O
virulence	O
gene	O
expression	O
,	O
leading	O
to	O
fitness	O
loss	O
and	O
strong	O
attenuation	O
.	O

We	O
predict	O
that	O
RpoE	B-Protein
confers	O
a	O
similar	O
fine	O
-	O
tuning	O
effect	O
on	O
Salmonella	B-Organism
virulence	O
gene	O
expression	O
that	O
is	O
required	O
for	O
optimal	O
within	O
-	O
host	O
fitness	O
during	O
infection	O
.	O

When	O
we	O
examined	O
the	O
-	O
10	O
and	O
-	O
35	O
positions	O
of	O
the	O
promoters	O
studied	O
here	O
relative	O
to	O
the	O
transcriptional	O
start	O
sites	O
identified	O
previously	O
[	O
24	O
]	O
,	O
these	O
promoters	O
did	O
not	O
appear	O
to	O
contain	O
sigmaE	B-Regulon-operon
consensus	O
sequences	O
.	O

Instead	O
they	O
appeared	O
to	O
have	O
consensus	O
sites	O
for	O
sigma70	B-Protein
.	O

Although	O
a	O
bioinformatics	O
screen	O
identified	O
sigmaE	B-Regulon-operon
consensus	O
sequences	O
upstream	O
of	O
the	O
SPI	O
-	O
2	O
genes	O
ssaU	B-Protein
,	O
ssaJ	B-Protein
,	O
sscA	B-Protein
and	O
ssaC	B-Protein
[	O
26	O
]	O
,	O
these	O
genes	O
were	O
not	O
tested	O
for	O
sigmaE	B-Regulon-operon
-	O
dependence	O
in	O
the	O
present	O
study	O
because	O
the	O
identified	O
consensus	O
sites	O
are	O
in	O
coding	O
sequence	O
within	O
operons	O
,	O
and	O
as	O
a	O
result	O
may	O
not	O
be	O
directly	O
relevant	O
.	O

Due	O
to	O
the	O
high	O
degree	O
of	O
conservation	O
in	O
sigma	O
factor	O
binding	O
sequences	O
,	O
sigmaE	B-Regulon-operon
may	O
not	O
be	O
directly	O
regulating	O
SsrB	B-Protein
-	O
dependent	O
promoters	O
.	O

The	O
lack	O
of	O
a	O
canonical	O
sigmaE	B-Regulon-operon
sequence	O
at	O
these	O
promoters	O
suggests	O
that	O
another	O
regulatory	O
gene	O
may	O
be	O
epistatic	O
to	O
sigmaE	B-Regulon-operon
or	O
that	O
these	O
promoters	O
encode	O
functional	O
,	O
but	O
non	O
-	O
canonical	O
sigmaE	B-Regulon-operon
-	O
binding	O
sites	O
due	O
to	O
their	O
horizontal	O
acquisition	O
and	O
gradual	O
integration	O
into	O
the	O
sigmaE	B-Regulon-operon
regulatory	O
network	O
.	O

This	O
integration	O
may	O
help	O
Salmonella	B-Organism
coordinate	O
expression	O
of	O
the	O
virulence	O
-	O
associated	O
T3SS	O
in	O
response	O
to	O
host	O
factors	O
that	O
compromise	O
bacterial	O
membrane	O
integrity	O
(	O
Figure	O
4	O
)	O
.	O

This	O
mechanism	O
would	O
activate	O
a	O
restorative	O
sigmaE	B-Regulon-operon
pathway	O
,	O
which	O
is	O
consistent	O
with	O
the	O
enhanced	O
susceptibility	O
of	O
rpoE	B-Protein
mutants	O
to	O
oxidative	O
stress	O
and	O
antimicrobial	O
peptides	O
[	O
13	O
,	O
15	O
,	O
16	O
]	O
,	O
both	O
of	O
which	O
perturb	O
membrane	O
integrity	O
in	O
vivo	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
that	O
sigmaE	B-Regulon-operon
can	O
directly	O
repress	O
transcription	O
,	O
the	O
negative	O
effect	O
on	O
two	O
promoters	O
observed	O
here	O
might	O
be	O
due	O
to	O
an	O
intermediate	O
RpoE	B-Protein
-	O
regulated	O
repressor	O
or	O
compensatory	O
effect	O
where	O
loss	O
of	O
rpoE	B-Protein
increases	O
the	O
relative	O
abundance	O
of	O
another	O
sigma	O
factor	O
that	O
can	O
directly	O
activate	O
the	O
ssaG	B-Protein
and	O
srfN	B-Protein
promoters	O
.	O

Future	O
work	O
will	O
be	O
required	O
to	O
resolve	O
these	O
possibilities	O
.	O

Our	O
results	O
indicate	O
that	O
rpoE	B-Protein
deletion	O
has	O
no	O
effect	O
on	O
SsrB	B-Protein
levels	O
under	O
SPI	O
-	O
2	O
inducing	O
conditions	O
suggesting	O
that	O
the	O
sigmaE	B-Regulon-operon
pathway	O
regulates	O
effector	O
expression	O
downstream	O
of	O
ssrAB	B-Protein
transcription	O
.	O

Unlinking	O
ssrAB	B-Protein
transcription	O
from	O
the	O
sigmaE	B-Regulon-operon
regulon	O
would	O
be	O
advantageous	O
to	O
the	O
cell	O
to	O
prevent	O
commitment	O
to	O
a	O
virulence	O
gene	O
expression	O
program	O
in	O
response	O
to	O
envelope	O
stress	O
not	O
associated	O
with	O
infection	O
.	O

The	O
results	O
from	O
this	O
study	O
demonstrate	O
that	O
sigmaE	B-Regulon-operon
has	O
the	O
ability	O
to	O
affect	O
expression	O
of	O
SsrB	B-Protein
-	O
regulated	O
virulence	O
genes	O
and	O
offers	O
potential	O
insight	O
into	O
the	O
virulence	O
attenuation	O
of	O
rpoE	B-Protein
mutants	O
.	O

Although	O
when	O
considered	O
individually	O
,	O
each	O
promoter	O
was	O
modestly	O
affected	O
by	O
deletion	O
of	O
rpoE	B-Protein
,	O
the	O
cumulative	O
effects	O
of	O
mild	O
rewired	O
inputs	O
on	O
multiple	O
virulence	O
promoters	O
has	O
been	O
shown	O
to	O
severely	O
compromise	O
in	O
-	O
host	O
fitness	O
and	O
virulence	O
ability	O
[	O
25	O
]	O
.	O

Conclusion	O

Based	O
on	O
these	O
and	O
other	O
data	O
[	O
4	O
,	O
12	O
-	O
15	O
]	O
,	O
the	O
genetic	O
interaction	O
between	O
sigmaE	B-Regulon-operon
and	O
a	O
subset	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
may	O
serve	O
to	O
coordinate	O
the	O
spatial	O
and	O
temporal	O
activation	O
of	O
virulence	O
genes	O
in	O
a	O
host	O
setting	O
,	O
likely	O
in	O
response	O
to	O
membrane	O
damage	O
resulting	O
from	O
oxidative	O
anti	O
-	O
microbial	O
systems	O
and	O
membrane	O
-	O
targeted	O
host	O
defence	O
peptides	O
.	O

Caenorhabditis	B-Organism
elegans	I-Organism
Semi	O
-	O
Automated	O
Liquid	O
Screen	O
Reveals	O
a	O
Specialized	O
Role	O
for	O
the	O
Chemotaxis	O
Gene	O
cheB2	B-Protein
in	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
Virulence	O

Pseudomonas	B-Organism
aeruginosa	I-Organism
is	O
an	O
opportunistic	O
human	B-Organism
pathogen	O
that	O
causes	O
infections	O
in	O
a	O
variety	O
of	O
animal	O
and	O
plant	O
hosts	O
.	O

Caenorhabditis	B-Organism
elegans	I-Organism
is	O
a	O
simple	O
model	O
with	O
which	O
one	O
can	O
identify	O
bacterial	O
virulence	O
genes	O
.	O

Previous	O
studies	O
with	O
C	B-Organism
.	I-Organism
elegans	I-Organism
have	O
shown	O
that	O
depending	O
on	O
the	O
growth	O
medium	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
provokes	O
different	O
pathologies	O
:	O
slow	O
or	O
fast	O
killing	O
,	O
lethal	O
paralysis	O
and	O
red	O
death	O
.	O

In	O
this	O
study	O
,	O
we	O
developed	O
a	O
high	O
-	O
throughput	O
semi	O
-	O
automated	O
liquid	O
-	O
based	O
assay	O
such	O
that	O
an	O
entire	O
genome	O
can	O
readily	O
be	O
scanned	O
for	O
virulence	O
genes	O
in	O
a	O
short	O
time	O
period	O
.	O

We	O
screened	O
a	O
2	O
,	O
200	O
-	O
member	O
STM	O
mutant	O
library	O
generated	O
in	O
a	O
cystic	O
fibrosis	O
airway	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	O
,	O
TBCF10839	B-Organism
.	O

Twelve	O
mutants	O
were	O
isolated	O
each	O
showing	O
at	O
least	O
70	O
%	O
attenuation	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
.	O

The	O
selected	O
mutants	O
had	O
insertions	O
in	O
regulatory	O
genes	O
,	O
such	O
as	O
a	O
histidine	O
kinase	O
sensor	O
of	O
two	O
-	O
component	O
systems	O
and	O
a	O
member	O
of	O
the	O
AraC	B-Protein
family	O
,	O
or	O
in	O
genes	O
involved	O
in	O
adherence	O
or	O
chemotaxis	O
.	O

One	O
mutant	O
had	O
an	O
insertion	O
in	O
a	O
cheB	B-Protein
gene	O
homologue	O
,	O
encoding	O
a	O
methylesterase	B-Chemical
involved	O
in	O
chemotaxis	O
(	O
CheB2	B-Protein
)	O
.	O

The	O
cheB2	B-Protein
mutant	O
was	O
tested	O
in	O
a	O
murine	B-Organism
lung	O
infection	O
model	O
and	O
found	O
to	O
have	O
a	O
highly	O
attenuated	O
virulence	O
.	O

The	O
cheB2	B-Protein
gene	O
is	O
part	O
of	O
the	O
chemotactic	O
gene	O
cluster	O
II	O
,	O
which	O
was	O
shown	O
to	O
be	O
required	O
for	O
an	O
optimal	O
mobility	O
in	O
vitro	O
.	O

In	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
,	O
the	O
main	O
player	O
in	O
chemotaxis	O
and	O
mobility	O
is	O
the	O
chemotactic	O
gene	O
cluster	O
I	O
,	O
including	O
cheB1	B-Protein
.	O

We	O
show	O
that	O
,	O
in	O
contrast	O
to	O
the	O
cheB2	B-Protein
mutant	O
,	O
a	O
cheB1	B-Protein
mutant	O
is	O
not	O
attenuated	O
for	O
virulence	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
whereas	O
in	O
vitro	O
motility	O
and	O
chemotaxis	O
are	O
severely	O
impaired	O
.	O

We	O
conclude	O
that	O
the	O
virulence	O
defect	O
of	O
the	O
cheB2	B-Protein
mutant	O
is	O
not	O
linked	O
with	O
a	O
global	O
motility	O
defect	O
but	O
that	O
instead	O
the	O
cheB2	B-Protein
gene	O
is	O
involved	O
in	O
a	O
specific	O
chemotactic	O
response	O
,	O
which	O
takes	O
place	O
during	O
infection	O
and	O
is	O
required	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
pathogenicity	O
.	O

Introduction	O

The	O
ubiquitous	O
Gram	O
-	O
negative	O
bacterium	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
is	O
an	O
opportunistic	O
pathogen	O
able	O
to	O
infect	O
a	O
broad	O
range	O
of	O
animals	O
and	O
plants	O
hosts	O
including	O
humans	B-Organism
.	O

In	O
the	O
course	O
of	O
infection	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
adapts	O
to	O
changing	O
environmental	O
conditions	O
and	O
coordinates	O
the	O
production	O
of	O
molecular	O
determinants	O
involved	O
in	O
host	O
colonization	O
and	O
virulence	O
[	O
1	O
]	O
.	O

Among	O
these	O
are	O
pili	O
and	O
flagella	O
,	O
which	O
are	O
required	O
for	O
attachment	O
and	O
spreading	O
on	O
surfaces	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

Also	O
necessary	O
are	O
protein	O
secretion	O
systems	O
[	O
4	O
]	O
and	O
toxins	O
required	O
for	O
cytotoxicity	O
and	O
survival	O
within	O
the	O
host	O
.	O

One	O
powerful	O
approach	O
to	O
dissect	O
the	O
interaction	O
between	O
pathogen	O
and	O
host	O
is	O
the	O
use	O
of	O
simple	O
infection	O
models	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
nematode	O
Caenorhabditis	B-Organism
elegans	I-Organism
can	O
be	O
an	O
effective	O
model	O
for	O
studying	O
virulence	O
mechanisms	O
used	O
by	O
a	O
variety	O
of	O
bacterial	O
pathogens	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	I-Organism
is	O
capable	O
of	O
killing	O
C	B-Organism
.	I-Organism
elegans	I-Organism
in	O
several	O
distinct	O
ways	O
.	O

When	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
strain	I-Organism
PA14	I-Organism
is	O
cultured	O
on	O
a	O
high	O
-	O
osmolarity	O
peptone	O
-	O
glucose	O
-	O
sorbitol	O
medium	O
(	O
PGS	O
)	O
,	O
worms	O
succumb	O
to	O
intoxication	O
termed	O
"	O
fast	O
killing	O
"	O
,	O
as	O
the	O
exposed	O
worms	O
die	O
within	O
hours	O
[	O
7	O
]	O
.	O

Nematodes	O
exposed	O
to	O
PA14	B-Organism
grown	O
on	O
nematode	O
growth	O
media	O
(	O
NGM	O
)	O
,	O
succumb	O
to	O
"	O
slow	O
killing	O
"	O
.	O

In	O
this	O
case	O
the	O
bacteria	O
colonize	O
the	O
gut	O
and	O
the	O
infected	O
worms	O
die	O
over	O
a	O
number	O
of	O
days	O
rather	O
than	O
hours	O
[	O
8	O
]	O
.	O

The	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	I-Organism
PAO1	I-Organism
cultured	O
on	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
agar	O
induces	O
worm	O
paralysis	O
and	O
death	O
within	O
hours	O
[	O
9	O
]	O
.	O

Finally	O
,	O
C	B-Organism
.	I-Organism
elegans	I-Organism
death	O
,	O
called	O
red	O
death	O
,	O
is	O
observed	O
in	O
response	O
to	O
PAO1	B-Organism
grown	O
on	O
phosphate	B-Chemical
-	O
depleted	O
medium	O
in	O
conjunction	O
with	O
physiological	O
stress	O
on	O
the	O
nematodes	O
[	O
10	O
]	O
.	O

It	O
is	O
known	O
that	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolates	I-Organism
PA14	I-Organism
and	O
PAO1	B-Organism
show	O
genomic	O
diversity	O
.	O

Strains	O
cultured	O
in	O
vitro	O
for	O
years	O
are	O
known	O
to	O
undergo	O
changes	O
in	O
gene	O
expression	O
.	O

Individual	O
genes	O
and	O
even	O
entire	O
genomic	O
islands	O
have	O
been	O
lost	O
from	O
laboratory	O
isolates	O
when	O
compared	O
to	O
pathogenic	O
strains	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
strain	I-Organism
TBCF10839	I-Organism
(	O
TB	B-Organism
)	O
,	O
which	O
was	O
isolated	O
from	O
a	O
Cystic	O
Fibrosis	O
(	O
CF	O
)	O
patient	B-Organism
[	O
14	O
]	O
.	O

The	O
TB	B-Organism
strain	O
belongs	O
to	O
an	O
abundant	O
clonal	O
complex	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
population	O
[	O
15	O
]	O
.	O

It	O
has	O
a	O
high	O
resistance	O
to	O
detergents	O
[	O
16	O
]	O
and	O
reactive	O
oxygen	B-Chemical
intermediates	O
[	O
17	O
]	O
and	O
is	O
able	O
to	O
grow	O
within	O
polymorphonuclear	O
leukocytes	O
[	O
18	O
]	O
.	O

We	O
developed	O
a	O
high	O
-	O
throughput	O
killing	O
assay	O
using	O
C	B-Organism
.	I-Organism
elegans	I-Organism
as	O
a	O
host	O
,	O
which	O
will	O
be	O
appropriate	O
for	O
a	O
systematic	O
screen	O
of	O
mutant	O
libraries	O
of	O
any	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
isolate	O
of	O
interest	O
.	O

Increasing	O
throughput	O
in	O
an	O
assay	O
such	O
that	O
an	O
entire	O
genome	O
can	O
readily	O
be	O
scanned	O
in	O
a	O
short	O
time	O
period	O
is	O
an	O
important	O
advance	O
.	O

Our	O
protocol	O
is	O
based	O
on	O
a	O
standard	O
killing	O
assay	O
and	O
makes	O
use	O
of	O
a	O
Biosorter	O
to	O
distribute	O
nematodes	O
into	O
the	O
wells	O
of	O
microtitre	O
plates	O
in	O
a	O
fully	O
automated	O
manner	O
.	O

We	O
screened	O
a	O
TB	B-Organism
STM	I-Organism
(	I-Organism
signature	I-Organism
tagged	I-Organism
mutagenesis	I-Organism
)	I-Organism
mutant	I-Organism
library	O
of	O
2	O
,	O
200	O
non	O
-	O
redundant	O
clones	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
and	O
selected	O
a	O
small	O
group	O
of	O
mutants	O
,	O
significantly	O
attenuated	O
for	O
virulence	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
.	O

By	O
testing	O
these	O
mutants	O
in	O
additional	O
phenotypic	O
assays	O
,	O
including	O
adherence	O
to	O
epithelial	O
cells	O
and	O
virulence	O
in	O
a	O
mouse	B-Organism
model	O
,	O
we	O
identified	O
a	O
gene	O
,	O
cheB2	B-Protein
,	O
necessary	O
for	O
in	O
vivo	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
virulence	O
.	O

The	O
cheB2	B-Protein
gene	O
belongs	O
to	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
chemotaxis	O
che2	O
gene	O
cluster	O
(	O
cluster	O
II	O
,	O
PA0180	B-Protein
-	O
PA0173	B-Protein
)	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

P	B-Organism
.	I-Organism
aeruginosa	I-Organism
has	O
multiple	O
copies	O
of	O
chemotaxis	O
genes	O
arranged	O
in	O
five	O
clusters	O
(	O
Figure	O
1	O
)	O
[	O
22	O
]	O
.	O

The	O
chemotaxis	O
gene	O
cluster	O
I	O
(	O
PA1456	B-Protein
-	O
PA1464	B-Protein
)	O
and	O
cluster	O
V	O
(	O
PA3349	B-Protein
-	O
PA3348	B-Protein
)	O
have	O
previously	O
been	O
shown	O
to	O
be	O
essential	O
for	O
chemotaxis	O
and	O
flagellar	O
mobility	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
23	O
]	O
,	O
[	O
24	O
]	O
.	O

The	O
wsp	O
genes	O
contained	O
in	O
cluster	O
III	O
(	O
PA3708	B-Protein
-	O
PA3702	B-Protein
)	O
have	O
been	O
proposed	O
to	O
contribute	O
to	O
bacterial	O
biofilm	O
formation	O
[	O
25	O
]	O
,	O
whereas	O
the	O
cluster	O
IV	O
(	O
Pil	O
-	O
Chp	O
system	O
,	O
PA0408	B-Protein
-	O
PA0417	B-Protein
)	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
twitching	O
motility	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

The	O
che2	O
genes	O
from	O
cluster	O
II	O
,	O
and	O
more	O
particularly	O
the	O
cheB2	B-Protein
gene	O
,	O
were	O
initially	O
identified	O
as	O
required	O
for	O
an	O
optimal	O
chemotactic	O
response	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

The	O
CheB	O
proteins	O
are	O
essential	O
components	O
of	O
the	O
chemotactic	O
response	O
and	O
are	O
responsible	O
for	O
demethylation	O
of	O
glutamate	O
residues	O
in	O
methyl	O
-	O
accepting	O
chemotaxis	O
proteins	O
(	O
MCPs	O
)	O
and	O
also	O
deamidation	O
of	O
glutamine	O
residues	O
to	O
form	O
methyl	O
-	O
accepting	O
glutamates	O
[	O
28	O
]	O
.	O

MCPs	O
sense	O
the	O
chemical	O
stimuli	O
that	O
initiate	O
the	O
chemotactic	O
activity	O
[	O
29	O
]	O
.	O

In	O
Escherichia	B-Organism
coli	I-Organism
,	O
the	O
loss	O
of	O
CheB	O
leads	O
decreased	O
receptor	O
sensitivity	O
,	O
due	O
to	O
an	O
inability	O
to	O
reset	O
the	O
MCP	O
'	O
s	O
[	O
30	O
]	O
.	O

This	O
modification	O
leaves	O
the	O
chemotactic	O
pathway	O
in	O
active	O
states	O
causing	O
clockwise	O
rotation	O
of	O
the	O
flagella	O
and	O
continuous	O
tumbling	O
instead	O
of	O
runs	O
and	O
tumbles	O
.	O

It	O
has	O
been	O
reported	O
previously	O
in	O
Salmonella	B-Organism
typhimurium	I-Organism
that	O
a	O
loss	O
of	O
proper	O
chemotaxis	O
control	O
through	O
a	O
cheB	O
mutation	O
,	O
leads	O
to	O
a	O
'	O
tumbly	O
'	O
swimming	O
phenotype	O
and	O
a	O
strong	O
reduction	O
in	O
the	O
isolates	O
ability	O
to	O
invade	O
human	B-Organism
epithelial	O
HEP2	O
cells	O
as	O
well	O
as	O
a	O
reduction	O
in	O
infectivity	O
in	O
a	O
mouse	B-Organism
ligated	O
-	O
loop	O
model	O
[	O
31	O
]	O
.	O

In	O
our	O
study	O
we	O
further	O
compare	O
the	O
phenotypes	O
of	O
cheB2	B-Protein
and	O
cheB1	B-Protein
mutants	O
and	O
propose	O
that	O
the	O
cheB2	B-Protein
gene	O
has	O
a	O
specific	O
role	O
during	O
infection	O
,	O
which	O
is	O
essential	O
for	O
pathogenesis	O
.	O

Results	O

High	O
Throughput	O
Assay	O
for	O
Nematode	O
Killing	O
by	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
It	O
was	O
reported	O
earlier	O
that	O
relatively	O
high	O
-	O
throughput	O
screening	O
procedures	O
performed	O
on	O
plates	O
could	O
be	O
used	O
to	O
identify	O
virulence	O
factors	O
in	O
various	O
pathogens	O
such	O
as	O
Staphylococcus	B-Organism
aureus	I-Organism
[	O
32	O
]	O
,	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
8	O
]	O
or	O
Serratia	B-Organism
marcescens	I-Organism
[	O
33	O
]	O
.	O

Here	O
,	O
we	O
developed	O
a	O
high	O
throughput	O
screening	O
method	O
,	O
in	O
which	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
is	O
assessed	O
in	O
a	O
liquid	O
assay	O
and	O
which	O
allows	O
a	O
quick	O
selection	O
of	O
attenuated	O
candidates	O
within	O
large	O
transposon	O
libraries	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

We	O
prepared	O
a	O
bacterial	O
culture	O
medium	O
that	O
both	O
allowed	O
the	O
worms	O
to	O
thrive	O
feeding	O
on	O
the	O
non	O
-	O
pathogenic	O
E	B-Organism
.	I-Organism
coli	I-Organism
OP50	I-Organism
,	O
and	O
bacterial	O
isolates	O
being	O
tested	O
to	O
have	O
normal	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

We	O
filled	O
96	O
well	O
plates	O
with	O
the	O
medium	O
and	O
inoculated	O
the	O
bacterial	O
strains	O
to	O
be	O
tested	O
.	O

The	O
virulence	O
of	O
each	O
isolate	O
was	O
assessed	O
in	O
a	O
second	O
microtitre	O
plate	O
,	O
into	O
which	O
a	O
specific	O
population	O
of	O
nematodes	O
had	O
been	O
deposited	O
.	O

Evaluation	O
of	O
virulence	O
was	O
based	O
upon	O
the	O
number	O
of	O
live	O
worms	O
recovered	O
after	O
24	O
h	O
exposure	O
to	O
bacteria	O
.	O

Under	O
our	O
assay	O
conditions	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
worms	O
grown	O
on	O
E	B-Organism
.	I-Organism
coli	I-Organism
were	O
still	O
alive	O
after	O
24	O
h	O
.	O

In	O
contrast	O
,	O
more	O
than	O
50	O
%	O
of	O
the	O
worms	O
were	O
killed	O
within	O
24	O
h	O
when	O
cultured	O
with	O
any	O
one	O
of	O
three	O
isolates	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
,	O
PA14	B-Organism
,	O
PAO1	B-Organism
and	O
TB	B-Organism
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
confirm	O
that	O
this	O
assay	O
would	O
allow	O
the	O
recovery	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
mutants	O
with	O
an	O
attenuated	O
virulence	O
,	O
we	O
tested	O
previously	O
characterized	O
mutants	O
.	O

We	O
used	O
a	O
gacA	B-Protein
mutant	O
from	O
the	O
PA14	B-Organism
transposon	O
library	O
(	O
http	O
:	O
/	O
/	O
ausubellab	O
.	O
mgh	O
.	O
harvard	O
.	O
edu	O
/	O
cgi	O
-	O
bin	O
/	O
pa14	O
/	O
home	O
.	O
cgi	O
)	O
[	O
34	O
]	O
,	O
which	O
is	O
affected	O
in	O
a	O
gene	O
encoding	O
a	O
response	O
regulator	O
involved	O
in	O
virulence	O
[	O
8	O
]	O
.	O

C	B-Organism
.	I-Organism
elegans	I-Organism
infection	O
using	O
this	O
mutant	O
in	O
the	O
liquid	O
assay	O
resulted	O
in	O
only	O
40	O
%	O
killing	O
at	O
24	O
h	O
,	O
whereas	O
95	O
%	O
killing	O
was	O
observed	O
with	O
the	O
parental	O
PA14	B-Organism
strain	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
screen	O
a	O
large	O
number	O
of	O
bacterial	O
isolates	O
more	O
rapidly	O
,	O
the	O
assay	O
was	O
automated	O
using	O
the	O
COPAS	O
(	O
Complex	O
Object	O
Parametric	O
Analyzer	O
and	O
Sorter	O
)	O
Biosort	O
system	O
(	O
Union	O
Biometrica	O
)	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
unionbio	O
.	O
com	O
/	O
)	O
.	O

The	O
sorter	O
is	O
able	O
to	O
dispatch	O
systematically	O
a	O
fixed	O
number	O
of	O
worms	O
of	O
a	O
precise	O
developmental	O
stage	O
,	O
into	O
each	O
well	O
of	O
a	O
microtitre	O
plate	O
.	O

Screening	O
the	O
TB	B-Organism
Transposon	O
Library	O
for	O
Mutants	O
Attenuated	O
in	O
Virulence	O

A	O
signature	O
tagged	O
mutagenesis	O
(	O
STM	O
)	O
library	O
was	O
previously	O
generated	O
in	O
the	O
virulent	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
CF	I-Organism
isolate	I-Organism
,	O
TB	B-Organism
,	O
using	O
the	O
plasposon	O
vector	O
pTnModOGm	O
[	O
20	O
]	O
,	O
[	O
35	O
]	O
.	O

Auxotrophic	O
mutants	O
were	O
removed	O
from	O
the	O
library	O
by	O
pre	O
-	O
screening	O
post	O
-	O
conjugation	O
TB	B-Organism
isolates	O
onto	O
minimal	O
media	O
and	O
selecting	O
only	O
clones	O
,	O
which	O
grew	O
normally	O
.	O

This	O
pre	O
-	O
screening	O
eliminated	O
clones	O
that	O
might	O
have	O
exhibited	O
attenuated	O
virulence	O
based	O
upon	O
reduced	O
growth	O
or	O
viability	O
,	O
rather	O
than	O
loss	O
of	O
a	O
specific	O
virulence	O
function	O
.	O

After	O
this	O
initial	O
segregation	O
,	O
2	O
,	O
200	O
clones	O
were	O
picked	O
into	O
a	O
96	O
-	O
well	O
plate	O
and	O
tested	O
with	O
the	O
C	B-Organism
.	I-Organism
elegans	I-Organism
high	O
throughput	O
-	O
killing	O
assay	O
.	O

Each	O
mutant	O
was	O
tested	O
at	O
least	O
four	O
times	O
using	O
this	O
assay	O
.	O

The	O
mutants	O
selected	O
were	O
segregated	O
into	O
three	O
groups	O
based	O
upon	O
their	O
level	O
of	O
virulence	O
attenuation	O
as	O
compared	O
to	O
the	O
TB	B-Organism
parental	O
strain	O
,	O
which	O
killed	O
85	O
%	O
of	O
worms	O
under	O
the	O
test	O
conditions	O
.	O

In	O
group	O
1	O
,	O
we	O
included	O
187	O
mutants	O
(	O
9	O
%	O
of	O
total	O
library	O
)	O
which	O
allowed	O
more	O
than	O
50	O
%	O
worm	O
survival	O
,	O
group	O
2	O
between	O
30	O
%	O
and	O
50	O
%	O
(	O
536	O
mutants	O
,	O
25	O
%	O
)	O
,	O
and	O
group	O
3	O
below	O
30	O
%	O
(	O
1450	O
mutants	O
,	O
65	O
%	O
)	O
,	O
approaching	O
the	O
same	O
level	O
of	O
killing	O
as	O
the	O
parental	O
isolate	O
.	O

Within	O
group	O
1	O
,	O
the	O
12	O
most	O
highly	O
attenuated	O
isolates	O
,	O
classified	O
as	O
group	O
1A	O
(	O
0	O
.	O
4	O
%	O
of	O
the	O
total	O
library	O
)	O
,	O
were	O
further	O
studied	O
.	O

When	O
cultured	O
in	O
the	O
presence	O
of	O
these	O
mutants	O
more	O
than	O
70	O
%	O
of	O
worms	O
survived	O
,	O
representing	O
a	O
near	O
5	O
-	O
fold	O
reduction	O
in	O
virulence	O
compared	O
to	O
TB	B-Organism
.	O

Characterization	O
of	O
Selected	O
Attenuated	O
Mutants	O

Genomic	O
DNA	O
was	O
recovered	O
from	O
the	O
12	O
group	O
1A	O
isolates	O
.	O

The	O
transposon	O
insertion	O
site	O
was	O
determined	O
through	O
direct	O
genomic	O
DNA	O
sequencing	O
,	O
using	O
primers	O
located	O
upstream	O
from	O
each	O
transposon	O
inverted	O
repeat	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
sequences	O
obtained	O
were	O
compared	O
to	O
the	O
PAO1	B-Organism
genome	O
sequence	O
database	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
pseudomonas	O
.	O
com	O
)	O
[	O
22	O
]	O
followed	O
by	O
comparison	O
with	O
the	O
general	O
sequence	O
database	O
.	O

The	O
genes	O
identified	O
are	O
shown	O
in	O
Table	O
1	O
.	O

Two	O
potential	O
regulatory	O
genes	O
were	O
found	O
.	O

The	O
first	O
,	O
PA2588	B-Protein
,	O
encodes	O
an	O
AraC	O
-	O
type	O
regulatory	O
protein	O
,	O
with	O
48	O
%	O
similarity	O
to	O
the	O
PAO1	B-Organism
PA0831	B-Protein
gene	O
product	O
,	O
OruR	B-Protein
[	O
36	O
]	O
.	O

The	O
second	O
matched	O
PA4380	B-Protein
,	O
which	O
encodes	O
a	O
protein	O
with	O
76	O
%	O
similarity	O
to	O
Pseudomonas	B-Organism
fluorescens	I-Organism
ColS	B-Protein
,	O
a	O
histidine	O
kinase	O
sensor	O
from	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
.	O

In	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
ColS	B-Protein
has	O
been	O
implicated	O
in	O
root	O
colonization	O
while	O
in	O
Pseudomonas	B-Organism
putida	I-Organism
it	O
has	O
been	O
reported	O
to	O
be	O
involved	O
in	O
regulating	O
TN4652	B-Protein
transposition	O
and	O
heavy	O
metal	O
resistance	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Another	O
gene	O
was	O
identified	O
as	O
PA4554	B-Protein
,	O
which	O
encodes	O
the	O
type	O
4	O
fimbrial	O
adhesin	O
PilY1	B-Protein
[	O
41	O
]	O
.	O

We	O
recovered	O
two	O
additional	O
mutants	O
with	O
transposon	O
insertion	O
into	O
genes	O
which	O
have	O
functions	O
related	O
to	O
motility	O
.	O

First	O
,	O
PA4953	B-Protein
encodes	O
a	O
protein	O
with	O
similarity	O
to	O
the	O
E	B-Organism
.	I-Organism
coli	I-Organism
MotB	B-Protein
,	O
one	O
of	O
a	O
pair	O
of	O
proteins	O
,	O
which	O
contributes	O
to	O
flagellar	O
rotation	O
[	O
23	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Secondly	O
,	O
we	O
found	O
an	O
insertion	O
in	O
PA0173	B-Protein
(	O
cheB2	B-Protein
)	O
,	O
one	O
of	O
four	O
cheB	O
gene	O
homologues	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
genome	O
sequence	O
.	O

PA0173	B-Protein
lies	O
within	O
the	O
chemotactic	O
gene	O
cluster	O
II	O
found	O
in	O
the	O
PAO1	B-Organism
genome	O
(	O
Figure	O
1	O
)	O
[	O
21	O
]	O
.	O

CheB	O
proteins	O
are	O
responsible	O
for	O
removing	O
methyl	O
groups	O
from	O
MCPs	O
[	O
44	O
]	O
.	O

The	O
adaptation	O
of	O
the	O
chemotaxis	O
system	O
in	O
response	O
to	O
changes	O
in	O
attractant	O
binding	O
is	O
dependent	O
on	O
the	O
methylation	O
state	O
of	O
the	O
MCPs	O
.	O

CheB2	B-Protein
has	O
been	O
proposed	O
to	O
be	O
an	O
essential	O
component	O
for	O
an	O
optimal	O
chemotactic	O
response	O
[	O
21	O
]	O
.	O

In	O
the	O
remaining	O
mutants	O
,	O
one	O
contained	O
a	O
transposon	O
insertion	O
in	O
PA5479	B-Protein
,	O
which	O
encodes	O
a	O
protein	O
similar	O
to	O
GltP	B-Protein
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
a	O
glutamate	O
-	O
aspartate	O
carrier	O
protein	O
.	O

Another	O
mutant	O
had	O
an	O
insertion	O
in	O
PA2585	B-Protein
encoding	O
the	O
UvrABC	B-Protein
endonuclease	O
subunit	O
UvrC	B-Protein
,	O
required	O
for	O
the	O
excision	O
of	O
damaged	O
DNA	O
.	O

The	O
uvrC	B-Protein
gene	O
is	O
located	O
downstream	O
from	O
the	O
gacA	B-Protein
gene	O
encoding	O
a	O
response	O
regulator	O
known	O
to	O
be	O
involved	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
virulence	O
.	O

Since	O
,	O
in	O
addition	O
to	O
the	O
insertion	O
in	O
PA2585	B-Protein
,	O
we	O
isolated	O
a	O
mutant	O
with	O
an	O
insertion	O
in	O
a	O
neighbor	O
gene	O
PA2588	B-Protein
,	O
it	O
suggests	O
that	O
this	O
cluster	O
of	O
genes	O
might	O
be	O
required	O
for	O
virulence	O
.	O

Another	O
interrupted	O
gene	O
,	O
PA2478	B-Protein
,	O
encodes	O
a	O
probable	O
thiol	O
:	O
disulfide	O
interchange	O
protein	O
of	O
the	O
DsbD	O
family	O
.	O

Finally	O
,	O
4	O
interrupted	O
genes	O
,	O
PA0946	B-Protein
,	O
PA3080	B-Protein
,	O
PA0260	B-Protein
and	O
PA2769	B-Protein
,	O
encode	O
proteins	O
of	O
unknown	O
function	O
.	O

In	O
order	O
to	O
compare	O
our	O
liquid	O
assay	O
with	O
the	O
established	O
C	B-Organism
.	I-Organism
elegans	I-Organism
slow	O
killing	O
assay	O
,	O
we	O
compared	O
the	O
lethality	O
of	O
the	O
TB	B-Organism
strain	O
with	O
the	O
previously	O
tested	O
PA14	B-Organism
strain	O
.	O

We	O
observed	O
that	O
both	O
strains	O
kill	O
worms	O
with	O
similar	O
efficiency	O
(	O
data	O
not	O
shown	O
)	O
.	O

Each	O
of	O
the	O
12	O
group	O
1A	O
mutants	O
derived	O
from	O
TB	B-Organism
was	O
further	O
tested	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

The	O
parental	O
TB	B-Organism
isolate	O
is	O
able	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
in	O
the	O
slow	O
killing	O
assay	O
within	O
3	O
days	O
.	O

Seven	O
of	O
the	O
twelve	O
group	O
1A	O
isolates	O
showed	O
significant	O
virulence	O
attenuation	O
(	O
Table	O
1	O
)	O
.	O

For	O
example	O
,	O
three	O
group	O
1A	O
mutants	O
TB0173s	B-Organism
(	O
cheB2	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB4554s	B-Organism
(	O
pilY1	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
TB4380s	B-Organism
(	O
colS	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
each	O
required	O
at	O
least	O
one	O
additional	O
day	O
(	O
4	O
days	O
)	O
in	O
order	O
to	O
reach	O
50	O
%	O
killing	O
(	O
data	O
not	O
shown	O
)	O
.	O

Survival	O
curves	O
are	O
considered	O
significantly	O
different	O
from	O
the	O
control	O
when	O
p	O
-	O
values	O
are	O
<	O
0	O
.	O
05	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Phenotypic	O
Analysis	O
of	O
Selected	O
TB	B-Organism
mutants	I-Organism

Several	O
of	O
the	O
clones	O
recovered	O
were	O
mutated	O
in	O
genes	O
putatively	O
associated	O
with	O
adherence	O
and	O
motility	O
,	O
such	O
as	O
cheB2	B-Protein
(	O
PA0173	B-Protein
)	O
,	O
motB	B-Protein
(	O
PA4953	B-Protein
)	O
and	O
pilY1	B-Protein
(	O
PA4554	B-Protein
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
adherence	O
is	O
an	O
essential	O
first	O
step	O
in	O
the	O
process	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
colonization	O
,	O
allowing	O
the	O
bacteria	O
to	O
persist	O
,	O
expand	O
in	O
numbers	O
and	O
develop	O
a	O
biofilm	O
or	O
establish	O
intimate	O
contact	O
with	O
host	O
cells	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

We	O
wished	O
to	O
determine	O
if	O
our	O
selected	O
mutants	O
showed	O
a	O
reduction	O
in	O
their	O
capacity	O
to	O
adhere	O
to	O
a	O
biological	O
surface	O
such	O
as	O
the	O
human	B-Organism
epithelial	O
cell	O
line	O
16HBE14o	O
-	O
.	O

In	O
addition	O
to	O
TB4953s	B-Organism
(	O
motB	B-Protein
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
TB0173s	B-Organism
(	O
cheB2	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
that	O
presented	O
strongly	O
reduced	O
adherence	O
,	O
five	O
other	O
clones	O
were	O
significantly	O
affected	O
in	O
their	O
adherence	O
to	O
cells	O
when	O
compared	O
to	O
the	O
parental	O
TB	B-Organism
isolate	O
(	O
Figure	O
S1	O
and	O
Table	O
1	O
)	O
.	O

These	O
mutants	O
were	O
TB2588s	B-Organism
(	O
araC	B-Protein
-	O
like	O
,	O
PA2588	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB4380s	B-Organism
(	O
colS	B-Protein
-	O
like	O
,	O
PA4380	B-Protein
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
TB3080s	B-Organism
(	O
hypothetical	O
,	O
PA3080	B-Protein
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
TB2769s	B-Organism
(	O
hypothetical	O
,	O
PA2769	B-Protein
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
TB5479s	B-Organism
(	O
gltP	B-Protein
-	O
like	O
,	O
PA5479	B-Protein
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Motility	O
is	O
also	O
an	O
important	O
factor	O
for	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
colonization	O
and	O
spread	O
.	O

We	O
evaluated	O
each	O
of	O
the	O
twelve	O
attenuated	O
mutants	O
for	O
both	O
swarming	O
and	O
swimming	O
motility	O
(	O
data	O
not	O
shown	O
,	O
Table	O
1	O
and	O
Figure	O
2	O
)	O
.	O

The	O
TB0173s	B-Organism
(	O
cheB2	B-Protein
)	O
(	O
Figure	O
2	O
and	O
Table	O
1	O
)	O
and	O
TB4953s	B-Organism
(	O
motB	B-Protein
)	O
(	O
Table	O
1	O
)	O
mutants	O
showed	O
a	O
reduction	O
in	O
swimming	O
and	O
swarming	O
motility	O
,	O
respectively	O
.	O

Furthermore	O
,	O
the	O
mutants	O
TB0260s	B-Organism
(	O
hypothetical	O
,	O
PA0260	B-Protein
)	O
and	O
TB5479s	B-Organism
(	O
gltP	B-Protein
-	O
like	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swimming	O
motility	O
(	O
Table	O
1	O
)	O
whereas	O
the	O
mutants	O
TB2588s	B-Organism
(	O
araC	B-Protein
-	O
like	O
)	O
and	O
TB3080s	B-Organism
(	O
hypothetical	O
)	O
had	O
a	O
significant	O
reduction	O
in	O
swarming	O
motility	O
(	O
Table	O
1	O
)	O
.	O

Characterization	O
of	O
the	O
cheB2	B-Protein
Mutant	O

We	O
chose	O
to	O
further	O
characterize	O
the	O
TB0173s	B-Organism
mutant	O
(	O
cheB2	B-Protein
)	O
,	O
as	O
this	O
isolate	O
was	O
affected	O
in	O
all	O
phenotypes	O
tested	O
and	O
thus	O
exhibited	O
a	O
general	O
motility	O
and	O
virulence	O
defect	O
(	O
Table	O
1	O
)	O
.	O

To	O
ensure	O
that	O
the	O
cheB2	B-Protein
gene	O
in	O
the	O
TB	B-Organism
strain	O
is	O
located	O
in	O
a	O
cluster	O
similar	O
to	O
the	O
che2	O
cluster	O
described	O
for	O
the	O
PAO1	B-Organism
or	O
PA14	B-Organism
strains	O
,	O
we	O
further	O
analyzed	O
the	O
corresponding	O
TB	B-Organism
chromosomal	O
region	O
.	O

A	O
series	O
of	O
8	O
PCR	O
reactions	O
were	O
performed	O
using	O
oligonucleotides	O
based	O
on	O
the	O
nucleotide	O
sequence	O
obtained	O
from	O
the	O
PA14	B-Organism
genome	O
sequence	O
(	O
Table	O
S1	O
)	O
.	O

The	O
8	O
PCR	O
products	O
were	O
meant	O
to	O
cover	O
the	O
totality	O
of	O
the	O
che2	O
cluster	O
(	O
Figure	O
1	O
and	O
Figure	O
S2	O
)	O
starting	O
from	O
the	O
mcpA	B-Protein
gene	O
to	O
the	O
PA0171	B-Organism
gene	O
located	O
downstream	O
cheB2	B-Protein
(	O
PA0173	B-Protein
)	O
.	O

The	O
reactions	O
were	O
performed	O
simultaneously	O
using	O
PA14	B-Organism
or	O
TB	B-Organism
genomic	O
DNA	O
as	O
matrix	O
.	O

Each	O
paired	O
reaction	O
set	O
(	O
TB	B-Organism
/	O
PA14	B-Organism
)	O
resulted	O
in	O
products	O
running	O
at	O
the	O
same	O
migratory	O
rate	O
within	O
the	O
1	O
.	O
5	O
%	O
agarose	O
gel	O
(	O
data	O
not	O
shown	O
)	O
.	O

These	O
results	O
show	O
that	O
there	O
is	O
little	O
difference	O
between	O
the	O
two	O
isolates	O
,	O
TB	B-Organism
and	O
PA14	B-Organism
,	O
with	O
regards	O
the	O
overall	O
organization	O
of	O
the	O
che2	O
chromosomal	O
region	O
.	O

To	O
validate	O
that	O
the	O
loss	O
of	O
virulence	O
and	O
other	O
phenotypic	O
changes	O
observed	O
with	O
the	O
TB	B-Organism
strain	O
were	O
a	O
result	O
of	O
the	O
transposon	O
disruption	O
of	O
the	O
cheB2	B-Protein
gene	O
,	O
we	O
generated	O
a	O
new	O
mutant	O
by	O
interrupting	O
the	O
cheB2	B-Protein
gene	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
3A	O
,	O
the	O
newly	O
engineered	O
cheB2	B-Protein
mutant	O
,	O
called	O
TB0173i	B-Organism
(	O
p	O
<	O
0	O
.	O
005	O
)	O
,	O
showed	O
a	O
delayed	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
comparable	O
to	O
the	O
original	O
STM	O
cheB2	B-Protein
mutant	O
TB0173s	O
(	O
p	O
<	O
0	O
.	O
004	O
)	O
.	O

Both	O
cheB2	B-Protein
mutants	O
,	O
TB0173s	B-Organism
and	O
TB0173i	B-Organism
,	O
required	O
at	O
least	O
one	O
additional	O
day	O
,	O
as	O
compared	O
to	O
TB	B-Organism
,	O
to	O
kill	O
50	O
%	O
of	O
exposed	O
nematodes	O
.	O

In	O
addition	O
,	O
we	O
engineered	O
a	O
similar	O
cheB2	B-Protein
mutation	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
PA14	I-Organism
strain	I-Organism
,	O
yielding	O
PA140173i	B-Organism
(	O
see	O
Materials	O
and	O
Methods	O
)	O
,	O
and	O
observed	O
similar	O
virulence	O
attenuation	O
on	O
C	B-Organism
.	I-Organism
elegans	I-Organism
(	O
Figure	O
S3	O
)	O
.	O

This	O
further	O
confirmed	O
the	O
virulence	O
phenotype	O
of	O
a	O
cheB2	B-Protein
mutant	O
and	O
indicated	O
that	O
it	O
is	O
not	O
a	O
TB	B-Organism
strain	O
-	O
specific	O
trait	O
.	O

Finally	O
,	O
a	O
complementation	O
assay	O
was	O
performed	O
.	O

We	O
reintroduced	O
,	O
in	O
the	O
cheB2	B-Protein
mutant	O
,	O
the	O
wild	O
-	O
type	O
cheB2	B-Protein
gene	O
using	O
an	O
integration	O
-	O
proficient	O
vector	O
,	O
mini	O
-	O
CTX1	O
[	O
47	O
]	O
.	O

This	O
vector	O
contains	O
the	O
phiCTX	O
attachment	O
site	O
allowing	O
integration	O
of	O
exogenous	O
DNA	O
fragments	O
at	O
the	O
attB	O
site	O
within	O
the	O
genome	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

The	O
cheB2	B-Protein
gene	O
was	O
cloned	O
into	O
the	O
mini	O
-	O
CTX1	O
,	O
yielding	O
CTXp2B2	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

This	O
construct	O
was	O
introduced	O
into	O
the	O
cheB2	B-Protein
mutant	O
,	O
TB0173s	B-Organism
,	O
generating	O
the	O
TB0173sp2B2	B-Organism
strain	O
.	O

The	O
empty	O
vector	O
,	O
mini	O
-	O
CTX1	O
,	O
was	O
also	O
introduced	O
into	O
the	O
TB0173s	O
cheB2	B-Protein
mutant	O
,	O
generating	O
TB0173sCTX	B-Organism
.	O

As	O
shown	O
in	O
Figure	O
3B	O
the	O
virulence	O
was	O
restored	O
in	O
the	O
complemented	O
cheB2	B-Protein
mutant	O
TB0173sp2B2	O
(	O
p	O
<	O
0	O
.	O
009	O
)	O
,	O
whereas	O
the	O
cheB2	B-Protein
mutant	O
strain	O
TB0173sCTX	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
remained	O
fully	O
attenuated	O
.	O

A	O
cheB1	B-Protein
Mutant	O
Is	O
not	O
Attenuated	O
for	O
C	B-Organism
.	I-Organism
elegans	I-Organism
Virulence	O

Several	O
chemotactic	O
gene	O
clusters	O
have	O
been	O
identified	O
in	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
genome	O
[	O
21	O
]	O
,	O
[	O
23	O
]	O
.	O

The	O
che1	O
gene	O
cluster	O
encodes	O
the	O
principle	O
chemotactic	O
device	O
controlling	O
flagellar	O
mobility	O
[	O
23	O
]	O
.	O

We	O
investigated	O
whether	O
the	O
loss	O
of	O
virulence	O
observed	O
in	O
the	O
cheB2	B-Protein
mutant	O
on	O
C	B-Organism
.	I-Organism
elegans	I-Organism
is	O
specific	O
,	O
and	O
results	O
from	O
a	O
loss	O
of	O
chemotaxis	O
under	O
the	O
direction	O
of	O
the	O
che2	O
chemotactic	O
cluster	O
,	O
rather	O
than	O
being	O
linked	O
with	O
more	O
global	O
chemotactic	O
or	O
motility	O
deficiency	O
.	O

We	O
thus	O
investigated	O
the	O
fate	O
of	O
a	O
cheB1	B-Protein
mutant	O
in	O
a	O
similar	O
assay	O
.	O

The	O
cheB1	B-Protein
mutation	O
was	O
engineered	O
in	O
the	O
TB	B-Organism
strain	O
as	O
described	O
in	O
materials	O
and	O
methods	O
,	O
yielding	O
TB1459i	B-Organism
.	O

The	O
cheB1	B-Protein
mutant	O
was	O
used	O
to	O
feed	O
C	B-Organism
.	I-Organism
elegans	I-Organism
in	O
the	O
slow	O
killing	O
assay	O
and	O
the	O
survival	O
percentage	O
was	O
compared	O
to	O
those	O
obtained	O
when	O
using	O
the	O
cheB2	B-Protein
mutant	O
or	O
the	O
parental	O
TB	B-Organism
strain	O
(	O
Figure	O
3C	O
)	O
.	O

Interestingly	O
,	O
the	O
cheB1	B-Protein
mutant	O
showed	O
no	O
significant	O
reduction	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
when	O
compared	O
to	O
the	O
parental	O
TB	B-Organism
strain	O
,	O
with	O
only	O
36	O
%	O
of	O
the	O
worms	O
alive	O
after	O
4	O
days	O
post	O
infection	O
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
loss	O
of	O
virulence	O
in	O
the	O
original	O
cheB2	B-Protein
mutant	O
(	O
TB0173s	B-Organism
)	O
and	O
the	O
insertional	O
cheB2	B-Protein
mutant	O
TB0173i	O
.	O

The	O
mobility	O
of	O
the	O
cheB1	B-Protein
mutant	O
was	O
also	O
analyzed	O
and	O
both	O
swimming	O
and	O
swarming	O
motility	O
appeared	O
to	O
be	O
affected	O
as	O
shown	O
in	O
Figure	O
2	O
.	O

The	O
swimming	O
or	O
swarming	O
motility	O
defect	O
is	O
,	O
however	O
,	O
much	O
more	O
severe	O
in	O
the	O
cheB1	B-Protein
mutant	O
as	O
compared	O
to	O
the	O
cheB2	B-Protein
mutant	O
.	O

Finally	O
,	O
we	O
used	O
a	O
chemotactic	O
assay	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

The	O
parental	O
TB	B-Organism
strain	O
was	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
(	O
an	O
increase	O
of	O
slightly	O
more	O
than	O
half	O
a	O
log	O
of	O
bacteria	O
over	O
45	O
min	O
)	O
and	O
the	O
TB0173s	B-Organism
strain	O
(	O
cheB2	B-Protein
mutant	O
)	O
was	O
also	O
capable	O
of	O
chemotaxis	O
,	O
even	O
though	O
much	O
reduced	O
as	O
compared	O
to	O
TB	B-Organism
(	O
Figure	O
S4	O
)	O
.	O

However	O
,	O
the	O
TB1459i	B-Organism
strain	O
(	O
cheB1	B-Protein
mutant	O
)	O
was	O
no	O
longer	O
able	O
to	O
move	O
towards	O
the	O
attractant	O
,	O
and	O
thus	O
showed	O
a	O
defect	O
in	O
this	O
chemotaxis	O
assay	O
(	O
Figure	O
S4	O
)	O
.	O

The	O
cheB2	B-Protein
Mutant	O
Shows	O
Reduced	O
Virulence	O
in	O
Mice	B-Organism

We	O
further	O
tested	O
the	O
virulence	O
of	O
the	O
cheB2	B-Protein
mutant	O
TB0173s	O
in	O
a	O
mouse	B-Organism
model	O
of	O
lung	O
infection	O
,	O
utilizing	O
the	O
view	O
-	O
controlled	O
intratracheal	O
infection	O
protocol	O
[	O
48	O
]	O
.	O

Ten	O
female	O
C3H	B-Organism
/	I-Organism
HeN	I-Organism
mice	I-Organism
each	O
were	O
inoculated	O
with	O
7	O
.	O
5x106	O
CFU	O
equivalent	O
to	O
the	O
LD50	O
dose	O
of	O
the	O
wild	O
type	O
strain	O
determined	O
in	O
prior	O
experiments	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
4	O
displays	O
the	O
representative	O
outcome	O
of	O
one	O
of	O
three	O
independent	O
infection	O
experiments	O
.	O

The	O
cheB2	B-Protein
mutant	O
(	O
TB0173s	B-Organism
)	O
showed	O
a	O
significantly	O
attenuated	O
virulence	O
during	O
respiratory	O
tract	O
infection	O
of	O
mice	B-Organism
as	O
compared	O
to	O
the	O
parental	O
strain	O
TB	B-Organism
and	O
the	O
complemented	O
strain	O
TB0173sp2B2	B-Organism
.	O

Infection	O
with	O
the	O
wild	O
type	O
resulted	O
in	O
50	O
%	O
dead	O
animals	O
(	O
5	O
of	O
10	O
)	O
by	O
day	O
5	O
compared	O
to	O
10	O
%	O
deaths	O
for	O
the	O
TB0173s	O
cheB2	B-Protein
mutant	O
(	O
1	O
of	O
10	O
;	O
P	O
=	O
0	O
.	O
036	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
.	O

Infection	O
with	O
the	O
complemented	O
strain	O
TB0173sp2B2	B-Organism
resulted	O
in	O
60	O
%	O
dead	O
by	O
day	O
3	O
(	O
6	O
of	O
10	O
;	O
P	O
=	O
0	O
,	O
0018	O
,	O
Fisher	O
'	O
s	O
exact	O
test	O
)	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
have	O
also	O
evaluated	O
the	O
body	O
condition	O
of	O
the	O
mice	B-Organism
during	O
bacterial	O
infection	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Surviving	O
mice	B-Organism
infected	O
with	O
the	O
cheB2	B-Protein
mutant	O
showed	O
a	O
significantly	O
less	O
troubled	O
body	O
condition	O
from	O
days	O
3	O
to	O
6	O
post	O
infection	O
(	O
P	O
<	O
0	O
.	O
01	O
,	O
Mann	O
-	O
Whitney	O
rank	O
test	O
)	O
than	O
surviving	O
mice	B-Organism
infected	O
with	O
the	O
wild	O
type	O
strain	O
indicating	O
that	O
the	O
former	O
group	O
recovered	O
earlier	O
than	O
the	O
latter	O
(	O
Figure	O
4B	O
)	O
.	O

Pathohistological	O
Analysis	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
Infection	O

To	O
further	O
evaluate	O
the	O
change	O
in	O
virulence	O
between	O
the	O
parental	O
TB	B-Organism
isolate	O
and	O
the	O
TB0173s	O
cheB2	B-Protein
mutant	O
,	O
mice	B-Organism
were	O
sacrificed	O
2	O
days	O
after	O
bacterial	O
challenge	O
and	O
the	O
lungs	O
were	O
formalin	O
fixed	O
and	O
paraffin	O
embedded	O
.	O

Lungs	O
from	O
infected	O
mice	B-Organism
challenged	O
with	O
the	O
TB	B-Organism
strain	O
as	O
well	O
as	O
the	O
complemented	O
TB0173sp2B2	B-Organism
strain	O
had	O
a	O
pronounced	O
polymorphonuclear	O
neutrophil	O
(	O
PMN	O
)	O
infiltration	O
as	O
well	O
as	O
strong	O
peribronchiolar	O
and	O
perivascular	O
inflammation	O
(	O
Figure	O
5A	O
)	O
.	O

In	O
contrast	O
,	O
the	O
TB0173s	O
cheB2	B-Protein
mutant	O
had	O
caused	O
markedly	O
reduced	O
inflammation	O
and	O
very	O
little	O
PMN	O
infiltration	O
(	O
Figure	O
5B	O
)	O
.	O

Discussion	O

C	B-Organism
.	I-Organism
elegans	I-Organism
is	O
a	O
convenient	O
model	O
for	O
studying	O
bacterial	O
virulence	O
mechanisms	O
[	O
7	O
]	O
,	O
[	O
49	O
]	O
and	O
it	O
was	O
shown	O
that	O
virulence	O
factors	O
important	O
in	O
the	O
killing	O
of	O
C	B-Organism
.	I-Organism
elegans	I-Organism
are	O
relevant	O
for	O
virulence	O
in	O
mammalian	O
hosts	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

Growth	O
conditions	O
and	O
host	O
-	O
pathogen	O
interactions	O
affect	O
the	O
physiology	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
via	O
complex	O
regulatory	O
networks	O
,	O
which	O
in	O
turn	O
control	O
an	O
arsenal	O
of	O
virulence	O
factors	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

We	O
developed	O
a	O
liquid	O
-	O
based	O
high	O
throughput	O
C	B-Organism
.	I-Organism
elegans	I-Organism
killing	O
assay	O
to	O
speed	O
the	O
screening	O
process	O
of	O
bacterial	O
libraries	O
and	O
to	O
perform	O
multiple	O
screens	O
on	O
virulent	O
clinical	O
isolates	O
.	O

This	O
method	O
was	O
automated	O
using	O
the	O
COPAS	O
Biosort	O
worm	O
sorting	O
system	O
,	O
which	O
greatly	O
reduced	O
the	O
time	O
required	O
to	O
perform	O
the	O
assay	O
.	O

Under	O
slow	O
killing	O
conditions	O
(	O
Figure	O
3	O
)	O
the	O
TB	B-Organism
strain	O
requires	O
approximately	O
three	O
days	O
to	O
kill	O
50	O
%	O
of	O
a	O
given	O
worm	O
population	O
,	O
and	O
up	O
to	O
8	O
days	O
to	O
kill	O
all	O
the	O
worms	O
in	O
a	O
population	O
of	O
50	O
nematodes	O
.	O

The	O
liquid	O
killing	O
assay	O
by	O
contrast	O
,	O
is	O
read	O
after	O
overnight	O
feeding	O
of	O
the	O
nematodes	O
with	O
the	O
bacterial	O
strains	O
.	O

It	O
is	O
worth	O
noting	O
that	O
a	O
mutant	O
affected	O
in	O
the	O
gacA	B-Protein
gene	O
,	O
previously	O
identified	O
in	O
the	O
slow	O
killing	O
assay	O
,	O
appeared	O
to	O
be	O
attenuated	O
in	O
our	O
liquid	O
-	O
based	O
killing	O
assay	O
.	O

We	O
used	O
our	O
killing	O
assay	O
to	O
screen	O
a	O
STM	O
library	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
CF	I-Organism
isolate	I-Organism
TB	I-Organism
[	O
20	O
]	O
.	O

We	O
identified	O
several	O
factors	O
,	O
not	O
yet	O
associated	O
with	O
virulence	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

Several	O
of	O
the	O
genes	O
identified	O
relate	O
to	O
regulatory	O
,	O
motility	O
or	O
unknown	O
functions	O
.	O

We	O
tested	O
additional	O
virulence	O
and	O
motility	O
related	O
phenotypes	O
including	O
C	B-Organism
.	I-Organism
elegans	I-Organism
slow	O
killing	O
,	O
swarming	O
and	O
swimming	O
motility	O
,	O
or	O
adherence	O
to	O
human	B-Organism
cells	O
(	O
Table	O
1	O
)	O
.	O

Most	O
of	O
our	O
selected	O
mutants	O
were	O
impaired	O
in	O
at	O
least	O
one	O
of	O
the	O
additional	O
tested	O
phenotypes	O
.	O

One	O
of	O
the	O
identified	O
mutants	O
showed	O
reductions	O
in	O
all	O
aspects	O
of	O
virulence	O
we	O
tested	O
.	O

This	O
mutant	O
,	O
named	O
TB0173s	B-Organism
,	O
has	O
a	O
transposon	O
insertion	O
in	O
PA0173	B-Protein
,	O
cheB2	B-Protein
,	O
one	O
of	O
four	O
cheB	O
genes	O
found	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
.	O

CheB	O
protein	O
functions	O
involve	O
interactions	O
with	O
MCPs	O
.	O

As	O
many	O
as	O
26	O
MCPs	O
have	O
been	O
identified	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
[	O
56	O
]	O
,	O
and	O
it	O
has	O
been	O
proposed	O
that	O
the	O
CheB2	B-Protein
protein	O
functions	O
at	O
least	O
with	O
McpB	B-Protein
[	O
57	O
]	O
.	O

In	O
the	O
high	O
throughput	O
C	B-Organism
.	I-Organism
elegans	I-Organism
liquid	O
-	O
based	O
killing	O
assay	O
and	O
the	O
slow	O
killing	O
assay	O
,	O
the	O
cheB2	B-Protein
mutant	O
showed	O
significant	O
virulence	O
attenuation	O
.	O

The	O
cheB2	B-Protein
mutant	O
was	O
also	O
found	O
to	O
have	O
reduced	O
adhesive	O
capabilities	O
to	O
bronchial	O
epithelial	O
cells	O
(	O
Figure	O
S1	O
)	O
.	O

Finally	O
,	O
the	O
reductions	O
seen	O
in	O
the	O
motility	O
assays	O
,	O
swimming	O
and	O
swarming	O
,	O
are	O
in	O
agreement	O
with	O
previously	O
reported	O
results	O
revealing	O
a	O
partial	O
loss	O
of	O
motility	O
capabilities	O
[	O
21	O
]	O
.	O

Most	O
importantly	O
in	O
a	O
mouse	B-Organism
lung	O
model	O
of	O
infection	O
,	O
the	O
cheB2	B-Protein
mutant	O
was	O
highly	O
attenuated	O
and	O
failed	O
to	O
induce	O
strong	O
inflammatory	O
response	O
in	O
the	O
infected	O
mice	B-Organism
lungs	O
.	O

Interestingly	O
,	O
we	O
observed	O
that	O
a	O
mutation	O
in	O
the	O
cheB1	B-Protein
gene	O
yields	O
different	O
phenotypes	O
compared	O
to	O
the	O
cheB2	B-Protein
mutation	O
.	O

The	O
cheB1	B-Protein
mutant	O
virulence	O
is	O
not	O
attenuated	O
in	O
the	O
slow	O
killing	O
assay	O
.	O

Moreover	O
,	O
it	O
shows	O
more	O
severe	O
motility	O
defect	O
than	O
the	O
cheB2	B-Protein
mutant	O
.	O

Finally	O
,	O
in	O
chemotaxis	O
assays	O
using	O
tryptone	O
as	O
chemo	O
-	O
attractant	O
,	O
we	O
observed	O
that	O
,	O
while	O
the	O
cheB1	B-Protein
mutant	O
was	O
strongly	O
affected	O
,	O
the	O
cheB2	B-Protein
mutant	O
had	O
a	O
mild	O
phenotype	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
attenuation	O
in	O
virulence	O
of	O
the	O
cheB2	B-Protein
mutant	O
is	O
specific	O
and	O
not	O
due	O
to	O
a	O
global	O
effect	O
on	O
motility	O
or	O
chemotaxis	O
.	O

As	O
cluster	O
I	O
of	O
che	O
genes	O
plays	O
the	O
dominant	O
role	O
in	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
chemotaxis	O
and	O
flagellar	O
mobility	O
,	O
cluster	O
II	O
genes	O
may	O
be	O
induced	O
under	O
very	O
specific	O
conditions	O
and	O
function	O
in	O
fine	O
-	O
tuning	O
the	O
bacterial	O
response	O
to	O
conditions	O
encountered	O
within	O
a	O
host	O
.	O

Schuster	O
and	O
collaborators	O
have	O
reported	O
that	O
the	O
cluster	O
II	O
genes	O
are	O
induced	O
during	O
stationary	O
phase	O
,	O
are	O
regulated	O
by	O
quorum	O
sensing	O
and	O
that	O
RpoS	B-Protein
,	O
the	O
stationary	O
phase	O
RNA	O
polymerase	O
sigma	O
factor	O
,	O
plays	O
a	O
role	O
in	O
controlling	O
cheB2	B-Protein
gene	O
expression	O
[	O
58	O
]	O
.	O

Moreover	O
,	O
Burrowes	O
and	O
collaborators	O
reported	O
that	O
RsmA	B-Protein
exerted	O
control	O
over	O
cheB2	B-Protein
with	O
a	O
10	O
-	O
fold	O
reduction	O
in	O
expression	O
of	O
cheB2	B-Protein
in	O
an	O
rsmA	B-Protein
mutant	O
[	O
59	O
]	O
.	O

RsmA	B-Protein
works	O
in	O
conjunction	O
with	O
small	O
non	O
-	O
coding	O
RNA	O
to	O
regulate	O
the	O
expression	O
of	O
multiple	O
virulence	O
genes	O
,	O
including	O
the	O
quorum	O
sensing	O
lasI	B-Protein
and	O
rhlI	B-Protein
genes	O
[	O
60	O
]	O
.	O

Finally	O
,	O
using	O
fluorescent	O
protein	O
-	O
tagged	O
CheY	B-Protein
and	O
CheA	B-Protein
,	O
it	O
was	O
shown	O
that	O
the	O
Che1	O
proteins	O
(	O
cluster	O
I	O
)	O
localized	O
to	O
the	O
flagellated	O
pole	O
throughout	O
growth	O
[	O
61	O
]	O
.	O

While	O
the	O
Che1	O
proteins	O
are	O
still	O
found	O
as	O
bacterial	O
cells	O
entered	O
stationary	O
phase	O
,	O
a	O
patch	O
of	O
Che2	O
proteins	O
begins	O
to	O
co	O
-	O
localize	O
with	O
the	O
Che1	O
proteins	O
at	O
that	O
stage	O
.	O

This	O
might	O
indicate	O
that	O
during	O
stationary	O
phase	O
,	O
the	O
chemotactic	O
response	O
will	O
be	O
different	O
than	O
the	O
one	O
observed	O
with	O
exponentially	O
growing	O
cells	O
and	O
the	O
function	O
of	O
the	O
Che2	O
cluster	O
,	O
even	O
though	O
currently	O
unknown	O
,	O
might	O
be	O
to	O
respond	O
to	O
particular	O
stimuli	O
encountered	O
at	O
that	O
stage	O
.	O

It	O
has	O
been	O
shown	O
that	O
a	O
cheW	B-Protein
mutant	O
in	O
Helicobacter	B-Organism
pylori	I-Organism
is	O
unable	O
to	O
establish	O
a	O
normal	O
long	O
-	O
term	O
infection	O
in	O
mice	B-Organism
,	O
remaining	O
only	O
in	O
one	O
portion	O
of	O
the	O
stomach	O
.	O

The	O
bacterial	O
pathogen	O
may	O
lose	O
its	O
ability	O
to	O
perceive	O
its	O
niche	O
due	O
to	O
the	O
absence	O
of	O
chemotaxis	O
[	O
62	O
]	O
.	O

It	O
is	O
a	O
possibility	O
that	O
within	O
a	O
host	O
,	O
the	O
cluster	O
II	O
che	O
genes	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
might	O
play	O
a	O
similar	O
role	O
in	O
sensing	O
particular	O
conditions	O
during	O
infection	O
.	O

As	O
previously	O
mentioned	O
,	O
even	O
though	O
the	O
cheB2	B-Protein
mutant	O
is	O
impaired	O
in	O
motility	O
,	O
it	O
is	O
likely	O
that	O
the	O
cheB2	B-Protein
defect	O
in	O
virulence	O
is	O
not	O
linked	O
to	O
this	O
phenotype	O
but	O
to	O
additional	O
traits	O
of	O
virulence	O
and	O
attachment	O
that	O
have	O
not	O
yet	O
been	O
determined	O
.	O

We	O
have	O
shown	O
that	O
the	O
cheB1	B-Protein
mutant	O
is	O
affected	O
in	O
motility	O
but	O
still	O
is	O
virulent	O
.	O

Furthermore	O
,	O
in	O
our	O
study	O
,	O
we	O
isolated	O
a	O
second	O
mutant	O
with	O
reduced	O
motility	O
TB4953s	B-Organism
(	O
motB	B-Protein
mutant	O
)	O
(	O
Table	O
1	O
)	O
,	O
and	O
while	O
this	O
isolate	O
was	O
attenuated	O
in	O
the	O
high	O
throughput	O
assay	O
,	O
it	O
did	O
not	O
show	O
a	O
reduction	O
in	O
killing	O
in	O
the	O
slow	O
assay	O
(	O
data	O
not	O
shown	O
)	O
,	O
further	O
suggesting	O
that	O
the	O
loss	O
of	O
virulence	O
seen	O
in	O
the	O
cheB2	B-Protein
mutant	O
strain	O
(	O
TB0173s	B-Organism
)	O
is	O
not	O
solely	O
due	O
to	O
a	O
reduction	O
or	O
change	O
in	O
motility	O
.	O

While	O
some	O
bacteria	O
require	O
host	O
-	O
derived	O
factors	O
for	O
their	O
growth	O
and	O
are	O
difficult	O
to	O
grow	O
in	O
vitro	O
,	O
others	O
,	O
such	O
as	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
during	O
its	O
infection	O
of	O
C	B-Organism
.	I-Organism
elegans	I-Organism
[	O
33	O
]	O
,	O
grow	O
at	O
a	O
much	O
lower	O
rate	O
in	O
the	O
host	O
compared	O
to	O
in	O
vitro	O
.	O

Our	O
observations	O
support	O
the	O
hypothesis	O
that	O
the	O
che2	O
gene	O
cluster	O
plays	O
a	O
major	O
role	O
during	O
host	O
colonization	O
.	O

For	O
example	O
,	O
we	O
may	O
hypothesize	O
that	O
within	O
the	O
gut	O
of	O
the	O
nematode	O
,	O
or	O
the	O
lungs	O
of	O
the	O
mice	B-Organism
,	O
bacteria	O
might	O
reach	O
high	O
cell	O
density	O
and	O
develop	O
as	O
biofilm	O
.	O

This	O
could	O
be	O
a	O
condition	O
to	O
set	O
the	O
function	O
of	O
the	O
Che2	O
proteins	O
and	O
allow	O
non	O
-	O
growing	O
cells	O
to	O
sense	O
and	O
respond	O
to	O
the	O
environment	O
in	O
a	O
different	O
manner	O
as	O
compared	O
to	O
fast	O
-	O
growing	O
cells	O
.	O

While	O
the	O
idea	O
that	O
the	O
Che2	O
system	O
might	O
be	O
a	O
specialized	O
chemotaxis	O
system	O
required	O
during	O
host	O
infection	O
is	O
appealing	O
,	O
further	O
experiments	O
are	O
required	O
to	O
understand	O
the	O
chain	O
of	O
command	O
,	O
which	O
switches	O
on	O
the	O
Che2	O
system	O
and	O
directs	O
the	O
physiological	O
response	O
of	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
to	O
Che2	O
sensing	O
.	O

